0001144204-15-064712.txt : 20151112 0001144204-15-064712.hdr.sgml : 20151112 20151112161529 ACCESSION NUMBER: 0001144204-15-064712 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151112 DATE AS OF CHANGE: 20151112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN SHARED HOSPITAL SERVICES CENTRAL INDEX KEY: 0000744825 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 942918118 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08789 FILM NUMBER: 151224994 BUSINESS ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 BUSINESS PHONE: 415-788-5300 MAIL ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 10-Q 1 v423254_10q.htm FORM 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 10-Q

 

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2015 or

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________.

 

Commission file number 1-08789

 

 

 

American Shared Hospital Services

(Exact name of registrant as specified in its charter)

 

California 94-2918118
(State or other jurisdiction of (IRS Employer
Incorporation or organization) Identification No.)

 

Four Embarcadero Center, Suite 3700, San Francisco, California 94111
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (415) 788-5300

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x  No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer ¨ Accelerated Filer ¨ Non-Accelerated Filer ¨ Smaller reporting company x

 

As of November 1, 2015, there are outstanding 5,364,147 shares of the Registrant’s common stock.

 

   

 

 

PART I - FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   (unaudited)     
ASSETS  September 30, 2015   December 31, 2014 
           
Current assets:          
Cash and cash equivalents  $2,184,000   $1,059,000 
Restricted cash   50,000    50,000 
Certificate of deposit   -    9,000,000 
Accounts receivable, net of allowance for doubtful accounts of $100,000 at September 30, 2015 and $100,000 at December 31, 2014   3,451,000    3,192,000 
Other receivables   131,000    131,000 
Prepaid expenses and other current assets   405,000    448,000 
Current deferred tax assets   367,000    367,000 
           
Total current assets   6,588,000    14,247,000 
           
Property and equipment:          
Medical equipment and facilities   83,120,000    82,151,000 
Office equipment   721,000    721,000 
Deposits and construction in progress   10,544,000    13,736,000 
    94,385,000    96,608,000 
Accumulated depreciation and amortization   (46,136,000)   (46,572,000)
Net property and equipment   48,249,000    50,036,000 
           
Investment in equity securities   605,000    2,709,000 
Other assets   444,000    536,000 
           
Total assets  $55,886,000   $67,528,000 

 

LIABILITIES AND  (unaudited)     
SHAREHOLDERS' EQUITY  September 30, 2015   December 31, 2014 
         
Current liabilities:          
Accounts payable  $454,000   $421,000 
Employee compensation and benefits   156,000    179,000 
Other accrued liabilities   1,370,000    763,000 
           
Current portion of long-term debt   2,781,000    2,005,000 
Current portion of obligations under capital leases   4,254,000    4,103,000 
Advances on line of credit   -    8,780,000 
           
Total current liabilities   9,015,000    16,251,000 
           
Long-term debt, less current portion   7,465,000    8,586,000 
Long-term capital leases, less current portion   10,310,000    12,190,000 
Deferred revenue, less current portion   749,000    874,000 
           
Deferred income taxes   3,581,000    3,473,000 
           
Shareholders' equity:          
Common stock (5,364,000 shares at September 30, 2015 and 5,361,000 shares at December 31, 2014)   10,376,000    10,376,000 
Additional paid-in capital   5,660,000    5,508,000 
Retained earnings   3,743,000    5,542,000 
Total equity-American Shared Hospital Services   19,779,000    21,426,000 
Non-controlling interest in subsidiary   4,987,000    4,728,000 
Total shareholders' equity   24,766,000    26,154,000 
           
Total liabilities and shareholders' equity  $55,886,000   $67,528,000 

 

See accompanying notes

 

 2 

 

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three months ended September 30,   Nine months ended September 30, 
   2015   2014   2015   2014 
                 
Medical services revenue  $3,875,000   $3,982,000   $12,386,000   $11,425,000 
                     
Costs of revenue:                    
                     
Maintenance and supplies   252,000    382,000    866,000    1,320,000 
                     
Depreciation and amortization   1,521,000    1,478,000    4,619,000    4,695,000 
                     
Other direct operating costs   648,000    519,000    2,048,000    1,673,000 
                     
    2,421,000    2,379,000    7,533,000    7,688,000 
                     
Gross Margin   1,454,000    1,603,000    4,853,000    3,737,000 
                     
                     
Selling and administrative expense   904,000    933,000    2,704,000    2,792,000 
                     
Interest expense   235,000    396,000    900,000    1,376,000 
                     
Operating income (loss)   315,000    274,000    1,249,000    (431,000)
                     
(Loss) on write down investment in equity securities   -    -    (2,114,000)   - 
(Loss) on sale of subsidiary   -    -    -    (572,000)
Gain on foreign currency transactions   -    -    -    161,000 
Interest and other income   3,000    7,000    14,000    22,000 
                     
Income (loss) before income taxes   318,000    281,000    (851,000)   (820,000)
                     
Income tax expense   92,000    29,000    328,000    33,000 
                     
Net income (loss)   226,000    252,000    (1,179,000)   (853,000)
                     
Less: Net (income) attributable to non-controlling interests   (183,000)   (239,000)   (620,000)   (157,000)
                     
Net income (loss) attributable to American Shared Hospital Services  $43,000   $13,000   $(1,799,000)  $(1,010,000)
                     
Net income (loss) per share:                    
                     
Income (loss) per common share - basic  $0.01   $0.00   $(0.33)  $(0.21)
                     
Income (loss) per common share - assuming dilution  $0.01   $0.00   $(0.33)  $(0.21)

 

See accompanying notes

 

 3 

 

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

 

   Three months ended September 30,   Nine months ended September 30, 
   2015   2014   2015   2014 
                 
Net income (loss) attributable to American Shared Hospital Services  $43,000   $13,000   $(1,799,000)  $(1,010,000)
                     
Other comprehensive income:                    
Foreign currency translation adjustments   -    -    -    779,000 
                     
Total comprehensive income (loss)   43,000    13,000    (1,799,000)   (231,000)
Less comprehensive (loss) attributable to the non-controlling interest   -    -    -    (337,000)
                     
Comprehensive income (loss) attributable to American Shared Hospital Services  $43,000   $13,000   $(1,799,000)  $106,000 

 

See accompanying notes

 

 4 

 

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

 

   PERIODS ENDED DECEMBER 31, 2014 AND SEPTEMBER 30, 2015 
               Accumulated                 
           Additional   Other           Non-controlling     
   Common   Common   Paid-in   Comprehensive   Retained   Sub-Total   Interests in     
   Shares   Stock   Capital   Income (Loss)   Earnings   ASHS   Subsidiaries   Total 
                                 
Balances at January 1, 2014   4,609,000    8,578,000    4,990,000    (442,000)   6,494,000    19,620,000    4,435,000    24,055,000 
                                         
Repurchase common stock   (1,000)   (2,000)   -    -    -    (2,000)   -    (2,000)
                                         
Stock based compensation expense   3,000    -    373,000    -    -    373,000    -    373,000 
                                         
Private placement common stock   750,000    1,800,000    -    -    -    1,800,000    -    1,800,000 
                                         
Fair value of warrants issued with promissory notes   -    -    145,000    -    -    145,000    -    145,000 
                                         
Non-controlling interest investment in subsidiaries   -    -    -    -    -    -    517,000    517,000 
                                         
Cash distributions to non-controlling interests   -    -    -    -    -    -    (951,000)   (951,000)
                                         
Cumulative translation adjustment   -    -    -    442,000    -    442,000    337,000    779,000 
                                         
Net (loss) income   -    -    -    -    (952,000)   (952,000)   390,000    (562,000)
                                         
Balances at December 31, 2014   5,361,000    10,376,000    5,508,000    -    5,542,000    21,426,000    4,728,000    26,154,000 
                                         
Stock based compensation expense   3,000    -    152,000    -    -    152,000    -    152,000 
                                         
Non-controlling interest investment in subsidiaries   -    -    -    -    -    -    27,000    27,000 
                                         
Cash distributions to non-controlling interests   -    -    -    -    -    -    (388,000)   (388,000)
                                         
Net (loss) income   -    -    -    -    (1,799,000)   (1,799,000)   620,000    (1,179,000)
                                         
Balances at September 30, 2015   5,364,000    10,376,000    5,660,000    -    3,743,000    19,779,000    4,987,000    24,766,000 

 

See accompanying notes

 

 5 

 

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Nine Months ended September 30, 
   2015   2014 
Operating activities:          
Net (loss)  $(1,179,000)  $(853,000)
           
Adjustments to reconcile net (loss) to net cash from operating activities:          
           
Depreciation and amortization   4,659,000    4,808,000 
           
Loss on write down of investment in equity securities   2,114,000    - 
           
Loss on sale of subsidiary   -    572,000 
           
Deferred income tax   108,000    33,000 
           
(Gain) on foreign currency transactions   -    (161,000)
           
Stock based compensation expense   152,000    53,000 
           
(Gain) on sale of assets   -    (1,000)
           
Other non-cash items   (43,000)   - 
           
Changes in operating assets and liabilities:          
           
Receivables   (259,000)   431,000 
           
Prepaid expenses and other assets   113,000    141,000 
           
Customer deposits/deferred revenue   (43,000)   (37,000)
           
Accounts payable and accrued liabilities   535,000    (573,000)
           
Net cash from operating activities   6,157,000    4,413,000 
           
Investing activities:          
Payment for purchase of property and equipment   (1,517,000)   (338,000)
           
Investment in equity securities   (10,000)   (4,000)
           
Proceeds from sale of subsidiary   -    768,000 
           
Net cash (used in) from investing activities   (1,527,000)   426,000 
           
Financing activities:          
Principal payments on long-term debt   (1,417,000)   (2,457,000)
           
Principal payments on capital leases   (2,983,000)   (3,240,000)
           
Proceeds from long-term debt financing of property and equipment   1,036,000    - 
           
Proceeds from certificate of deposit   9,000,000    - 
           
Advances on line of credit   -    640,000 
           
Payments on line of credit   (8,780,000)   (1,200,000)
           
Non-controlling interest investment in subsidiaries   27,000    102,000 
           
Cash distributions to non-controlling interests   (388,000)   (748,000)
           
Common stock repurchased   -    (2,000)
           
Private placement common stock   -    1,580,000 
           
Net cash (used in) from financing activities   (3,505,000)   (5,325,000)
           
Effect of changes in foreign exchange rates on cash   -    (8,000)
           
Net change in cash and cash equivalents   1,125,000    (494,000)
           
Cash and cash equivalents at beginning of period   1,059,000    1,909,000 
           
Cash and cash equivalents at end of period  $2,184,000   $1,415,000 
           
Supplemental cash flow disclosure:          
Cash paid during the period for:          
           
Interest  $1,251,000   $1,604,000 
           
Income taxes  $1,000   $60,000 
           
Schedule of non-cash investing and financing activities          
Acquisition of equipment with capital lease financing  $1,343,000   $2,732,000 
           
Equipment relieved in sale of subsidiary  $-   $(4,921,000)
Other assets relieved in sale of subsidiary  $-   $(826,000)
Debt relieved in sale of subsidiary  $-   $5,181,000 
Other liabilities relieved in sale of subsidiary  $-   $14,000 
Net equity relieved in sale of subsidiary  $-   $1,351,000 
OCI released to net income in sale of subsidiary  $-   $(779,000)
Investment released to net income in sale of subsidiary  $-   $(1,360,000)

 

See accompanying notes

 

 6 

 

 

AMERICAN SHARED HOSPITAL SERVICES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1.Basis of Presentation

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals and entries to record the impairment of the Company’s investment in equity securities and the sale of EWRS Tibbi Cihazlar Ticaret Ltd Sti, “EWRS Turkey”) necessary to present fairly American Shared Hospital Services’ consolidated financial position as of September 30, 2015 and the results of its operations for the three and nine month periods ended September 30, 2015 and 2014, which results are not necessarily indicative of results on an annualized basis. Consolidated balance sheet amounts as of December 31, 2014 have been derived from audited financial statements.

 

These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2014 included in the Company’s 10-K filed with the Securities and Exchange Commission.

 

These condensed consolidated financial statements include the accounts of American Shared Hospital Services (the “Company”) and its wholly-owned subsidiaries: OR21, Inc. (“OR21”); MedLeader.com, Inc. (“MedLeader”); PBRT Orlando, LLC (“Orlando”); and American Shared Radiosurgery Services (“ASRS”); ASRS’ majority-owned subsidiary, GK Financing, LLC (“GKF”); GKF’s wholly-owned subsidiaries, GK Financing U.K., Limited (“GKUK”), Instituto de Gamma Knife del Pacifico S.A.C. (“GKPeru”); ASHS’ majority owned subsidiary, Long Beach Equipment, LLC (“LBE”), GKF’s majority owned subsidiaries, Albuquerque GK Equipment, LLC (“AGKE”), Jacksonville GK Equipment, LLC (“JGKE”) and EWRS, LLC (“EWRS”). EWRS owned 100% of EWRS Turkey. The Company sold EWRS Turkey on June 10, 2014.

 

The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to seventeen medical centers as of September 30, 2015 in the states of Arkansas, California, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas, and Washington.

 

The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (“IMRT”), Image Guided Radiation Therapy (“IGRT”) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.

 

The Company formed the subsidiaries GKUK and GKPeru, for the purposes of expanding its business internationally into the United Kingdom and Peru; LBE and Orlando to provide proton beam therapy services in Long Beach, California; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida. AGKE began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011. GKPeru is expected to begin operation in early 2016. GKUK is inactive and LBE is not expected to generate revenue within the next two years.

 

 7 

 

 

Based on guidance provided in accordance with Accounting Standards Codification (“ASC”) 830, Foreign Currency Matters (“ASC 830”), the Company has analyzed its operations outside the United States to determine the functional currency of each operation. Management determined that these operations were initially accounted for in U.S. dollars since the primary transactions incurred were in U.S. dollars and the Company provided significant funding towards the startup of the operation. When Management determined that the operation had become predominantly self-sufficient, the Company changed its accounting for the operation to the local currency from the U.S. dollar.

 

As of June 10, 2014 EWRS Turkey’s balance sheet accounts were translated at rates in effect as of those dates, respectively, and income and expense accounts were translated at the weighted average rates of exchange during those respective periods. Gains and losses from foreign currency transactions and remeasurement are listed in the Company’s Condensed Consolidated Statements of Operations. The Company recorded a net foreign currency gain of $161,000 for the nine month period ended September 30, 2014.

 

Based on guidance provided in accordance with Accounting Standards Update (“ASU”) No. 2014-08 Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”), the Company has analyzed the factors that define a discontinued operation and determined that the sale of EWRS Turkey is considered the sale of a significant component, but does not represent a major shift in the business, and therefore is not a discontinued operation.

 

Based on guidance provided in accordance with ASU No 2013-05 Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries of Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity (“ASU 2013-05”), the Company no longer holds a financial interest in EWRS Turkey. As of December 31, 2014, the cumulative translation adjustments previously recognized under accumulated other comprehensive income (loss) were released into net income as a component of the loss for the sale of EWRS Turkey in the statement of operations. The total cumulative translation adjustment of $779,000, previously recognized under accumulated other comprehensive income (loss), was included as a component of the loss calculation for the sale of EWRS Turkey, reported in the statement of operations for the year ended 2014.

 

Based on guidance provided in accordance with ASC 280 Segment Reporting (“ASC 280”), the Company has analyzed the factors that define an operating segment and determined that there is only one operating segment. The seventeen locations are aggregated into one reportable segment because, in the Company’s judgment, these operating segments have similar historical economic characteristics and are expected to have similar economic characteristics in the future. Furthermore, each operating segment utilizes the same business model and technologies, servicing the same end users (radiation therapy patients). All significant intercompany accounts and transactions have been eliminated in consolidation.

 

 8 

 

 

Effective May 31, 2014 (with closing occurring June 10, 2014) the Company sold EWRS Turkey for EUR 4.2 million (approximately $6.0M). The proceeds were used to reduce outstanding debt and the excess was cash to the Company of $768,000. Cash transactions were recorded for the time period June 1, to June 10, 2014, the date of closing. The Company recorded a loss on sale of subsidiary of $572,000. The Company was eligible for an earn-out in fiscal year 2014 based on future revenue derived from the units sold to Euromedic. The Company did not meet its 2014 earn-out milestone. The Company is also eligible for an earn-out in fiscal year 2015 based on future revenues, but does not anticipate it will meet the 2015 earn out therefore no amounts have been recorded as of September 30, 2015.

 

Based on guidance provided in ASC 320 Investments – Debt and Equity Securities (“ASC 320”) and Staff Accounting Bulletins (“SAB”) Topic 5M Other Than Temporary Impairment (“OTTI”) of Certain Investments in Equity Securities (“SAB Topic 5M”), the Company analyzed the recent events of Mevion Medical Systems, Inc. (“Mevion”), formerly Still River Systems, and determined that these circumstances indicate a decline in value of its Mevion investment that is other-than-temporary, and determined that a write-down of the carrying value should be recognized at this time. During the three months ended June 30, 2015, the Company adjusted its investment in Mevion to the determined fair value of $600,000 and recorded a $2,114,000 impairment loss. The $2,114,000 other than temporary impairment of its investment in Mevion is recorded in other income (loss) on the Company’s Condensed Consolidated Statement of Operations for the nine months ended September 30, 2015.

 

Recently Issued Accounting Pronouncements

 

In January 2015, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items (“ASU No. 2015-01”), which eliminates from United States Generally Accepted Accounting Principles (“GAAP”) the concept of extraordinary items and requires that an entity separately classify, present, and disclose extraordinary events and transactions. This ASU will also align more closely GAAP income statement presentation guidance with International Accounting Standards (“IAS”) 1, Presentation of Financial Statements, which prohibits the presentation and disclosure of extraordinary items. The new standard is effective for the Company on January 1, 2016. Early application is permitted. The standard permits the use of either the retrospective or prospective application. The Company is evaluating the effect that ASU 2015-01 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.

 

In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis (“ASU No. 2015-02”), which is intended to improve targeted areas of consolidation guidance for legal entities. The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB ASC and improves current GAAP. The new standard is effective for the Company on January 1, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2015-02 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.

 

 9 

 

 

In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability, be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The new standard is effective for the Company on January 1, 2016. Early adoption is permitted. The amendments should be applied on a retrospective basis, wherein the balance sheet of each individual period presented should be adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the effect that ASU 2015-03 will have on its consolidated financial statements and related disclosures.

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), ("ASU 2014-09"), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. In July 2015, the FASB voted to delay the effective date of this standard until the first quarter of 2018. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.

 

Note 2.Per Share Amounts

 

The following table sets forth the computation of basic and diluted earnings per share for the three and nine month periods ended September 30, 2015 and 2014:

 

   Three Months ended September 30,   Nine Months ended September 30, 
   2015   2014   2015   2014 
Net income (loss) attributable to American Shared Hospital Services  $43,000  $13,000  $(1,799,000)  $(1,010,000)
Weighted average common shares for basic earnings per share   5,494,000    5,261,000    5,485,000    4,858,000 
Diluted effect of stock options and restricted stock   22,000    43,000    -    - 
Weighted average common shares for diluted earnings per share   5,516,000    5,304,000    5,485,000    4,858,000 
                     
Basic earnings (loss) per share  $0.01   $0.00   $(0.33)  $(0.21)
Diluted earnings (loss) per share  $0.01   $0.00   $(0.33)  $(0.21)

 

Pursuant to GAAP, potentially dilutive common stock equivalents, such as dilutive stock options, are not considered when their inclusion in reporting earnings per share would be dilutive to reported losses incurred per share. Because the Company reported a loss for the nine month period ended September 30, 2015, the potentially dilutive effects of approximately 25,000 of the Company’s stock options, 200,000 warrants, and 7,000 unvested restricted stock units were not considered for the reporting period. Because the Company reported a loss for the nine month period ended September 30, 2014, the potentially dilutive effects of approximately 38,000 of the Company’s stock options and 8,000 unvested restricted stock units were not considered for the reporting period. 

 

 10 

 

 

Note 3.Stock-based Compensation

 

On June 2, 2010, the Company’s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the “2006 Plan”). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the “Plan”) and increased the number of shares of the Company’s common stock reserved for issuance under the Plan by an additional 880,000 shares from 750,000 shares to 1,630,000 shares. The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors. The Plan serves as successor to the Company’s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans. The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans. On June 16, 2015, the Company’s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years.

 

Stock-based compensation expense associated with the Company’s stock-based awards to employees is calculated using the Black-Scholes valuation model. The Company’s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates. The estimated fair value of the Company’s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award. The estimated fair value of the Company’s options is amortized over the period during which an employee is required to provide service in exchange for the award (requisite service period), usually the vesting period. Accordingly, stock-based compensation cost before income tax effect in the amount of $58,000 and $152,000 is reflected in net income for the three and nine month periods ended September 30, 2015, compared to $7,000 and $53,000 in the same periods in the prior year, respectively.

 

The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the nine month period ended September 30, 2015:

 

   Restricted
Stock
Awards/Units
   Grant Date
Weighted-
Average Fair
Value
   Intrinsic
Value
 
Outstanding at January 1, 2015   3,000   $2.43   $- 
Granted   31,000   $2.87   $- 
Vested   (24,000)  $2.84   $- 
Forfeited   -   $-   $- 
Outstanding at September 30, 2015   10,000   $2.80   $- 

 

 11 

 

 

The following table summarizes stock option activity for the nine month period ended September 30, 2015:

 

   Stock
Options
   Grant Date
Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Life (in
Years)
 
Outstanding at January 1, 2015   659,000   $3.13    5.57 
Granted   20,000   $2.48    - 
Exercised   (2,000)  $2.30    - 
Forfeited   (55,000)  $5.97    - 
Outstanding at September 30, 2015   622,000   $2.86    5.36 
Exercisable at September 30, 2015   82,000   $2.74    3.20 

 

Note 4.Investment in Equity Securities

 

As of September 30, 2015 and December 31, 2014, the Company had a $605,000 and $2,709,000 investment, respectively, in the common stock of Mevion. As of September 30, 2015, the Company also had $5,000,000 in non-refundable deposits toward the purchase of three MEVION S250 systems from Mevion.

 

The Company has carried its investment in Mevion at cost and reviews it for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may be below its cost basis on an other-than-temporary impairment basis. The Company evaluated this investment for impairment at December 31, 2014 and reviewed it at June 30, 2015 in light of the length of time and extent to which market value has been below cost, the financial condition and near term prospects of Mevion, current market conditions and events, and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value. On July 27, 2015, Mevion cancelled its planned initial public offering (“IPO”) and announced on August 4, 2015 that it had entered into an investment agreement where up to $200 million will be invested by HOPU Investments, YuanMing Capital and existing U.S. investors. Concurrent with this investment, Mevion and the lead investors intend to form a joint venture to produce, sell, and service proton therapy systems for the Chinese market. The Company’s investment in the common stock of Mevion, will represent an approximate 0.56% interest following this latest private placement transaction on a fully diluted basis.

 

The Company analyzed the recent events stated above and determined that the cancellation of Mevion’s IPO indicated a decline in value of its Mevion investment that is other-than-temporary, and determined that a write-down of the carrying value should be recognized. In assessing whether the impairment is OTTI, we evaluated the length of time and extent to which market value has been below cost, the financial conditions and near term prospects of Mevion, the significance of recent events and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value. There are no current plans to dispose of this investment but based on the extended period of impairment, coupled with the cancellation of a planned IPO, the Company adjusted its investment in Mevion to the determined fair value of $600,000 and recorded a $2,114,000 impairment loss during the nine months ended September 30, 2015.

 

 12 

 

 

In determining the fair value of the Company’s common stock in Mevion, the Company was able to obtain several common stock estimates based under a probability weighted expected return method (“P-WERM”). The P-WERM analysis considered the probability of several potential outcomes in its determination of a fair value of the Mevion investment. The Company reviewed certain scenarios from the P-WERM analysis as well as additional analyses and estimated the value of its common stock investment in Mevion at approximately $600,000.

 

The $2,114,000 other than temporary impairment of its investment in Mevion is recorded in other income (loss) on the Company’s Condensed Consolidated Statement of Operations. This transaction is treated as a capital loss for tax purposes which may be deducted only to the extent the Company has capital gains. The Company is not aware of any event or transaction planned where the Company would generate a capital gain. Therefore, a full valuation allowance was recorded against the income tax benefit from the impairment loss, and the net impact to the income tax provision for the three and nine month periods ended September 30, 2015 was $0.

 

The first MEVION S250, located at Barnes-Jewish Hospital in St. Louis, MO (“Barnes-Jewish Hospital”), treated its first patient on December 19, 2013. The second MEVION S250, located at the Ackerman Cancer Center in Jacksonville, Florida (“Ackerman Cancer Center”), treated its first patient in April 2015. The third MEVION S250, located at Robert Wood Johnson University Hospital in New Brunswick, New Jersey (“Robert Wood Johnson”), started in May 2015. The Company’s first MEVION S250 system was delivered to UF Health Cancer Center at Orlando Health in November 2014 and anticipates treating patients in the first quarter of 2016.

 

Note 5.Line of Credit

 

As of December 31, 2014, the Company had a $9,000,000 renewable line of credit with a bank secured by a certificate of deposit. The line of credit had been in place since June 2004. The Company’s earnings in 2013 were insufficient to satisfy the “profitability” covenant in the line of credit. The Bank waived this default on August 8, 2014 and agreed to change the maturity date of the facility to December 31, 2014. The line was paid-off using the proceeds from the certificate of deposit on January 2, 2015.

 

Borrowing under the line of credit was subject to interest expense at a rate equal to the bank’s prime rate minus 0.5 percentage point, or alternatively at the Company’s discretion, the LIBOR rate plus 1.0 percentage point. The weighted average interest rate on money borrowed against the line of credit during 2014 was 1.40%. As of December 31, 2014, there was $8,780,000 borrowed against the line of credit.

 

 13 

 

 

Note 6.Fair Value of Financial Instruments

 

The Company’s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Other than the methodology used to fair value the Company’s investment in equity securities, there have been no changes in methods or methodologies used in fair value assessment, which was consistent with those used in the prior year.

 

The estimated fair value of the Company’s assets and liabilities as of September 30, 2015 and December 31, 2014 were as follows (in thousands):

 

   Level 1   Level 2   Level 3   Total   Carrying
Value
 
September 30, 2015                         
                          
Assets:                         
Cash, cash equivalents, restricted cash  $2,234   $-   $-   $2,234   $2,234 
Investment in equity securities   -    -    600    600    605 
Total  $2,234   $-   $600   $2,834   $2,839 
                          
Liabilities                         
Debt obligations  $-   $10,088   $-   $10,088   $10,246 
Total  $-   $10,088   $-   $10,088   $10,246 
                          
December 31, 2014                         
                          
Assets:                         
Cash, cash equivalents, restricted cash  $1,109   $-   $-   $1,109   $1,109 
Certificate of deposit   9,000    -    -    9,000    9,000 
Investment in equity securities   -    -    330    330    2,709 
Total  $10,109   $-   $330   $10,439   $12,818 
                          
Liabilities                         
Advances on line of credit  $8,780   $-   $-   $8,780   $8,780 
Debt obligations   -    10,658    -    10,658    10,591 
Total  $8,780   $10,658   $-   $19,438   $19,371 

 

Note 7.Repurchase of Common Stock

 

In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares repurchased in 2015. There were 1,000 shares repurchased in the first quarter and no shares repurchased in the second or third quarters of 2014. There are approximately 72,000 shares remaining under this repurchase authorization.

 

 14 

 

 

Note 8.Income Taxes

 

We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annualized effective income tax rate expected to be applicable for the full fiscal year. However, when a reliable estimate of the annualized effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the results of operations reported within the year-to-date periods. Our effective income tax rate is highly influenced by relative income or losses reported and the amount of the nondeductible stock-based compensation associated with grants of our common stock options and historically from the results of foreign operations. A small change in estimated annual pretax income (loss) can produce a significant variance in the annualized effective income tax rate given the expected amount of these items. As a result, we have computed our provision for income taxes for the three and nine month periods ended September 30, 2015 and 2014 by applying the actual effective tax rates to income or (loss) reported within the condensed consolidated financial statements through those periods.

 

Note 9.Note, Warrant, & Common Stock Purchase Agreement

 

In June 2014, the Company sold in a private offering, an aggregate of 650,000 common shares for gross proceeds of approximately $1,600,000. The purchasers were three members of the Board of Directors. In October 2014, the Company issued an aggregate of $1,000,000 of 3-year promissory notes with warrants and 100,000 common shares to four members of the Board of Directors, for gross proceeds of approximately $1,220,000.

 

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This quarterly report to the Securities and Exchange Commission may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife and radiation therapy businesses, the risks of developing The Operating Room for the 21st CenturySM program, the risks of investing in a development-stage company, Mevion, and the risks of timing, financing and operations of the Company’s proton therapy business. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 16, 2015

 

The Company had seventeen Gamma Knife units in operation on September 30, 2015 and 2014. Two of the Company’s customer contracts are through subsidiaries where GKF or its subsidiary is the majority owner and managing partner. Ten of the Company’s seventeen current Gamma Knife customers are under fee-per-use contracts, and seven customers are under retail arrangements. The Company’s contract to provide radiation therapy and related equipment services to an existing Gamma Knife customer is also considered a retail arrangement. Retail arrangements are further classified as either turn-key or revenue sharing. Revenue from fee per use contracts is determined by each hospital’s contracted rate. For revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. Under turn-key arrangements, the Company receives payment from the hospital in the amount of its reimbursement from third party payors, and is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For the turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs.

 

 15 

 

 

Prior to April 1, 2013, Medicare’s reimbursement rate for Gamma Knife treatment had been relatively stable. Congress’s enactment of the American Taxpayer Relief Act of 2012, however, reduced Medicare’s Gamma Knife reimbursement rate from approximately $10,000 to $5,600, effective April 1, 2013. This change caused a substantial reduction in the Company’s revenues during 2013 and 2014. Effective January 1, 2015, the Centers for Medicare and Medicaid (CMS) established a Comprehensive Ambulatory Payment Classification for single session radiosurgery treatments, which increased the reimbursement rate by more than $4,000 to $9,768. CMS has proposed a 2016 total reimbursement rate of approximately $8,830 for a Medicare Gamma Knife treatment. CMS’s 2016 proposal is subject to change before final adoption.

 

Medical services revenue decreased by $107,000 and increased by $961,000 to $3,875,000 and $12,386,000 for the three and nine month periods ended September 30, 2015, respectively, from $3,982,000 and $11,425,000 for the three and nine month periods ended September 30, 2014, respectively. For the three month period ended September 30, 2015, the revenue decrease was due to a decrease in procedures. For the nine month period ended September 30, 2015, excluding revenue from EWRS Turkey in 2014, Gamma Knife revenue increased $1,492,000. The increase in Gamma Knife revenue was due to an increase in procedures at existing sites, procedures performed at the Company’s new site which began treating patients in December 2014, and higher revenue per procedures compared to the Company’s historical average.

 

The number of Gamma Knife procedures decreased by 15 and 91 to 481 and 1,478 for the three and nine month periods ended September 30, 2015, respectively, from 496 and 1,569 in the same periods in the prior year.  For the three month period ended September 30, 2015, the decline in procedures was due to one customer site experiencing downtime in order to perform a Cobalt-60 reload. Excluding procedures performed in Turkey in 2014, procedures increased by 133 for the nine month period ended September 30, 2015, compared to the same period in the prior year. The increase in procedures was due to increased volume at the Company’s existing sites and procedures performed at the Company’s new site which began treating patients in December 2014.

 

Total costs of revenue increased by $42,000 and decreased by $155,000 to $2,421,000 and $7,533,000 for the three and nine month periods ended September 30, 2015, respectively, from $2,379,000 and $7,688,000 for the three and nine month periods ended September 30, 2014, respectively. Excluding costs of revenue from EWRS Turkey, for the nine months ended September 30, 2015, costs of revenue increased $416,000, compared to the same period prior year. Maintenance and supplies decreased by $130,000 and $266,000 for the three and nine month periods ended September 30, 2015 compared to the same periods in the prior year, due to the expiration of four maintenance contracts at existing sites. Depreciation and amortization increased by $43,000 and $315,000 for the three and nine month periods ended September 30, 2015, respectively, compared to the same periods in the prior year. The increase for the three and nine month periods is primarily due to the addition of one new site at the end of 2014 and two Cobalt-60 reloads which were done in the first and second quarters of 2015. When a reload is performed the book value of the unit increases which increases depreciation expense. Other direct operating costs increased by $129,000 and $367,000 for the three and nine month periods ended September 30, 2015, respectively, compared to the same periods in the prior year. The increase for the three and nine month periods was due to property taxes and operating costs at the Company’s retail sites.

 

 16 

 

 

Selling and administrative costs decreased by $29,000 for the three month period ended September 30, 2015 to $904,000 from $933,000 in the three month period ended September 30, 2014, and decreased $88,000 for the nine month period ended September 30, 2015 to $2,704,000 from $2,792,000 for the nine month period ended September 30, 2014. For the three month period the decrease is primarily due to reduced consultant fees. For the nine month period the decrease was primarily due to reduced consultant fees and state and county taxes.

 

Interest expense decreased by $161,000 and $476,000 to $235,000 and $900,000 for the three and nine month periods ended September 30, 2015, respectively, compared to $396,000 and $1,376,000 for the same periods in the prior year. For the three month period ended September 30, 2015, interest expense decreased due to the closure of the Company’s line of credit on January 2, 2015, the pay-down of the Company’s existing debt obligation for its IGRT machine at the end of 2014, and a one-time benefit for a prior year lease modification, recorded in the third quarter 2015. The impact of this modification was not material to the financial statements. Excluding interest expense in Turkey, interest expense decreased for the nine month period ended September 30, 2015, by $376,000 due to the closure of the Company’s line of credit on January 2, 2015, the pay-down of the Company’s existing debt obligation for its IGRT machine at the end of 2014 and an existing lease obligation for a Gamma Knife site at the end of the first quarter 2014, and a one-time benefit for a prior year lease modification, recorded in the third quarter 2015. The impact of this modification was not material to the financial statements.

 

The Company recorded a loss on the write down of its equity investment in Mevion of $2,114,000 for the nine month period ended September 30, 2015. The Company determined its investment in Mevion was other-than-temporary and wrote down the carrying value of the investment accordingly. In determining the fair value of the Company’s common stock in Mevion, the Company reviewed certain scenarios from the P-WERM analysis as well as additional analyses and estimated the value of its common stock investment in Mevion at approximately $600,000. The Company adjusted its investment in Mevion to the determined fair value of $600,000 and recorded a $2,114,000 impairment loss. This transaction is treated as a capital loss for tax purposes which may be deducted only to the extent the Company has capital gains. The Company is not aware of any event or transaction planned where the Company would generate a capital gain. Therefore a full valuation allowance was recorded against the income tax benefit from the impairment loss, and the net impact to the income tax provision for the nine month period ended September 30, 2015 was $0.

 

 17 

 

 

The Company recorded a loss from sale of EWRS Turkey of $572,000 for the nine month period ended September 30, 2014. The loss on sale represents the net book value of EWRS’s investment in EWRS Turkey at the date of the sale, after proceeds from the sale were used to pay off outstanding debt. The Company also recorded income tax expense due to the write off of a deferred tax asset of $165,000 related to losses sustained by EWRS Turkey through December 31, 2013, for the nine month period ended September 30, 2014. The deferred tax asset could no longer be utilized since EWRS Turkey was sold on June 10, 2014.

 

The gain from foreign currency transactions was $0 for the three and nine month periods ended September 30, 2015, respectively, compared to $0 and $161,000 for the three and nine month periods ended September 30, 2014, respectively. The gain or loss from foreign currency transactions was driven by fluctuations in the exchange rate between the US Dollar and Turkish Lira.

 

Interest and other income decreased by $4,000 to $3,000 for the three month period ended September 30, 2015 and decreased by $8,000 to $14,000 for the nine month period ended September 30, 2015. Interest income is generated from interest earned on the Company’s certificate of deposit and other investments.

 

The Company had an income tax expense of $92,000 and $328,000 for the three and nine month periods ended September 30, 2015, respectively, compared to income tax expense of $29,000 and $33,000 for the three and nine month periods ended September 30, 2014, respectively. For both periods, the increase in income tax expense is primarily due to higher taxable income attributable to American Shared Hospital Services. For the nine month period ended September 30 2015, the Company recorded a valuation allowance of $2,114,000 against the income tax benefit from the Mevion impairment loss, and the net impact to the income tax provision for the nine month period was $0.

 

Net income attributable to non-controlling interest decreased $56,000 and increased $463,000 to $183,000 and $620,000 for the three and nine month periods ended September 30, 2015, respectively, from $239,000 and $157,000 for the three and nine month periods ended September 30, 2014, respectively. Non-controlling interest primarily represents the 19% interest of GK Financing owned by a third party, as well as non-controlling interests in subsidiaries of GK Financing owned by third parties that began operations in 2011. Variances in net income attributable to non-controlling interest represent the relative increase or decrease in profitability of GKF and these ventures.

 

The Company had net income of $43,000, or $0.01 per diluted share, and a net loss of $1,799,000, or ($0.33) per diluted share, for the three and nine month periods ended September 30, 2015, respectively, compared to net income of $13,000, or $0.00 per diluted share, and a net loss of $1,010,000, or ($0.21) per diluted share, in the same periods in the prior year. For the three month period ended September 30, 2015 net income was attributable to lower selling and administrative costs and interest expense. For the nine month period ended September 30, 2015 the net loss was attributable to an impairment charge of $2,114,000 related to the Company’s equity investment in Mevion.

 

 18 

 

 

Liquidity and Capital Resources

 

The Company had cash and cash equivalents of $2,184,000 at September 30, 2015 compared to $1,059,000 at December 31, 2014. The Company’s cash position increased by $1,125,000 due to net cash from operating activities of $6,157,000, proceeds from long-term debt financing on property and equipment of $1,036,000, capital contributions of $27,000, and net proceeds from the certificate of deposit and pay-down on the line of credit of $220,000. These increases were offset by payments for the purchase of property and equipment of $1,517,000, investment in equity securities of $10,000, principal payments on long term debt and capital leases of $4,400,000, and distributions to non-controlling interests of $388,000.

 

The Company had cash and cash equivalents of $1,415,000 at September 30, 2014 compared to $1,909,000 at December 31, 2013. The Company’s cash position decreased by $494,000 due to payments for the purchase of property and equipment of $338,000, investment in equity securities of $4,000, principal payments on long term debt and capital lease of $5,697,000, net payments on the Company’s line of credit with a bank of $560,000, distributions to non-controlling interests of $748,000, repurchase of common stock of $2,000 and changes in cash from foreign exchange rates of $8,000. These decreases were offset by net cash from operating activities of $4,413,000, capital contributions of $102,000, proceeds from the sale of EWRS Turkey of $768,000 and private placement of common stock of $1,580,000 to three directors of the Company which closed on June 12, 2014.

 

The Company has scheduled interest and principal payments under its debt obligations of approximately $3,345,000 and scheduled capital lease payments of approximately $5,122,000 during the next 12 months. The Company believes that its cash flow from cash on hand, operations, and other cash resources are adequate to meet its scheduled debt and capital lease obligations during the next 12 months. See additional discussion below related to commitments.

 

The Company as of September 30, 2015 had shareholders’ equity of $24,766,000, negative working capital of $2,427,000 and total assets of $55,886,000.

 

Commitments

 

The Company has commitments to purchase three MEVION S250 PBRT systems for $33,600,000 as of September 30, 2015. The Company has $5,000,000 in non-refundable deposits toward the purchase of these three PBRT systems from Mevion.  The non-refundable deposits are recorded in the Condensed Consolidated Balance Sheets as deposits and construction in progress. The Company’s first PBRT system was delivered in November 2014. There is a cash payment of approximately $7,800,000 due in January 2016 for the first PBRT system, which is expected to be financed with $9,000,000 in lease financing, pending execution of definitive documents. The lease financing commitment is structured so that the Company will be reimbursed $1,000,000 of the progress payments paid, to date, the remainder will fund the payment due. The remaining two PBRT projects do not have anticipated delivery datesThe timing of progress payments for PBRT contracts two and three are dependent upon future events and the Company has some flexibility to delay the due dates of these commitments.  Approximately $25,800,000 of these commitments are not expected to start becoming due until 2017 or later and the Company is in discussions with lenders to finance the remaining two proton systems.  There are no cash requirements for these commitments in the next 12 months.   

 

 19 

 

 

The Company has commitments to purchase one Gamma Knife Perfexion system and is scheduled to install one Gamma Knife Model 4C system, which the Company previously financed and owns, as of September 30, 2015.  Total Gamma Knife commitments as of September 30, 2015 are $2,750,000.  The Model 4C unit is scheduled to be installed in early 2016 at the Company’s new customer site in Peru.  There are cash requirements for the Peru commitment in the next 12 months of approximately $600,000. The Company believes that cash flow from cash on hand and operations will be sufficient to cover this payment. The Perfexion unit is for a site yet to be determined and it is the Company’s intent to finance this unit. There are no cash requirements for the Perfexion system in the next 12 months.  There can be no assurance that financing will be available for the Company’s current or future projects, or at terms that are acceptable to the Company.

 

The Company estimates the following commitments for each of the equipment systems, with expected timing of payments as follows as of September 30, 2015:

 

   2015   2016   Thereafter   Total 
                 
Proton Beam Units  $-   $7,800,000   $25,800,000   $33,600,000 
                     
Gamma Knife Units   600,000    2,150,000    -    2,750,000 
                     
Total  $600,000   $9,950,000   $25,800,000   $36,350,000 

 

Item 3.Quantitative and Qualitative Disclosures about Market Risk

 

The Company does not hold or issue derivative instruments for trading purposes and is not a party to any instruments with leverage or prepayment features. The Company does not have affiliation with partnerships, trusts or other entities whose purpose is to facilitate off-balance sheet financial transactions or similar arrangements, and therefore has no exposure to the financing, liquidity, market or credit risks associated with such entities. At September 30, 2015 the Company had no significant long-term, market-sensitive investments.

 

Item 4.Controls and Procedures

 

Under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934. These controls and procedures are designed to ensure that material information relating to the company and its subsidiaries is communicated to the chief executive officer and the chief financial officer. Based on that evaluation, our chief executive officer and our chief financial officer concluded that, as of September 30, 2015, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to the chief executive officer and the chief financial officer, and recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

 20 

 

 

There were no changes in our internal control over financial reporting during the three months ended September 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 1.Legal Proceedings.

None.

 

Item 1A.Risk Factors.

There are no changes from those listed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

None.

 

Item 3.Defaults Upon Senior Securities.

None.

 

Item 4.Mine Safety Disclosures

Not applicable.

 

Item 5.Other Information.

None.

 

 21 

 

 

Item 6.Exhibit Index

 

        Incorporated by reference herein
Exhibit                
Number   Description   Form   Exhibit   Date
10.1   Addendum Two to Equipment Lease Agreement for a Gamma Knife Unit dated as of July 31, 2015, between Mercy Hospital Oklahoma City, Inc., an Oklahoma not for profit corporation and GK Financing, LLC *          
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *          
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *          
32.1   Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ǂ          
101.INS   XBRL Instance Document *          
101.SCH   XBRL Taxonomy Extension Schema Document *          
101.CAL   XBRL Taxonomy Calculation Linkbase Document *          
101.DEF   XBRL Taxonomy Definition Linkbase Document *          
101.LAB   XBRL Taxonomy Label Linkbase Document *          
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document *          

 

  * Filed herewith.
  ǂ Furnished herewith.

 

 22 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

AMERICAN SHARED HOSPITAL SERVICES

Registrant

 

Date: November 12, 2015 /s/ Ernest A. Bates, M.D.
    Ernest A. Bates, M.D.
    Chairman of the Board and Chief Executive Officer
     
Date: November 12, 2015 /s/ Craig K. Tagawa
    Craig K. Tagawa
    Senior Vice President
    Chief Operating and Financial Officer

  

 23 

 

EX-10.1 2 v423254_ex10-1.htm EXHIBIT 10.1

 

Exhibit 10.1

 

ADDENDUM TWO

TO EQUIPMENT LEASE AGREEMENT

 

This ADDENDUM TWO TO EQUIPMENT LEASE AGREEMENT (this “Addendum”) is dated effective as of July 31, 2015, between Mercy Hospital Oklahoma City, Inc., an Oklahoma not for profit corporation, formerly known as Mercy Health Center, Inc. (“Hospital”), and GK Financing, LLC, a California limited liability company (“GKF”).

 

Recitals:

 

WHEREAS, GKF and Hospital are parties to a certain Equipment Lease Agreement dated May 28, 2004, as amended by certain Addendum One dated December 23, 2011 (as amended, the “Lease”), and desire to extend the term of the Lease as set forth herein.

 

NOW, THEREFORE, in consideration of the mutual covenants, conditions, and agreements set forth herein, and for the other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

Agreement:

 

1.            Defined Terms. Unless otherwise defined herein, the capitalized terms used herein shall have the same meanings set forth in the Lease.

 

2.            Extension of Term.

 

a.It is acknowledged that the First Procedure Date under the Lease was August 9, 2005, and with the inclusion of 24 days of down time due to the cobalt Reload, the Lease is currently set to expire on September 2, 2015.

 

b.The Term of the Agreement is hereby extended to September 2, 2016, and cannot be further extended without the written approval of both parties.

 

3.            Full Force and Effect. Except as amended by this Addendum, all of the terms and provisions of the Lease shall remain in full force and effect.

 

IN WITNESS WHEREOF, the parties have executed this Addendum effective as of the date first written above.

 

GKF:

 

Hospital:

         
GK Financing, LLC   Mercy Hospital Oklahoma City, Inc., an Oklahoma not for profit corporation (formerly known as Mercy Health Center, Inc.)
         
         
By: /s/ Ernest A. Bates, M.D.   By: /s/ Jim R. Gebhart
  Ernest A. Bates, M.D.   Name: Jim R. Gebhart
  Policy Committee Member   Title: President

 

 

 

 

EX-31.1 3 v423254_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION

 

I, Ernest A. Bates, M.D., as chief executive officer of American Shared Hospital Services, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of American Shared Hospital Services;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (or the fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

 

November 12, 2015  
   
/s/ Ernest A. Bates, M.D.  
Ernest A. Bates, M.D.  
   
Chief Executive Officer  

 

   
EX-31.2 4 v423254_ex31-2.htm EXHIBIT 31.2

 

 

Exhibit 31.2

 

CERTIFICATION

 

I, Craig K. Tagawa., as chief financial officer of American Shared Hospital Services, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of American Shared Hospital Services;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (or the fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

 

November 12, 2015  
   
/s/ Craig K. Tagawa  
Craig K. Tagawa  
   
Chief Financial Officer  

 

   
EX-32.1 5 v423254_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of American Shared Hospital Services for the quarterly period ended September 30, 2015 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

 

Ernest A. Bates, M.D., the Chief Executive Officer and Craig K. Tagawa, the Chief Financial Officer of American Shared Hospital Services, each certifies that, to the best of his knowledge:

 

1.          the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.          the information contained in the Report fairly presents, in all material respects, the financial condition and results of operationsof American Shared Hospital Services.

 

November 12, 2015

 

  /s/ Ernest A. Bates, M.D.
  Ernest A. Bates, M.D.
  Chief Executive Officer
   
  /s/ Craig K. Tagawa
  Craig K. Tagawa
  Chief Financial Officer

 

   
EX-101.INS 6 ams-20150930.xml XBRL INSTANCE DOCUMENT 0000744825 2014-01-01 2014-09-30 0000744825 2014-01-01 2014-12-31 0000744825 2015-01-01 2015-09-30 0000744825 2014-07-01 2014-09-30 0000744825 2015-07-01 2015-09-30 0000744825 2015-08-04 0000744825 2015-09-30 0000744825 2015-11-01 0000744825 2008-12-31 0000744825 2014-12-31 0000744825 2013-12-31 0000744825 2014-09-30 0000744825 us-gaap:CommonStockMember 2013-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000744825 us-gaap:RetainedEarningsMember 2013-12-31 0000744825 us-gaap:ParentMember 2013-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2013-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-09-30 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-09-30 0000744825 us-gaap:RetainedEarningsMember 2015-01-01 2015-09-30 0000744825 us-gaap:ParentMember 2015-01-01 2015-09-30 0000744825 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-09-30 0000744825 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000744825 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000744825 us-gaap:ParentMember 2014-01-01 2014-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2014-01-01 2014-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0000744825 us-gaap:CommonStockMember 2015-01-01 2015-09-30 0000744825 us-gaap:CommonStockMember 2014-12-31 0000744825 us-gaap:RetainedEarningsMember 2014-12-31 0000744825 us-gaap:ParentMember 2014-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2014-12-31 0000744825 us-gaap:CommonStockMember 2015-09-30 0000744825 us-gaap:AdditionalPaidInCapitalMember 2015-09-30 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-09-30 0000744825 us-gaap:RetainedEarningsMember 2015-09-30 0000744825 us-gaap:ParentMember 2015-09-30 0000744825 us-gaap:NoncontrollingInterestMember 2015-09-30 0000744825 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000744825 ams:EwrsTurkeyMember 2015-09-30 0000744825 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0000744825 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-09-30 0000744825 ams:UnvestedRestrictedStockUnitsMember 2014-01-01 2014-09-30 0000744825 ams:IncentiveCompensationPlanMember 2010-06-02 0000744825 ams:IncentiveCompensationPlanMember us-gaap:MinimumMember 2010-06-02 0000744825 ams:IncentiveCompensationPlanMember us-gaap:MaximumMember 2010-06-02 0000744825 us-gaap:RestrictedStockUnitsRSUMember 2014-12-31 0000744825 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-09-30 0000744825 us-gaap:RestrictedStockUnitsRSUMember 2015-09-30 0000744825 ams:MevionMedicalSystemsIncMember 2015-09-30 0000744825 ams:MevionMedicalSystemsIncMember 2014-12-31 0000744825 us-gaap:InvestorMember 2015-08-04 0000744825 ams:MevionMedicalSystemsIncMember 2015-01-01 2015-09-30 0000744825 ams:MevionMedicalSystemsIncMember ams:PWermMember 2015-09-30 0000744825 ams:ShareRepurchaseProgramMember 2014-07-01 2014-09-30 0000744825 us-gaap:PrivatePlacementMember 2014-06-01 2014-06-30 0000744825 ams:NoteAndWarrantPurchaseAgreementMember 2014-10-01 2014-10-31 0000744825 ams:FourDirectorsMember 2014-10-01 2014-10-31 0000744825 ams:SaleOfEwrsTurkeyMember 2014-05-01 2014-05-31 0000744825 ams:SaleOfEwrsTurkeyMember 2015-01-01 2015-09-30 0000744825 ams:MevionMedicalSystemsIncMember 2015-06-30 0000744825 ams:MevionMedicalSystemsIncMember 2015-03-31 2015-06-30 0000744825 us-gaap:WarrantMember 2015-01-01 2015-09-30 0000744825 ams:UnvestedRestrictedStockUnitsMember 2015-01-01 2015-09-30 0000744825 ams:MevionMedicalSystemsIncMember 2015-07-01 2015-09-30 0000744825 us-gaap:FairValueInputsLevel1Member 2015-09-30 0000744825 us-gaap:FairValueInputsLevel2Member 2015-09-30 0000744825 us-gaap:FairValueInputsLevel3Member 2015-09-30 0000744825 us-gaap:FairValueInputsLevel1Member 2014-12-31 0000744825 us-gaap:FairValueInputsLevel2Member 2014-12-31 0000744825 us-gaap:FairValueInputsLevel3Member 2014-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:EUR xbrli:pure 2184000 1059000 50000 50000 0 9000000 3451000 3192000 131000 131000 405000 448000 367000 367000 6588000 14247000 83120000 82151000 721000 721000 10544000 13736000 46136000 46572000 48249000 50036000 605000 2709000 444000 536000 55886000 67528000 454000 421000 156000 179000 1370000 763000 2781000 2005000 4254000 4103000 0 8780000 9015000 16251000 7465000 8586000 10310000 12190000 749000 874000 3581000 3473000 10376000 10376000 5660000 5508000 3743000 5542000 19779000 21426000 4987000 4728000 55886000 67528000 24766000 26154000 933000 904000 396000 235000 274000 3982000 3875000 382000 252000 1478000 1521000 519000 648000 1603000 1454000 315000 0 0 7000 3000 281000 318000 29000 92000 252000 226000 239000 183000 13000 43000 0 0.01 0 0.01 2792000 2704000 1376000 900000 -431000 11425000 12386000 1320000 866000 4695000 4619000 1673000 2048000 3737000 4853000 1249000 161000 0 22000 14000 -820000 -851000 33000 328000 -853000 -1179000 157000 620000 -1010000 -1799000 -0.21 -0.33 -0.21 -0.33 0 0 0 -572000 0 0 2114000 0 0 0 13000 43000 0 0 -337000 0 106000 -1799000 779000 0 24055000 8578000 4990000 -442000 6494000 19620000 4435000 4609000 2000 152000 0 0 152000 0 3000 0 0 1800000 0 750000 373000 0 373000 0 373000 0 152000 0 2000 0 442000 337000 0 0 0 2000 0 1000 1800000 1800000 0 517000 0 0 0 0 0 517000 0 0 0 -952000 -952000 390000 -1799000 620000 0 0 0 -1799000 5361000 779000 0 0 442000 0 0 0 388000 -562000 951000 0 0 0 0 0 951000 388000 0 0 5542000 21426000 4728000 10376000 5660000 0 3743000 19779000 4987000 5364000 10376000 5508000 0 145000 145000 145000 27000 0 0 0 0 0 27000 0 0 0 0 0 3000 -141000 -113000 -37000 -43000 -573000 535000 4413000 6157000 4808000 4659000 1604000 1251000 60000 1000 2732000 1343000 161000 0 33000 108000 53000 152000 -431000 259000 2457000 1417000 3240000 2983000 640000 0 1200000 8780000 -748000 -388000 2000 0 -8000 0 -494000 1125000 1909000 1415000 338000 1517000 0 43000 0 -9000000 0 -572000 10000 4000 0 768000 1036000 0 0 1580000 0 -4921000 0 -826000 0 5181000 0 14000 0 -779000 0 -1360000 -1527000 426000 -3505000 -5325000 27000 102000 1 161000 5494000 5261000 5485000 4858000 22000 43000 0 0 5516000 5304000 5485000 4858000 38000 25000 8000 880000 750000 1630000 7000 53000 3000 31000 24000 0 10000 2.43 2.87 2.84 0 2.8 0 0 0 0 0 659000 20000 2000 55000 622000 82000 3.13 2.48 2.3 5.97 2.86 2.74 P5Y4M10D P3Y2M12D P5Y6M25D 605000 5000000 2709000 200000000 0.0056 600000 2114000 0 600000 9000000 0.0140 2014-12-31 1000000 72000 1000 650000 1600000 1000000 P3Y 100000 1220000 10-Q false 2015-09-30 2015 Q3 AMERICAN SHARED HOSPITAL SERVICES 0000744825 --12-31 Smaller Reporting Company AMS 5364147 94385000 96608000 100000 100000 5364000 5364000 5361000 5361000 2421000 2379000 7533000 7688000 43000 13000 -1799000 -231000 0 1000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div style="CLEAR:both;CLEAR: both">Note 1.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Basis of Presentation</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals and entries to record the impairment of the Company&#8217;s investment in equity securities and the sale of EWRS Tibbi Cihazlar Ticaret Ltd Sti, &#8220;EWRS Turkey&#8221;) necessary to present fairly American Shared Hospital Services&#8217; consolidated financial position as of September 30, 2015 and the results of its operations for the three and nine month periods ended September 30, 2015 and 2014, which results are not necessarily indicative of results on an annualized basis. Consolidated balance sheet amounts as of December 31, 2014 have been derived from audited financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2014 included in the Company&#8217;s 10-K filed with the Securities and Exchange Commission.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">These condensed consolidated financial statements include the accounts of American Shared Hospital Services (the &#8220;Company&#8221;) and its wholly-owned subsidiaries: OR21, Inc. (&#8220;OR21&#8221;); MedLeader.com, Inc. (&#8220;MedLeader&#8221;); PBRT Orlando, LLC (&#8220;Orlando&#8221;); and American Shared Radiosurgery Services (&#8220;ASRS&#8221;); ASRS&#8217; majority-owned subsidiary, GK Financing, LLC (&#8220;GKF&#8221;); GKF&#8217;s wholly-owned subsidiaries, GK Financing U.K., Limited (&#8220;GKUK&#8221;), Instituto de Gamma Knife del Pacifico S.A.C. (&#8220;GKPeru&#8221;); ASHS&#8217; majority owned subsidiary, Long Beach Equipment, LLC (&#8220;LBE&#8221;), GKF&#8217;s majority owned subsidiaries, Albuquerque GK Equipment, LLC (&#8220;AGKE&#8221;), Jacksonville GK Equipment, LLC (&#8220;JGKE&#8221;) and EWRS, LLC (&#8220;EWRS&#8221;). EWRS owned <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of EWRS Turkey. The Company sold EWRS Turkey on June 10, 2014.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to seventeen medical centers as of September 30, 2015 in the states of Arkansas, California, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas, and Washington.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (&#8220;IMRT&#8221;), Image Guided Radiation Therapy (&#8220;IGRT&#8221;) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The Company formed the subsidiaries GKUK and GKPeru, for the purposes of expanding its business internationally into the United Kingdom and Peru; LBE and Orlando to provide proton beam therapy services in Long Beach, California; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida. AGKE began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011. GKPeru is expected to begin operation in early 2016. GKUK is inactive and LBE is not expected to generate revenue within the next two years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">Based on guidance provided in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 830, <i>Foreign Currency Matters</i> (&#8220;ASC 830&#8221;), the Company has analyzed its operations outside the United States to determine the functional currency of each operation. Management determined that these operations were initially accounted for in U.S. dollars since the primary transactions incurred were in U.S. dollars and the Company provided significant funding towards the startup of the operation. When Management determined that the operation had become predominantly self-sufficient, the Company changed its accounting for the operation to the local currency from the U.S. dollar.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">As of June 10, 2014 EWRS Turkey&#8217;s balance sheet accounts were translated at rates in effect as of those dates, respectively, and income and expense accounts were translated at the weighted average rates of exchange during those respective periods. Gains and losses from foreign currency transactions and remeasurement are listed in the Company&#8217;s Condensed Consolidated Statements of Operations. The Company recorded a net foreign currency gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">161,000</font> for the nine month period ended September 30, 2014.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">Based on guidance provided in accordance with Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-08 <i>Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity</i> (&#8220;ASU 2014-08&#8221;), the Company has analyzed the factors that define a discontinued operation and determined that the sale of EWRS Turkey is considered the sale of a significant component, but does not represent a major shift in the business, and therefore is not a discontinued operation.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">Based on guidance provided in accordance with ASU No 2013-05 <i>Parent&#8217;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries of Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity</i> (&#8220;ASU 2013-05&#8221;), the Company no longer holds a financial interest in EWRS Turkey. As of December 31, 2014, the cumulative translation adjustments previously recognized under accumulated other comprehensive income (loss) were released into net income as a component of the loss for the sale of EWRS Turkey in the statement of operations. The total cumulative translation adjustment of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">779,000</font>, previously recognized under accumulated other comprehensive income (loss), was included as a component of the loss calculation for the sale of EWRS Turkey, reported in the statement of operations for the year ended 2014.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">Based on guidance provided in accordance with ASC 280 <i>Segment Reporting</i> (&#8220;ASC 280&#8221;), the Company has analyzed the factors that define an operating segment and determined that there is only one operating segment. The seventeen locations are aggregated into one reportable segment because, in the Company&#8217;s judgment, these operating segments have similar historical economic characteristics and are expected to have similar economic characteristics in the future. Furthermore, each operating segment utilizes the same business model and technologies, servicing the same end users (radiation therapy patients). All significant intercompany accounts and transactions have been eliminated in consolidation.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">Effective May 31, 2014 (with closing occurring June 10, 2014) the Company sold EWRS Turkey for EUR <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.2</font> million (approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6.0</font>M). The proceeds were used to reduce outstanding debt and the excess was cash to the Company of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">768,000</font>. Cash transactions were recorded for the time period June 1, to June 10, 2014, the date of closing. The Company recorded a loss on sale of subsidiary of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">572,000</font>. The Company was eligible for an earn-out in fiscal year 2014 based on future revenue derived from the units sold to Euromedic. The Company did not meet its 2014 earn-out milestone. The Company is also eligible for an earn-out in fiscal year 2015 based on future revenues, but does not anticipate it will meet the 2015 earn out therefore no amounts have been recorded as of September 30, 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">Based on guidance provided in ASC 320 <i>Investments &#150; Debt and Equity Securities</i> (&#8220;ASC 320&#8221;) and Staff Accounting Bulletins (&#8220;SAB&#8221;) Topic 5M <i>Other Than Temporary Impairment (&#8220;OTTI&#8221;) of Certain Investments in Equity Securities</i> (&#8220;SAB Topic 5M&#8221;), the Company analyzed the recent events of Mevion Medical Systems, Inc. (&#8220;Mevion&#8221;), formerly Still River Systems, and determined that these circumstances indicate a decline in value of its Mevion investment that is other-than-temporary, and determined that a write-down of the carrying value should be recognized at this time. During the three months ended June 30, 2015, the Company adjusted its investment in Mevion to the determined fair value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">600,000</font> and recorded a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,114,000</font> impairment loss. The $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,114,000</font> other than temporary impairment of its investment in Mevion is recorded in other income (loss) on the Company&#8217;s Condensed Consolidated Statement of Operations for the nine months ended September 30, 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Recently Issued Accounting Pronouncements</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">In January 2015, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2015-01, <i>Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items</i> (&#8220;ASU No. 2015-01&#8221;), which eliminates from United States Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) the concept of extraordinary items and requires that an entity separately classify, present, and disclose extraordinary events and transactions. This ASU will also align more closely GAAP income statement presentation guidance with <i> International Accounting Standards</i> (&#8220;IAS&#8221;) <i>1, Presentation of Financial Statements</i>, which prohibits the presentation and disclosure of extraordinary items. The new standard is effective for the Company on January 1, 2016. Early application is permitted. The standard permits the use of either the retrospective or prospective application. The Company is evaluating the effect that ASU 2015-01 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">In February 2015, the FASB issued ASU No. 2015-02, <i>Consolidation (Topic 810): Amendments to the Consolidation Analysis</i> (&#8220;ASU No. 2015-02&#8221;), which is intended to improve targeted areas of consolidation guidance for legal entities. The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB ASC and improves current GAAP. The new standard is effective for the Company on January 1, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2015-02 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">In April 2015, the FASB issued ASU No. 2015-03, <i>Interest&#151;Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs</i> (&#8220;ASU 2015-03&#8221;), which requires that debt issuance costs related to a recognized debt liability, be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The new standard is effective for the Company on January 1, 2016. Early adoption is permitted. The amendments should be applied on a retrospective basis, wherein the balance sheet of each individual period presented should be adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the effect that ASU 2015-03 will have on its consolidated financial statements and related disclosures.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">In May 2014, the FASB issued ASU No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i>, ("ASU 2014-09"), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. In July 2015, the FASB voted to delay the effective date of this standard until the first quarter of 2018. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 4200000 6000000 768000 572000 600000 2114000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The following table sets forth the computation of basic and diluted earnings per share for the three and nine month periods ended September 30, 2015 and 2014:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Three&#160;Months&#160;ended&#160;September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Nine&#160;Months&#160;ended&#160;September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Net income (loss) attributable to American Shared Hospital Services</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">43,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">13,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,799,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,010,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Weighted average common shares for basic earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,494,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,261,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,485,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4,858,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Diluted effect of stock options and restricted stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">22,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">43,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Weighted average common shares for diluted earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,516,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,304,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,485,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4,858,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Basic earnings (loss) per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.21)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Diluted earnings (loss) per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.21)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 200000 7000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div style="CLEAR:both;CLEAR: both">Note 3.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Stock-based Compensation</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"></font></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"></font></font></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">On June 2, 2010, the Company&#8217;s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the &#8220;2006 Plan&#8221;). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the &#8220;Plan&#8221;) and increased the number of shares of the Company&#8217;s common stock reserved for issuance under the Plan by an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">880,000</font></font> shares from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 750,000</font></font> shares to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,630,000</font> shares. The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors. The Plan serves as successor to the Company&#8217;s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans. The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans. On June 16, 2015, the Company&#8217;s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years.</font></font></font></font></font></div> <font style="FONT-WEIGHT: normal">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">Stock-based compensation expense associated with the Company&#8217;s stock-based awards to employees is calculated using the Black-Scholes valuation model. The Company&#8217;s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates. The estimated fair value of the Company&#8217;s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award. The estimated fair value of the Company&#8217;s options is amortized over the period during which an employee is required to provide service in exchange for the award (requisite service period), usually the vesting period. Accordingly, stock-based compensation cost before income tax effect in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">58,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">152,000</font> is reflected in net income for the three and nine month periods ended September 30, 2015, compared to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">53,000</font> in the same periods in the prior year, respectively.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> &#160;<font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the nine month period ended September 30, 2015:</font></div> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Restricted<br/> Stock<br/> Awards/Units</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average&#160;Fair<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Intrinsic<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.43</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.87</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(24,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.84</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>10,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.80</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0px 0in 0in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes stock option activity for the nine month period ended September 30, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Stock<br/> Options</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life&#160;(in<br/> Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>659,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3.13</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>20,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.48</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(55,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.97</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>622,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercisable at September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>82,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.74</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3.20</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the nine month period ended September 30, 2015:</div> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Restricted<br/> Stock<br/> Awards/Units</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average&#160;Fair<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Intrinsic<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.43</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.87</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(24,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.84</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>10,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.80</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0px 0in 0in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The following table summarizes stock option activity for the nine month period ended September 30, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Stock<br/> Options</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life&#160;(in<br/> Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>659,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3.13</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>20,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.48</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(55,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.97</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>622,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercisable at September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>82,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.74</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3.20</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 2114000 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div><b>Note 5.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>Line of Credit</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">As of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">December 31, 2014</font>, the Company had a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,000,000</font> renewable line of credit with a bank secured by a certificate of deposit. The line of credit had been in place since June 2004. The Company&#8217;s earnings in 2013 were insufficient to satisfy the &#8220;profitability&#8221; covenant in the line of credit. The Bank waived this default on August 8, 2014 and agreed to change the maturity date of the facility to December 31, 2014. The line was paid-off using the proceeds from the certificate of deposit on January 2, 2015.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">Borrowing under the line of credit was subject to interest expense at a rate equal to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">the bank&#8217;s prime rate minus 0.5 percentage point, or alternatively at the Company&#8217;s discretion, the LIBOR rate plus 1.0 percentage point.</font> The weighted average interest rate on money borrowed against the line of credit during 2014 was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1.40</font>%. As of December 31, 2014, there was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,780,000</font> borrowed against the line of credit.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> the banks prime rate minus 0.5 percentage point, or alternatively at the Companys discretion, the LIBOR rate plus 1.0 percentage point. <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The estimated fair value of the Company&#8217;s assets and liabilities as of September 30, 2015 and December 31, 2014 were as follows (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Carrying<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div style="CLEAR:both;CLEAR: both">September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">605</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,834</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,839</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,246</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,246</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div style="CLEAR:both;CLEAR: both">December 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Certificate of deposit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">9,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">9,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">9,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">330</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">330</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,709</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">330</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,439</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">12,818</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Advances on line of credit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,591</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">19,438</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">19,371</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 2234000 1109000 605000 2709000 9000000 2839000 12818000 10246000 10591000 8780000 10246000 19371000 2234000 1109000 2234000 0 0 1109000 0 0 9000000 9000000 0 0 600000 330000 0 0 600000 0 0 330000 2834000 10439000 2234000 0 600000 10109000 0 330000 8780000 8780000 0 0 10088000 10658000 0 10088000 0 0 10658000 0 10088000 19438000 0 10088000 0 8780000 10658000 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 2.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Per Share Amounts</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The following table sets forth the computation of basic and diluted earnings per share for the three and nine month periods ended September 30, 2015 and 2014:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Three&#160;Months&#160;ended&#160;September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Nine&#160;Months&#160;ended&#160;September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Net income (loss) attributable to American Shared Hospital Services</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">43,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">13,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,799,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,010,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Weighted average common shares for basic earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,494,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,261,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,485,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4,858,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Diluted effect of stock options and restricted stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">22,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">43,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Weighted average common shares for diluted earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,516,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,304,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5,485,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4,858,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Basic earnings (loss) per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.21)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Diluted earnings (loss) per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">0.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(0.21)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">Pursuant to GAAP, potentially dilutive common stock equivalents, such as dilutive stock options, are not considered when their inclusion in reporting earnings per share would be dilutive to reported losses incurred per share. Because the Company reported a loss for the nine month period ended September 30, 2015, the potentially dilutive effects of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25,000</font> of the Company&#8217;s stock options, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 200,000</font> warrants, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7,000</font> unvested restricted stock units were not considered for the reporting period. Because the Company reported a loss for the nine month period ended September 30, 2014, the potentially dilutive effects of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 38,000</font> of the Company&#8217;s stock options and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8,000</font> unvested restricted stock units were not considered for the reporting period.</font></font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 4.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Investment in Equity Securities</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">As of September 30, 2015 and December 31, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2014<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal"><font color="#008080">,</font></font></font> the Company had a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">605,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,709,000</font> investment, respectively, in the common stock of Mevion. As of September 30, 2015, the Company also had $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,000,000</font> in non-refundable deposits toward the purchase of three MEVION S250 systems from Mevion.</font></font></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The Company has carried its investment in Mevion at cost and reviews it for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may be below its cost basis on an other-than-temporary impairment basis. The Company evaluated this investment for impairment at December 31, 2014 and reviewed it at June 30, 2015 in light of the length of time and extent to which market value has been below cost, the financial condition and near term prospects of Mevion, current market conditions and events, and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value. On July 27, 2015, Mevion cancelled its planned initial public offering (&#8220;IPO&#8221;) and announced on August 4, 2015 that it had entered into an investment agreement where up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">200</font> million will be invested by HOPU Investments, YuanMing Capital and existing U.S. investors. Concurrent with this investment, Mevion and the lead investors intend to form a joint venture to produce, sell, and service proton therapy systems for the Chinese market. The Company&#8217;s investment in the common stock of Mevion, will represent an approximate <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.56</font>% interest following this latest private placement transaction on a fully diluted basis.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">The Company analyzed the recent events stated above and determined that the cancellation of Mevion&#8217;s IPO indicated a decline in value of its Mevion investment that is other-than-temporary, and determined that a write-down of the carrying value should be recognized. In assessing whether the impairment is OTTI, we evaluated the length of time and extent to which market value has been below cost, the financial conditions and near term prospects of Mevion, the significance of recent events and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value. There are no current plans to dispose of this investment but based on the extended period of impairment, coupled with the cancellation of a planned IPO, the Company adjusted its investment in Mevion to the determined fair value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">600,000</font> and recorded a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,114,000</font> impairment loss during the nine months ended September 30, 2015.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">In determining the fair value of the Company&#8217;s common stock in Mevion, the Company was able to obtain several common stock estimates based under a probability weighted expected return method (&#8220;P-WERM&#8221;). The P-WERM analysis considered the probability of several potential outcomes in its determination of a fair value of the Mevion investment. The Company reviewed certain scenarios from the P-WERM analysis as well as additional analyses and estimated the value of its common stock investment in Mevion at approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">600,000</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,114,000</font> other than temporary impairment of its investment in Mevion is recorded in other income (loss) on the Company&#8217;s Condensed Consolidated Statement of Operations. This transaction is treated as a capital loss for tax purposes which may be deducted only to the extent the Company has capital gains. The Company is not aware of any event or transaction planned where the Company would generate a capital gain. Therefore, a full valuation allowance was recorded against the income tax benefit from the impairment loss, and the net impact to the income tax provision for the three and nine month periods ended September 30, 2015 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The first MEVION S250, located at Barnes-Jewish Hospital in St. Louis, MO (&#8220;Barnes-Jewish Hospital&#8221;), treated its first patient on December 19, 2013. The second MEVION S250, located at the Ackerman Cancer Center in Jacksonville, Florida (&#8220;Ackerman Cancer Center&#8221;), treated its first patient in April 2015. The third MEVION S250, located at Robert Wood Johnson University Hospital in New Brunswick, New Jersey (&#8220;Robert Wood Johnson&#8221;), started in May 2015. The Company&#8217;s first MEVION S250 system was delivered to UF Health Cancer Center at Orlando Health in November 2014 and anticipates treating patients in the first quarter of 2016.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 6.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Fair Value of Financial Instruments</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Other than the methodology used to fair value the Company&#8217;s investment in equity securities, there have been no changes in methods or methodologies used in fair value assessment, which was consistent with those used in the prior year.&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The estimated fair value of the Company&#8217;s assets and liabilities as of September 30, 2015 and December 31, 2014 were as follows (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Carrying<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div style="CLEAR:both;CLEAR: both">September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">605</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,234</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,834</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,839</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,246</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,088</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,246</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div style="CLEAR:both;CLEAR: both">December 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Certificate of deposit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">9,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">9,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">9,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">330</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">330</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,709</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">330</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,439</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">12,818</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Advances on line of credit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,591</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">8,780</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">10,658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">19,438</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">19,371</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 7.</div> </td> <td style="TEXT-ALIGN: justify"> <div>Repurchase of Common Stock</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,000,000</font> shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares repurchased in 2015. There were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,000</font> shares repurchased in the first quarter and no shares repurchased in the second or third quarters of 2014. There are approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 72,000</font> shares remaining under this repurchase authorization.</font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 8.</div> </td> <td style="TEXT-ALIGN: justify"> <div>Income Taxes</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annualized effective income tax rate expected to be applicable for the full fiscal year. However, when a reliable estimate of the annualized effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the results of operations reported within the year-to-date periods. Our effective income tax rate is highly influenced by relative income or losses reported and the amount of the nondeductible stock-based compensation associated with grants of our common stock options and historically from the results of foreign operations. A small change in estimated annual pretax income (loss) can produce a significant variance in the annualized effective income tax rate given the expected amount of these items. As a result, we have computed our provision for income taxes for the three and nine month periods ended September 30, 2015 and 2014 by applying the actual effective tax rates to income or (loss) reported within the condensed consolidated financial statements through those periods.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 1in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 9.</div> </td> <td style="TEXT-ALIGN: justify"> <div>Note, Warrant, &amp; Common Stock Purchase Agreement</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">In June 2014, the Company sold in a private offering, an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 650,000</font> common shares for gross proceeds of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,600,000</font>. The purchasers were three members of the Board of Directors. In October 2014, the Company issued an aggregate of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,000,000</font> of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3</font>-year promissory notes with warrants and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100,000</font> common shares to four members of the Board of Directors, for gross proceeds of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,220,000</font>.</font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0 1351000 58000 152000 EX-101.SCH 7 ams-20150930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:definitionLink link:calculationLink 106 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 107 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Per Share Amounts link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Investment in Equity Securities link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Line of Credit link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Repurchase of Common Stock link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Note, Warrant, & Common Stock Purchase Agreement link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Per Share Amounts (Tables) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Basis of Presentation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Per Share Amounts (Details) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Per Share Amounts (Details Textual) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Stock-based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Stock-based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Stock-based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Investment in Equity Securities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Line of Credit (Details Textual) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Fair Value of Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Repurchase of Common Stock (Details Textual) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Note, Warrant, & Common Stock Purchase Agreement (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 ams-20150930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 ams-20150930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 ams-20150930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 ams-20150930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`+>-;$?U42*BIP$``&<4```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RV[",!!%?P5E6Q%CT]*'@$WIMD5J?\!-)L3"CBW;!/C[V@&J-J(5 MM$2:31[<\=R;C',6C-^V!EQOHV3E)DGIO7D@Q&4E*.Y2;:`*2J&MXC[_[V".9CE]JL%;DT'O<";'W).'&2)%Q+W1%ZBIO=>WK MHA`9Y#I;J;`D]<$:KH*>].;<^F>N0@NRD:01=D>:1IU76I!-C2N%V5L];4(7%WZ;)$%U)SFT%_Z63*@X M-%,MOJV(]W]\EM9+K)6<6;X6+8.ZLS'%< M:W/]T]`;T9'FU"$DSLK!D.08(LEQC23'#9(<(R0Y;I'DN$.2XQY)#CK`$@0+ M42D6I%(L3*58H$JQ4)5BP2K%PE6*!:P4"UD9%K(R+&1E6,C*L)"582$KPT)6 MAH6L#`M9&1:R,BQD'7Z2E33_+TX_`%!+`P04````"`"WC6Q'2'4%[L4````K M`@``"P```%]R96QS+RYR96QSK9++;L)`#$5_)9I]<4HE%A%AQ88=0OR`.^,\ ME,QXY#$B_?N.V(#"0ZW$TJ][CZZ\#JFL#C2B]AQ2U\=43'X,JQW8OG*\M"_V/Z'D4 MX$G1H>)%]2-F`Q+M*;V"^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%`````@` MMXUL1Z^6X@AN`0``-Q,``!H```!X;"]?1O@T( M+(W_JQ\6^]:GNR>I;:BZUI=5[V?O3=WZW?#^D)0A]#MC?%Y*8_V\ZZ4=5J^= M:VP8'EUA>IO?;"&&TW1EW'1.%^=H@,?$@C@!-&;U;T9HS>K.C-H+.V M=MC&Z,V*WHS1FQ6]&:,W*WHS1F]6]&:,WJSHS1B]6=&;,7JSHC=C],X4O3., MWME$;U]:)Y?GX*JV\(^N^39<+9K@[<.]EL>GC%/5AHG68=A)S'A]^-=LG/H9 M8G[](SM^`%!+`P04````"`"WC6Q'9W8`_HP"```M"0``$````&1O8U!R;W!S M+V%P<"YX;6R]5M]/VS`0_E>L/$Q,`A(*8UM7(I4V:$A0JC4KS\:YM!:)G=E. M5?CK=W':+&'I1/*POO1\_KX[WR\[(Z&]X5S)#)3AH,DV380>HO+*61N3#5U7 MLS6D5)\B1.!N+%5*#2[5RI5QS!E,)-ZE"UL#(H+H)*N,.OZH\#+. MLH0S:K@4_CUG2FH9&Q)L&20C]RW`,M#R`EBNN'GQO1)35UG,@M$$)NC+CVFB MH43]45K,1*89%2]NN;KCXEG_S$(YI0;JK.9&:7U-%43HM&&]4EK,]Q>,,RFX MDS45*XCJV+\W][E8@M)%I&>#4P]_50KV^M(VT(B+U9QRI?W1Q@PWP(Q4NS)M M3-\J19(51=?+$,^G'?)$-13BE;.ABE-A'*+Y*RX'3NFVU%HYR;11_J-4SWH- M8/3(K916K&/K,K_PSSV+0*F)=*O(_%W:&G$7FI";!/1#/*?*_*=4V)CVB3CW MG%KT>Q-D+"(2"(/M2&Y%Z0J+5T]))4T>9M-@M@BF!*7%P]WM=!SBXGI\-YY- M`M*#<]Z%LPCQ[SZ8]>!\ZL&Y[,'YW,JYIIIK(F,R5Z`QYX:"!+_RHM*[&PBOME8.WB-0G'>" MMP0WK9`;;&RRI$EN@3=<4,$X3;"'<#=/6SD_(,L56^.YK7&9IE(0&\R!DS.9 M`@GI]L`Q9]+`,7FD2N$,'I,/-,V^-L[NDY^_K^ M-B%'4S"4)[I]O%I"V>';8SF,)R$^?!WCM]3NG,%%#T[["/^SNP?M(]SL[F8" M-;$=6 MRUQ8/@$``&D#```1````9&]C4')O<',O8V]R92YX;6S-DTU/PS`,AO\*ZKW+ ML@^0HJX'0)R8A,00B%M(O"VL^5#BJ>N_)\NZE@&7WKC5M=_'K^.D$(X)Z^') M6P<>%82K@ZY,8,(MLBVB8X0$L07-PRA6F)A<6Z\YQM!OB.-BQS=`)N/Q-=&` M7'+DY`C,74?,RD(*)CQPM+[%2]'AW=Y7"28%@0HT&`R$CBC)RA>S,[8V!>GU M91$=5SS@TDJU5B!OF[[L=RIV1O`ZG.0@N_;I[Y\>4H9D;>4AJ*ZJKNM1/4UU M<6!*WI:/S^EL&UL[5I;<]HX M%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'EDD81_OTV2 M3;J;/`0LZ?O.14?GZ#AY\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@ M?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR M@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZ MG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2BW`A(5M>5`TR``6'!VULS2`Y9>*?IUE!K9';O=05SP M6.XYB1'^QL4$UFG2&98T1G*=D`4.`#?$T4Q0?*]!MHK@PI+27)#6SRFU4!H( MFLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5& MT?95O-RCEU@5`9<8WS2J-2S%UGB5P/&MG#P=$Q+-E`L&08:7)"82J3E^34@3 M_BNEVOZKR2.FJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\ M6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B" MRV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y M'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+`.7\N?<^E[[GT/:'2MSAD6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FO MH70^+,_Y/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWG MV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"X MU_$L%.!D8"V@!X.O40+R4E5@,5O&`RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO M*7<9;2)2.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DAC ME!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F M\M\M#`DL6XA9$N)-7>W5YYNTB42%(JP#`4A%W+C[^^3:G>,U_HL@6V$5#)DU1?* M0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@ M'K.'YA,L0Z1^P7V*BH`1JV*^NJ]/^26< M.[1[\8$@F_S6VZ3VW>`,?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;: M,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D M3@H\W/[O#;#"Q([A[8N_`5!+`P04````"`"WC6Q'5.&N^V8"``!."P``#0`` M`'AL+W-T>6QEJD\R_?@W$-)E:4EN)'TZYSN?CHYS%%9J0_']$F,%UHSR M*H)+IE2\Q0-1$EYGHG%Y(AI9>R\*I28I15QHE1;^K[,X\APF$<\IK- MF:I`*FJN(OBA@X#SOQ49CN##^=N?M5`W;X`;S]Z=G?D/%S?;^+G=N(#`<7S) M(AC,+J'W?-*)OYM7[VU1S_90/_W^,R8?H(UB$(X:=Q2VB))'$@#EBA&X@ MF2\VI3X<%QP[D=9NCW4AT2:87@X<[*#C)D)F6':1`]A"<4AQKK2#),72C$J4 M1KI02C`]R0@J!$?44+8>S433IIC2>_.)_JJ6!OG>]2>.B17U+3\;/6J]$E^-KI.3BX MA>YJEF`YMW][_R[I_=7^*[-?)]R2^;I5M:@,8[:8H>"I"94$=YJ0.8ATNPHE M^G$[BJ+),IRCFJKO9"64W8Q@/_]JY`>SSFK1442PGW_#&:G9M570OZ#COU!+ M`P04````"`"WC6Q'PFS..EH#``#G"@``#P```'AL+W=OZME,Z9 M=5-]UU"K%4]AJ-(R!VD;-(X[#0V"6:ZD6?/"1%N:^0C-%!I89M8`-A<;6,ZX MC,Y.37?%!=R`-@Y,6%%,60Z]Z$E$1#!C1QFWD/6BEINJ1ZA=T&5Q7G+A)^VX M'34\[&6K,TU2E<$&MEAS<[N]$9$,5JP4=N$6^_+>7I30%J6=#<,_=L/AT6"@ MOT!8:OD#+-BR%\418:55%UQ8T$-FX:=69<'EG6-%9,6UL7._W>K)G$N>\V>_ M;CX-YM\5MT;+T]J#EBVO_4GTHD[L@`_< M\"47W/[I1=58@-])X\U6JO2_CHBLDO-RQ*0O,S*2UE'(6&X.SZ7&K\$]/,ZJ M%^LN=P,]SI)-JC!H<#4=CJ;ST9"XT?QJ,A[V%VYRWI_TIX,102"*0/2SH"8" M-1&H^6'0?.%^+D=3!&HA4.NSH#8"M1&H_5E0!X$Z"-3Y+.@(@8X0Z&@7=,X, M-T2MR$R#<1J\/?1C%'Z\&SX#3>9KIH'T?ULR`QD9 MJ-P5#;-C7(R5BW<98_G@:D*E+Y=D]+OT]LXA+36W'/!BDIJ]`7TG7(+/PT"# M*S$X$NN:!'R]8%R3&R;**OZ"2R93SH3[BHS598Y16-@D8.PU%*5.URXGU5)4 MGKNB6"4*4["M24#7L4Q5#F3!GNHIP'(F`3NGRL(AN65:,VD/R1>6%S]JBR`S MC,.*)@%'=]P@!ZZP"3!?,07[F00$?4^3+0RCL*M)0-:]!Y6<8!1V-PG(&_QL MR,$0+./"U(H==I@&'`ZD:8O!>:+87QKP]WT,6<`3%IK6ZF]`Z/=37A$Q"@M- M`T+O1=$61F&K:<#J_2APS/=E MIGJ5:VQ2WZRYGTVQ;;7]Q^?GEZZ!ZT6^RW(-52G$P%V[DA/%JEYD0WYIS\[^ M`E!+`P04````"`"WC6Q'2;SE6%`"``#R!P``&````'AL+W=O(#(_BB35T;P3C.H@XW?5@6NN^5E06]B[;IR2L+^+WK,/MW)"T= M]R$(GQUOS:T6JB,JBVCV79J.]+RA?<#(=1\>P.X$D))HQ>^&C-RJ!VKP9TK? M5>/G91_&:@RD)950(;`L'N1$VE9%DN2_4]!/IC+:]6?T[WJZ[1*Y<%J@P"\71**!6@%D1R=@S`*X#CM"R0Q?@9"L2-R#QS"#1]D3; MD=N./':D[4C;4^<"V(K,#4@]@-2RYTZ`K=BX`9D'D%GVK1-@*T#L)N0>0F[[ MP1+1&X21I&:;8Y"Z(1L/9&-#G"?E:"29D:PZCM=2L'"[@N;\'`.T([O.UT,"5`P9\EQ@D M=@3@IBPT<(7BN^O`OLHP<>W-:=*8O4F3#`&4?T%%5HKM"+OIIX<'%;WWPN32 MN7=^W@Y0I^A/>5D,^$9^879K>AZ'+.MWQ]A4_9?V$L_C/X>V:ZIAW.U>L_[2Q6H_%S5U!GGN MLZ8ZG=?;S?S;UVZ[:=^&^G2.7[M5_]8T5??/4ZS;Z^/:K#]^^'9Z/0[3#]EV MD]WK]JUYU\?"X_MD\/-M\BLR)/T_QVI/MU03_TK;?IYW?]X_K?&*( M==P-TR&J\>L]/L>ZGHXTMOSW[:#_M3D5TNV/H_\ZG^Z(_U+U\;FM_SKMA^-( MFZ]7^WBHWNKA6WO]+=[.P4T'W+5U/W^N=F_]T#8?)>M54_U8OD_G^?NZ_%/D MM[)T`=P*X%Y@K%J`MP+\5)`M9/-Y_5(-U7;3M==5MUR,2S5=<_.`8\_M5N/) M].OIK[F[IL1V\[X%N\G>I^.PR-,2@2622CRSA+M'LK'].P0H$##7XU+OT_6H MU.-<;Y?ZP!'/RTDLD;!$3&'S/$_EGFG.Y*ZD.<9C%1Y+>8HDSQ)Q<\3E$HV< M8BQ.87&4I4RR.-)*FH,FIBX12;Q"X@D))MMY\J0=M,Y(_<)RI@21)R@\@?*8 M)$\@[1@4<908HRD4FH+20)*F(,W8W$DT+&8+D:94:$I*@TF:DEX#'R0:)<9H M)N7*ELHICTWRW#)+2]X5A43$@L:"5:!4=1JB+12T9S3O&:"GY=.G!82V0`.B M+'@2C),'HM%L:JA.,:W36V9I*X!X9V@Y3J3YU%"A8EJHAKIR-+<5%<^3&-#+ M5)I9#54KIM5JF#DM%N)=RY/>Y_*-:S3+&JI9F]:LH?[\R7K#NX!A?8JZ(,O6 M:+8U5+T:*E0O>Y?E(.3RW,%HZC74 MO3;M7D.M:I6A3G-.Z230[`O4OC9M7Z!2=:-]Q1'%DCXXD`%6AHI`B%//D'S;1`3>O2I@5JT#(WHFI9T'A0ICJ@N1:H M:UW:M4`=&L8GH`A%@X4K9-NB9ENDMG5IVR*;PN;S*X?P/LN28$KY\J%F6S24 MRJ6I#.LI\>'-O2OD4^U<4@/@/T)*?2E(M4N2ZM7*0F==[+0Y(%G3+114VY2)7KT\I%ME`0 M+(I,GC%9>9*+FG*1*M>GE8MLM:`,0;Y/:!+&-U7EZFGJ1:I>GU8OLE6#LA#? MYWDP*+,WU,R+U+P^;5ZD0AU?T[T\SEG2&R<[Q6KNM=2]/NW>6R;\_TR7)869 M;D:6:R_5:_RCZEY/YW[UT@Y#V\QKMX>V'>)XO/S+>.,<8[6_[]3Q,$R;8=SN MEC7J96=H+Q]+[O=U_^V_4$L#!!0````(`+>-;$?:H>PFN`$``)($```8```` M>&PO=V]R:W-H965T&ULC93;;IPP$(9?Q?(#Q)PW6K%(#565 M7%2*>V%84&Q,;>^2OGU\8`D;$5HNL,?^__$WQC@?A7Q5+8!&;YSUZH!; MK8<](:IJ@5-U)P;HS4PC)*?:A/)$U""!UL[$&8F"(".<=CTNGB62)TYI_+O`S`Q'G"(KP,OW:G5=H`4.9E]=<>A5YWHD83F@+^%^S*Q"B?X MU<&H%GUDV8]"O-K@J3[@P"(`@TK;#-0T%RB!,9O(+/QGROFQI#4N^]?L/URU MAOY(%92"_>YJW1K8`*,:&GIF^D6,CS"5D-J$E6#*O5%U5EKPJP4C3M]\V_6N M'?U,EDRV=4,T&:+9$&X;XLD0?S(03^;J^DXU+7(I1B3]MQBH_>3A/C8[5R%3 MC,)VRFV7513YIP@OV3E)&-AG359NR&YHX@V:>$FS6Z7QDM1)TCA+OL+YI`N_Y$DV>)(ES_TJ M3_*?/,D_>AS4ET9ZD10H/)%MRE&+7F@I@#!HVVW9WI M2__/^$"+X7H#S-=0\0Y02P,$%`````@`MXUL1X?*`O1B!```/Q8``!@```!X M;"]W;W)K?MAJ]0YD8_IFR20[RR_#?C'ZWM5_VS.QK3>KR(O MF]?%N6VO*]]O]F=39,U+=35E]\^QJHNL[0[KD]]<:Y,=AJ`B]WD01'Z17;X^OBC:U2+GMD(/ZYF'L#?GM]\^]5];,_^.OPN@CZ'DQN]FV?(NN^ M/LS.Y'F?J:O\[Y3TJV8?"']_9O]CD-NU_YXU9E?E/RZ']MQU&RR\@SEFM[S] M7MW_-).&L$^XK_)F^/3VMZ:MBL^0A5=DO\;O2SE\W\=_(CV%V0/X%,`?`8\Z M]@`Q!8BO`.D,D%.`_-T*X100/E7P1^W#R"59FVW6=77WZG&ZKUE_5;%5V,W- MWNN&JUGT?PT3TA.;]<'XCI MB!P=B#'19R,&)W*(BZ"XT"HN@G5"SBAUB)-*4_(@)R,64_HP%].3KQSZ%-07 M6?4I4">25-L[B(5DUPG$>$"F2R''(B5(==JA3D-URJI.PWXD/7N($XK4!SD5 M"D'I0URD-:DO=NB+H3YMU1>CJRZ4E#[$10'5=P(YJ4-2'^2$$HK4UR_L]$H5 M0(6Q5>'$C*7B@%2(.7)F$L1Q129,G\"8TQJ=JS$#&K6UU'9B/B\_+)(@9,F[E9^49D^&1;F\`9-0E+"+DO.B9I%D'DD1 ML@R5XWYS^14NV&Q86SFN:19)Y)$4(BQS7GLNE,&A3M-VF,.@7J(??#E&* MO+>PER$O/XAQQW2Y'`J#%D7;+0I3Z-E!>A3$<4TM]@GBECJDP/0)=)A,YO(I M#!H5;38&+TN#B\!%97M./P'9\8()AH&;P(ZS*=/F.<$N;R`QSZ@=CN!R9F M3IB<%R9_3YB<$>:#W;'"U*=A7[+Q]M6M;,=I?IQ]['V^\7YW[>G\EJUVS'(^ M8:MTW-G\2K]97[.3^3NK3Y>R\=ZKMJV*85?N6%6MZ?H.7KJE_VRRP^,@-\>V M_ZFZW_6XOSD>M-7U<[OVL6>\^1]02P,$%`````@`MXUL1R]:O[5J`@``R@@` M`!@```!X;"]W;W)K]YSSGAA"VF'R20N$F/55 M5PU=V05C[=)QZ+Y`-:2ON$4-?W+$I(:,#\G)H2U!\"!%=>7XKAL[-2P;.TOE MW#O)4GQF5=F@=V+1-*MRM;,^^3GR4IX*)"2=+G4%W*&O4T!(W%D'' ME?WF+;>)("3PJT0=U>XM4?L.XT\Q^'%8V:XH`55HST0$R"\7M$%5)0+QQ'_Z MF+>40JC?7Z-_DVYY]3M(T097O\L#*WBQKFT=T!&>*_:!N^^HMQ")@'M<4?EK M[<^4X?HJL:T:?JEKV9!7XO\`?!D,9>=RR&"6$MQ91*UV"\6?REM&?&WV%F\7M<4CN2""R-)+M@A3YR+B MW"%KA?@2`:X)R77$&PB'YQ^*\,>+6/N:W#"Z1FJC4]X8E>O4BP<6BQ%P>P^ZGJN#=^[""7>AC!(H M=Y%9'TWH([T[L;$["HDD8N[,+)'/$EN=`&`QVHQXPDRLFP%&,[&69GRI=6I\ MJ75JG,2;A3T.>WNOG5GJ3L MG-]5>6E?5J>NNSZ[;KL_R:IHO]57>>F_.=9-573]:?/FMM=&%H^.T[U55-/]N95G?7E9D=?_@Q_GMU`T?N)NU M^X@[G"MY:<_UQ6GD\67U!WG.J3\@(_'S+&^M0E5,5OZ?W\V5\OTW?!&(.TP?0 M.8`^`HAO#/#G`/\10*DQ@,T![!'@!\8`/@?P1P#GQH!@#@@^AV2>M)@#Q&<` M,P:$9KL!K,5SHY#GL+Y>]TW>P70U?C=?( M0&S6'QOB>6OW8T@$F.W$T)DA.B:&#-4Q.\CX.B:!#-,Q*62XCLD@$^B8'#+B MP;B];@_QJ$$\.B9@-4/7K)DS_:`6IDH`IV^6'(!:@:)U:/M[$AB1U(XHHAC M(\J6@CD`_F4"3K+?B1/61N!U(9D=RPZS@KH[)(E-HD9%]'=5!/ODA=IN) MJ=6U[NQ(8D=2.Y+9D=PX+ZBAR1]3X(^1U92J1O*IOU)1;T+M#MF.)'8D_3(D M$6%#RA:3.2"_;)Q!18V;C<`O4^WM8TOA=J,(L'4H!J1Q004D'S,B\E+;O2(% MB"\8MNN1P>%%N&W-*=P0#0T_>I.5IL!*4^T61DQ5I]DOJ.S_M5QE__U:O,F_ MBN;M?&F=U[KKZFK[7Y#U!+`P04````"`"WC6Q'N#I*JC\%``"P'0``&````'AL+W=O#^8>Z_CX<_/YT,\\&#]6V>NR& M+LK^Z[VZK[;;H:=^Y+]/G7Z..31,?W_T_NL8;F__H6RK^WK[U^:I>^W=9O/9 M4_5WQKNWKWT60^VY4_IN_-?OP^3O_D'\WT M!GAJ@.<&X#>@4P/Z;,!CI).S,:Y?RJYI]#1A6B_>A(Z&YFS0X:0BTA[C#I#EJ`]RGBMP8@9P@ M:&Q/IR"BW@$['?#8`9\ZR*7)_13&I,E'S15`OLRR3!/>"V$1*-4)1\%Q%$1( MA=Y!=#J(24AY4".:)&&4<`QF0$)79(494.[XR46*EZJA/!D(`=@RE.H,*X5C MI4BMD#K$7:$.D9I(%2%',RE+Q\E2.`'5R3(9!V3R4SNIC.PY-Y#-AD$F_*#J MYR3R4B,D5Q#!MN.R"5([8-B!-#\!K?P(G7-3@H.R6T"1(-(=X>4$H4B0;<:C M'I`PP[H92D=B,M-#E^\I\!`*G!*+@M&%QSP((J"H!Q32@-"FEA`R.4GV,`I1 M>-(?#9`2$L!.LM"Q8\DC*0B44J%;RO_G=1G?1X=$118;+. MZI/H?-'0OFBIDC':ICS>HB@RV4`V>GA$@4?6D8U1Q,7.9!1*Y&#S"#U$HD`D MZ]1&@3Y<%B8DI9*0,]N6ATD4F&2=W)CB#S**IBN]1I5V/$*B)*1.;4S!-SQL M33O+RW;(8R.EU6?0BV&Z7'P*270N%7F4)4'9H#\]2+"SR`LS.5()F#FV/,R2 M*$!!G]B4\M.&B)!!9J]@R%U["\Z"/J=)5*%4F*L8*6Y M)(CL9,C#+(FR%G3V4[AL)I5`*)PIY"&;!+*#_J@F`>*^5C.K-:D,A,&VY2&; M!+*#_KPF?>4O_`A6._/'`S4)4`?CD@E0`]HI$@4M+^V*ACQ#.DA4W(C2X\T+(` M;="QQH*@&,",2PAC9L\`]EC+@K5!?V`SB1E@.4I5T48)NZ]-Q9H_6EUX<&0! MQZB3F@7YR%[-"B'F9!.;/42R0&34$W92R160 M!K!%LA&VJYJ7<8.PG3W6;_MNVFPZGSUO0MZ.>Y`_G;^#Z_MI*_&SF_7J4+Y4 M?Y3-RV;?SA[JKJMWXT;;]FVE"<#KKZ M\+$_>MZD7?\+4$L#!!0````(`+>-;$>`*/HPH@$``+$#```8````>&PO=V]R M:W-H965T&UL?5/;3N,P$/T5RQ^`D[3`;I5&HB#$/JR$>-A] M=I-)8F%[@NTT\/?XDH:""B^V9WS.F3.^E!.:9]L#./*JI+9;VCLW;!BS=0^* MVPL<0/N=%HWBSH>F8W8PP)M(4I(567;%%!>:5F7,/9JJQ-%)H>'1$#LJQ\3G M$/QIMC0+%D!"[8("]],!;D'*(.0+O\R:'R4#\71]5+^/W7KW>V[A%N5_T;C> MF\TH::#EHW1/.#W`W,)E$*Q1VCB2>K0.U9%"B>*O:18ZSE/:^97-M/.$8B84 M7P@L%8HV[[CC56EP(B8=[<###>:;PA]$3;PW2\-6[#X@JO)0Y5>_2W8(0I\P MNX0I$F9!,*^^E"B^+[$K3NC%>?KJ!X>K2%^EZM?9>8'U#P+K*+">!?*S+7[& M?'7)3LY4@>GBT[&DQE&[='A+=GF=-T6\DP]X50Z\@[_<=$);LD?G;S;>38OH MP)O(+BXIZ?W_60()K0O+:[\VZ4FEP.%P_"#++ZW>`5!+`P04````"`"WC6Q' M1VP]':0!``"Q`P``&````'AL+W=O5-2VST=G!MWC-EF`,7M#8Z@_4Z'1G'G0],S.QK@;20IR?(L MNV6*"TWK*N:>3%WAY*30\&2(G93BYN\!),Y[NJ'GQ+/H!Q<2K*[8RFN%`FT% M:F*@V]/[S>Y0!D0$_!8PVXLU"=Z/B"\A^-GN:18L@(3&!07NIQ,\@)1!R!=^ M733?2P;BY?JL_AB[]>Z/W,(#RC^B=8,WFU'20LK-75&Q4Q#Z@#DD3)XP*X)Y];5$_O\2A_R"GE^G M%U\X+"*]6!R6UP7*+P3**%`N`MNK+7[$W'XJPB[.5('IX].QI,%)NW1X:W9] MG??Q$MD[O*Y&WL,O;GJA+3FB\S<;[Z9#=.!-9#=;2@;_?]9`0N?"\LZO37I2 M*7`XGC_(^DOK?U!+`P04````"`"WC6Q'3UE]RZ8!``"Q`P``&0```'AL+W=O MILGT!9CCGS!DNQ8CFU78`CKPKJ>V.=L[U6\9L MU8'B]@9[T'ZG0:.X\Z%IF>T-\#J2E&1YEMTQQ86F91%SSZ8L<'!2:'@VQ`Y* M5? M4;O.F\THJ:'A@W0O./Z"J87;(%BAM'$DU6`=JA.%$L7?TRQTG,>TL[Z;:-<) M^43(9\(FB\93H6CS)W>\+`R.Q*2C[7FXP<4V]P=1$>_-TK`5NP^(LCB6B_6Z M8,<@=('9)TR>,#.">?6Y1/[_$OO\C)Y?IR^_<;B,].7D<'-=8/6-P"H*K":! M'U=;O,!LLB]%V-F9*C!M?#J65#AHEPYOSLZO\SZ/=_()+XN>M_#$32NT)0=T M_F;CW32(#KR)[.:6DL[_GSF0T+BP7/NU24\J!0[[TP>9?VGY#U!+`P04```` M"`"WC6Q'(]A7$Z,!``"Q`P``&0```'AL+W=O:UE7,/9FZPLE)H>')$#LIQ<7Z$I85M M$&Q0VCB29K(.U9E"B>*O:18ZSG/:V68+[3JA6`C%2KB-!)8*19L_N.-U97`F M)AWMR,,-YKO"'T1#O#=+PU;L/B#JZE3GMWG%3D'H'>:0,$7"K`CFU=<2Q>9;=,"VEHD:?&PHPMZ2KS(IO4QP8JV)M'[`?$U!K^K''M]<%5M\( MK)+`:A*XN]KB)6;SI0@[.U,-MDE/QY$2>^/'PYNS\^N\Y^E./N%%WHD&GH1M MI''D@#[<;+J;&M%#,)'=K"EIP_^9`P6UC\N[L+;CDQH#C]WI@\R_M/@'4$L# M!!0````(`+>-;$=CK#MTI`$``+$#```9````>&PO=V]R:W-H965T9)!:V)]A.P_[] M^I*&@@HOMF=\SIDSOI03FE?;`SCRKJ2V6]H[-VP8LW4/BML+'$#[G1:-XLZ' MIF-V,,";2%*2%5EVQ107FE9ES#V;JL312:'AV1`[*L7-OQU(G+8TI\?$B^AZ M%Q*L*MG":X0";05J8J#=TMM\LUL'1`3\$3#9DS4)WO>(KR%X:K8T"Q9`0NV" M`O?3`>Y`RB#D"[_-FA\E`_%T?51_B-UZ]WMNX0[E7]&XWIO-*&F@Y:-T+S@] MPMS"91"L4=HXDGJT#M610HGB[VD6.LY3VEE=S;3SA&(F%`OA.HO&4Z%H\YX[ M7I4&)V+2T0X\W&"^*?Q!U,1[LS1LQ>X#HBH/57Y]4[)#$/J$V25,D3`+@GGU MI43Q?8E=<4(OSM-7/SA<1?HJ5;_)S@NL?Q!81X'U+)"?;?$SYJM+=G*F"DP7 MGXXE-8[:I<-;LLOKO"WBG7S`JW+@'?SFIA/:DCTZ?[/Q;EI$!]Y$=G%)2>__ MSQ)(:%U8_O)KDYY4"AP.QP^R_-+J/U!+`P04````"`"WC6Q'*M#&!:0!``"Q M`P``&0```'AL+W=O^>&+6.V[D%Q>X4#:+_3HE'<^=!TS`X&>!-)2K(\RZZ9XD+3JHRY M)U.5.#HI-#P98D>EN/FW!XG3CJ[H*?$LNMZ%!*M*MO`:H4!;@9H8:'?T9K7= M%P$1`7\$3/9L38+W`^)+"!Z;'\E`/%^? MU.]CM][]@5NX1?E7-*[W9C-*&FCY*-TS3@\PM[`)@C5*&T=2C]:A.E$H4?PM MS4+'>4H[FVRF72;D,R%?"#\C@:5"T>8==[PJ#4[$I*,=>+C!U3;W!U$3[\W2 ML!6[#XBJ/%:K7^N2'8/0!\P^8?*$61#,JR\E\J]+[/,S>GZ9OO[&X3K2U[/# MXK)`\8U`$06*66!SL<6/F.M/1=C9F2HP77PZEM0X:I<.;\DNK_,FCW?R#J_* M@7?PFYM.:$L.Z/S-QKMI$1UX$]G5AI+>_Y\ED-"ZL/SAUR8]J10X'$X?9/FE MU7]02P,$%`````@`MXUL1R?K)>.E`0``L0,``!D```!X;"]W;W)K&UL?5/+;MLP$/P5@A\0RK+S,F0!<8HB/10(:.=`*\C24F69]D-4UQH6A8Q]VS*`@`0I@Y`O_&?2_"P9B.OUK/X]=NO=G[B%1Y2_1>TZ;S:CI(:& M#]*]X/@$4PO70;!":>-(JL$Z5#.%$L7?TBQTG,>TLYUIEPGY1,@7PET6C:=" MT>8W[GA9&!R)24?;\W"#FWWN#Z(BWINE82MV'Q!E<2XW][<%.P>AOS#'A,D3 M9D$PK[Z4R/]?XIBOZ/EE^O8+A]M(WTX.[RX+[+X0V$6!W21P?['%-<8_VW^* ML-69*C!M?#J65#AHEPYOR2ZO\R&/=_()+XN>M_"3FU9H2T[H_,W&NVD0'7@3 MV=4U)9W_/TL@H7%A>>O7)CVI%#CLYP^R_-+R`U!+`P04````"`"WC6Q'@N)6 M]J,!``"Q`P``&0```'AL+W=O+D^J?](W0;W!^'@`=5?V?@^F,TH::`5H_+/./V$I87;*%BC@\ MZA.%$BW>YEF:-$_SSEV^T*X3^$+@*^%[EHS/A9+-1^%%55J+8IV3$*OOZ% MPSS1\\7A)P+%%P)%$B@6@?QJB^\QQ8MC#O0SOM^SYBK.M#" MW6$/)MPT:+7P86M;YGH+HDXDK1C/LBW30AI:%NGLR98%#EY)`T^6N$%K8?\< M0>%XH"MZ.7B6;>?C`2L+MO!JJ<$XB898:`[T?K4_YA&1`+\DC.YJ3:+W$^)+ MW/RH#S2+%D!!Y:.""-,9'D"I*!0"O\Z:[R$C\7I]4?^6L@WN3\+!`ZK?LO9= M,)M14D,C!N6?`\Z@N%$BW>IEF:-(_3S?;K3+M-X#.! M+X0O63(^!4HV'X4796%Q)'8J;2]B!U=['@I1D>#-T7B5LH^(LCB7/-L4[!R% M/F".$X8GS&I!L*"^A.#_#W'D5W1^F[[^Q.$ZT==3]%U^6R#_1"!/`OFCJ.5#@8/Q5O.5U>YSU//7F'ET4O6O@I;"N-(R?TH;.I M-PVBAV`BN]M0TH7_LVP4-#XN=V%MIR="Q.D+,C,J[D$ M9;E6R$"SQX_Y[K`)B`CXS6&T%WT4LA^U?@N#G_4>9R$""*A<4&"^.<$3"!&$ MO/'?2?/#,A`O^V?UYUBM3W]D%IZT^,-KU_FP&48U-&P0[E6//V`J(2:LM+#Q MBZK!.BW/%(PD>T\M5[$=T\HVFVC+!#H1Z"<"248QYG?F6%D8/2*3MK9GX03S M'?4;42&?S>*P%*L/B+(XE33;%N04A*XPAX2A$9//".+59POZM<6!7M#I,GUU M(^$JTE?)_6&[++"^(;".`NNIQ&^+)5YA\FS99'/#9',ED"^:7&,^;P6Y.#@) MIHWWTZ)*#\JE$YIGYR?P2./!?\#+HF2"@<:'[X/LFW=LT<+H_O\+Y5U#^!U!+`P04````"`"WC6Q'H*1=HZ,! M``"Q`P``&0```'AL+W=OVS MZP$\>='*N#WMO1]VC+FZ!RW<#0Y@PDV+5@L?3-LQ-U@032)IQ7B6W3(MI*%5 MF7R/MBIQ]$H:>+3$C5H+^^\`"J<]S>G9\22[WD<'JTJV\AJIP3B)AEAH]_0N MWQV*B$B`WQ(F=W$F,??7Z9M/,MPD^F:. M_BV[+E!\(E`D@6(IL;A:XEO,]ET0=M%3#;9+3\>1&D?CY^:MWO5UWO$TDU=X M50ZB@U_"=M(XRS.J_"U+0Z]R&]FWA-3^>&%]PDMCI>?N\)%63T\JJR6%N/\+9,P( M_V.[G-N`>2$%VC$MD[>&3+$E1<*4V\A\I^AV3$X?G-_5U MEVYK_SUKR)(6O_,].[5N@6WMR2&[%.R57C=$YN!SP1TMFN[7VET:1LL;Q;;* M[$L<\ZH[7L4_(9`T/0%)`NH)"!H)KB2X4PF>)'A3";XD^%,)@20$4PE8$O!4 M0B@)X51")`G15`*_Y^+.@9X"O:Z%Q"WO&F:5L2R):WJU:M'EYXP_3'`&>4_N MK+9-&IO_US4BAR3Q9X)@$#N?7$G!+`0&20S6859##`8Z2#J$0!UBJP8*>XS3 M9M*G@PSI+)"B$.FB+!4,TGI=J1BMVR<5@W28M8IQM769$&LS06>K8CP=YEG% M^/H*NZ:&<3L%5RH$>@7/I.!U"IY4T+;3LXH9Z03?%,57%'YT0B6J*C!8=&0` M`0#Z0($I4#`,Y`)=H#08!-(B-@+AB^M8),5K%B!ND!;/+""<30:*#0% M"I5`2!=H%=[+>7T7D8:#JB`(O:';8?7T2DH^D2F?2,G'U2OPB6L8I&#*@P'- MPQ@J/CQM725(%"4`8*0F3Q*'[^!2DY[JW31Y'R&:T!,2A._=T*>IP-0(5.T; MQQIT%?LCDQ$:!QOT)K6`<6Q!=6Z-O&P5D*M]:Z>C(-6-<;9!=;CA$0WC4()X M4E6,\P:J`V>D%893P#1#H7$60'48A+I8"PD:/EQ:4TL)C#J@]X#TCI!QM""@ M.-*^RU()$HY\C/[/WAE\&I:D/G9[D<;:T4O%A'J_VN]W'A'_M/RQOH"S)=2L MK^!LK5M/X6PC=CG?89/XG!W)KZP^YE5CO5/6?NIVGZH'2AEI$P(/;?^>VIU= M?U&0`^.GN#VOQ5Y'7#!ZOFW=^OUC\@]02P,$%`````@`MXUL1QSE#Z*:`@`` MLPD``!D```!X;"]W;W)K&ULC9;+;J,P%(9?!;%O ML,T](DC-932S&*GJ8KIV$R=!!9S!3M-Y^_&%$!/9-)N`S?\?G^^8X%-<:/?! MCH1P[ZNI6[;PCYR?YD'`MD?28#:C)]**)WO:-9B+87<(V*DC>*=,31T@`)*@ MP57KEX6:>^G*@IYY7;7DI?/8N6EP]V]):GI9^-"_3KQ6AR.7$T%9!(-O5S6D M915MO8[L%_XSG&]RJ5""/Q6Y,./>D[F_4_HA![]V"Q_(%$A-MEQ&P.+R25:D MKF4@L?#?/N9M26DT[Z_1?RA:D?T[9F1%Z[=JQX\B6>![.[+'YYJ_TLM/TB/$ M,N"6UDS]>MLSX[2Y6GROP5_Z6K7J>M%/DJRWV0VH-Z#!,*QC-X2](;P9HDE# MU!NB1U>(>T-\MT*@V57EUICCLNCHQ>OT;I^P?*G@/!9[L_5$N9@O'ZD-D8JR M^"Q1!(K@4P8::99:@Y0FM4K6I@0.BD`D,&2!W%DLD6%'M@56IB*%UAR^#;)Q M!!FE&4X4*U3^L"^6(T`T$2!2`2(5(+^K9*M+H26IDD0A`%;5RE1!EVIMJIY@ MFN<.X68L!!"8PA%=/$$7&W0H0E8\K8F5)H[RR`4XTJ$$NA#'\;+816CJA"QS M`B83@,D(,+0")L9""+GP3)5SE]>FRHYE5XR`T@F@=`0468%2L\(Q3%Q((UT( M7#N[3A_D.JAE@WI:>6ZX_I\/LT&\\(WFD MW-;$>3:%&PO=V]R:W-H965T1N7XKIQ M\LSLO?$\8U=)Z@;>.!)72C'_=P#"NKWC._>-][JLI-YP\\P=>.>:0B-JUB`. ME[WSZN^.OH$8Q.\:.C&:(YW\B;$/O?AYWCN>S@$(%%)+8#7/Y7?V[L:O2/V$!1T;^U&=9J6P]!YWA@J]$OK/N!_0>8BU8,"+,/RJN M0C)ZISB(XD\[UHT9.WN2>CUMGA#TA&`@#''F"6%/"!^$R#BUF1E?W[#$><99 MA[A]&"W6S]S?A:IR!5)FA*./3+DT(L]N>1`EF7O30A/,P6("@_$'A*O4AQ#! M$8C'&<3>U&5C MZV`QL<5X^C<9INB*0/N$T'3E-QCY'H.,8E"X68[N2 MRG:22C`OH*_R\MOO/5,.?_4"^4\4I`?%=]!"22:P<*8H[NAR4^"E:7H"%>S: M2'N!AMVAL;X&NCE\V3_HAFN:QD,FSUI5P8DZ#R\U[4 M*URI3\*P('"1>IJH.;=-TBXD:^\]?_CPY/\!4$L#!!0````(`+>-;$?UPT\1 M>`(``%4)```9````>&PO=V]R:W-H965TOGF0%F'A>RR8\3/C."]#NK: M",5Q'G6XZ<.ZTF,OK*[H1;1-3UY8P"]=A]G?#6GI;15">!]X;8XGH0:BNHK& MN'W3D9XWM`\8.:S"-2PW4"J)5OQJR(U/VH%*?DOIF^K\V*_"6.5`6K(3R@++ MQY4\D[953I+\9S#]8*K`:?ON_DU/5Z:_Q9P\T_9WLQ5/&0Y@[``T!:`Q(=$!D0#K- MKUC@NF+T%C#S;<]8+2$LD?P0NT#FQD/U2L]>*>KJ6J,LJ:*K,K(T&Z-!6@.C M(I+N(P+-(S9H$HZRU&V0>'),M$$R&&1N@]1CD&J#=##([4GV)DNCR;0FB>/8 M3( M/'8BR@E"?;`9S),'\V1AP(DQFM)H%FGBIJAM/K^58HN#G)Q!!/%`*HL9DG?3 M@D5*W"3X1)K9>>#9NVM`%BEUD]#__P;@V^"0/+!"@PC@/I\9D*\0@%4)\LP- M2A^8CJ\0@%4)]@>P!BJ\.@%4(]@?P!BJ\*@%4&Y@0?J`/@*`92/ MK(L1%4Y*-#GV.L*.^G3GP8Y>>F'.MW%TO$&LD3XV/^1U=<9'\A.S8]/S8$N% M/'SU\7F@5!"90[R0JW:2=YRQTY*#4,U"MIDY]4U'T//]$C/>I.I_4$L#!!0` M```(`+>-;$=J4?PIH`(``.T)```9````>&PO=V]R:W-H965TV.#7WCE6-JDJMI#I=4>VC.;D,1:VZ1`-MMO7QZ. M%R),]V(>_L_\9D`,-%?*7OF)$!&]#_W(U_%)B/-#DO#=B0R8K^B9C/+/@;(! M"SEDQX2?&<%[;33T"4S3,AEP-\9MH^>>6-O0B^B[D3RQB%^&`;._&]+3ZSH& M\6WBN3N>A)I(VB:9[?;=0$;>T3%BY+".'\'#%E1*HA6_.G+E5C]2P;]0^JH& M/_;K.%4QD)[LA'*!9?-&MJ3OE2=)_C,Y_6`J0[M_\_Y-IRO#?\&<;&G_N]N+ MDXPVC:,].>!++Y[I]3N9!D`&<#6`0-LLD@NS-(3&0ZKZ]8X+9A]!HQLQEGK/8 M+J5HF[<6EG63O"E'CF9C-%!K@$^QM140H%F3R`CF,.!R&!MH._`B'$7A)V2! M1#-MGQG[*O4[R`,.RV-S)_*7_SO14M:A M4@2<6H1R?S"NZ/ZB2:S;=2#LJ%\=/-K1RRC,-3K/SB^;1ZAOYP]YVYSQD?S$ M[-B-/'JA0M[Q^I8^4"J(C")=R;4_R;?7/.C)0:AN)?O,O$;,0-#S[7$UO_#: M?U!+`P04````"`"WC6Q'"[`&V68"``"2"```&0```'AL+W=OUAI-(?=LT.<@`8P:SO# M[-^O'X3`R#!BZH5.AHK;31*V]TC0A=UX6-7ZE%KM7%:+_=K@D M[<8&]F/AK;CE7"XX:>+TO$M1X9H5I+8HOF[L+5B?@"=G8KLP!ESCC4@*)VP?>X[*42B+RWT[T&5,2A^.'^DG9%>F?$<-[4OXI M+CP7V;JV=<%7="_Y&VE_X,Y#(`4S4C)UM;([XZ1Z4&RK0I_Z7M3JWNHGL=O1 MS`38$6!/Z..8"5Y'\)X$?Y;@=P1_:82@(P1+(X0=(?Q"<'2Q5*D/B*,TH:2U MJ/X^&B0_0[`.QE] M[2[PVH&T61!ZTV[!;`\!HUC>A,1,`]@"N,CQW,8#WA+'WL!Q%!@,.X/^66%Z M4T<=LS)RK[E.L%_MC],ME/WWR_H.K/?`L'X`ZZ,^+)_R:=*@&_Z%Z*VHF74F M7'1]U;>OA'`L$G=?Q.[)Q0]"/RGQEKG8Z9W5[\V%4NY\ED75+-T+Y]>%YS6'"RU)\\2NM&J_G%A= M$MZ^UF>ON=:4'"6I+#P$0.25)*_<+)5MKW66LALO\HJ^UDYS*TM2_UO1@MV7 M+G0?#;_R\X6+!B]+O9YWS$M:-3FKG)J>ENXS7.QA(B`2\3NG]V;P[`CS;XR] MBY6-'(JW.X-9R5#XKKE.2SN^>5O-^[+Q%0 M-#,!*0+J"7T<,\%7!/^+$%@)@2($PX3F'O$MX^)+OJ_RCGL;6X5C@\@=O:]'3KMNH)_1D+2H$F5\-:`?$4<&M5U-W;2C<,M(X?^9]" M6QF%X:RI:RM\,)HS_-',8;7@=$NV,@FQ9@F-2-A*$XQG=8RML,!D>DV_*)": M,P`8?S_>8*]6TOHL-^Z-^];^.\,=[N,.4>\<08IZUW\-1.GDM[W.E?"GKBXA&WSW5W`.A> M.+L^SC/]H2K[#U!+`P04````"`"WC6Q':71B;@`"``#G!0``&0```'AL+W=O MHU2_0%C637` MB'S@/71ZYV;E7D6?\JFC;P:M`\LH8 M$?\*H'PX>H%WGWAK+XTR$SC/\,RK6P:=;'F'!)R/WE-P*%.#L(#?+0QRT4JWOCP`E,)L1&L.)7V'U57J3B[4SS$R,?8MIUMAW$E#B>: MFQ!.A'`FI/XF(9H(T4P(]K;2,9FMZP=1),\$'Y`8SZ(GYLB#0Z1WKD*Z&.F9 M);M=!I%GMSSRHPS?C-`*4XR8T&("%Z)<(L(@G3%8)YACA-_'*,*E@--BA8C= M#M%&H9'E1U.A.[?`;D-@9P5VDT"\#MF-(4=,8C&/OOVYC>(-HWAEM'<>R1J3 MN$WV&R;[E4#J-%EC'MTFR89)LA0(?->6%'&Q&(B+?7`DJOBU4^,-FF?G-^W)7GW\"<^SGES@%Q&7MI/HQ)6^ MWO:"GCE7H$/X#_IH&_WJS@,*9V6ZB>Z+\2$:!XKW]V=U?MOS_U!+`P04```` M"`"WC6Q';?>HN><#```-&```&0```'AL+W=OG*.I.5U,7W1=[,\WP MY&+;NNB'R_8MZFZM*[J"[*)CSLIWM?V\/>OO=5V9BO;="]UW71 M_OMB*GM_#E7X>>-;^7;MQQO181\]XLYE;9JNM$W0FLMS^(MZ.NI\E$R*OTIS M[U;GP6C^U=KOX\4?Y^?S=+#\F8\&2K;OH;G-Z[WM:? M(6%0%S_F8]E,Q_O\)%5+F#L`E@!X!"C-!N`2@#\%1+.SJ:]?B[XX[%M[#]IY M,F[%..?J"8>1.P5#,UTX/IJ&:U0<]A\'5+B//L9$1/,R:V#2@$MQ)(KD(8D& M`P\7P+B`*1X7%]J=`)D$."702X*$FFSF-F9-.IL$U"[1<2U2*L[=5C1C11,K M.V>569-,FCR.8W>5A*F2D"JIL^%D5647.P?EN-9`ZNMWQSC9$2>9T\EN727# MW&EE+5*0K5(1+RGC)27KR--,QB3(ULU`[/29K7QF:>:9O)RIDI,JRCED^7HT M8M#NA4152:[<9D:>^1$0"V9P$6WYH;(<4Y\AEDEJ/8T`GA0<4!20(49W3[!> MECXB$)4?"8K#DR)\`D\A%%%!`@ M`Q+(@`PRP$$&))"!;'L2W1)JA(,+2.`"^;:17#0HR'$%*5<\&QCDN((BKB#' M%91P!6%S1#P2:H1]LY(0!5%0A<,)2G""VSCQ2*@1#BUM/7W$OUO9F2!1_&5;!U13GQT5E+OUXF@[G[?RU>K[H M[>WSX_OC/P"'_P!02P,$%`````@`MXUL1P46QG;Y`0``K@4``!D```!X;"]W M;W)K&ULC53;;J,P$/T5BP^H"9?`1@2I2;1J'U:J M^K#[[,`04'UA;2=T_WYM0PB)*&H>\.U<9B;V9)V0'ZH&T.B34:ZV7JUUN\%8 M%34PHIY$"]R<5$(RHLU2GK!J)9#2D1C%@>^O,2,-]_+,[;W)/!-G31L.;Q*I M,V-$_ML!%=W66WG7C??F5&N[@?,,C[RR8/7'TM(L\N>1B&&;Y8H3O,KL<$#I/X(P0;^=$C^-IC%TSYJSF+ M_102S"$.4T081O-1A`N9ADX@'`3B>8%H02!R`M$@L+Z/DO=1]IC885:^^\T; MQ0M&\9U1,F>TCR=&2?"ES7K!9GUGD\X+)`L"R7[O];@[MJ;GP#V7&SS/6G*"7T2>&J[046CSZ-RSJ830 M8*+PGTR]:],\QP6%2MMI8N:R[R?]0HOVVAW'%IW_!U!+`P04````"`"WC6Q' MK0L8\$("``"`!P``&0```'AL+W=O7*FK,%"+MD%\(X1?-)& M30U0$"2@P57KYYG>>V5Y1J^BKEKRRCQ^;1K,_NU)3?NM#_W[QEMU*87:`'D& M1KM3U9"65[3U&#EO_1W<'&"D(!KQNR(]G\P]Y?R1TG>U^'G:^H'R@=2D$(H" MR^%&#J2N%9-4_CN0/C25X71^9W_6X4KWCYB3`ZW_5"=12F\#WSN1,[[6XHWV M+V2((5:$!:VY_O>**Q>TN9OX7H,_S%BU>NS-29H.9O,&:#!`H\&H,V\0#@;A MPT"G#AC/=%P_L,!YQFCO,7,9'59W#C>AS%SAR6"XKXYTNA0BSVYY&`49N"DB M"[,W&*0Q"*8C!DC^400MB^S1A"",X)S(P<:@>9'0$4FH":*!()PGB!P$D28( M!X)HGB!V$,26![$=9FM283"QQL!`_>9U$H=.8NDDLSH&DQH=A):%4H=0:@DM M7/S*0;#Z3DK7#H+UURD]K"+E2%51+]=!8"FM9I4&T)#5Q'%]T%EST-): M+U`X*FH'T7Z.C\H.J<;X:7^O'AO=,!\T>=;A"_F%V:5JN7>D0K9=W3C/ ME`HB/0R>9.66\CD<%S4Y"S5-Y9R9!\(L!.WN[]WXZ.;_`5!+`P04````"`"W MC6Q'*'H`(;$B```KBP``%````'AL+W-H87)E9%-T&UL[3W;;N-& MEL^9KR@$V1T;D-2ZV&Z[)Q-`OG4[[=M8[C0&P3Y09%EBFB(57NQ6L`^#_8A= M#+#[!_L5\RGS)7LN5<6BR*)DIV>Q6`0S'4MB74Z=.O=SJOAMEN6BB,.?"WF2 M%''^QZ]'^Z.OQ>=%%&=__'J>Y\LWKUYE_EPNO*R7+&4,3QZ2=.'E\#6=O#?O]@U<++XR__N[;+/SNV_R[T\0O%C+.Q3@.Q%FR)4;\CAOW!_OK# MZ^2Q)_J#YH<&'AN('R_#6(J+7"ZR?W%VN%\MY?K#0;_[I_7?QM`ZH![GD3=; M?_K@15EM&#/'K4S#!/$4B%,OK[73R_[=5U^UKNT\S'PO$G^67BK.X<<:=M=; MJGD;V_YIM/Z+VL8[.0NS//5@F&MO40-V?'5V=W$ROA:3=^.[LU/Q[F9R>W$_ MOA23L[L?+D[.)HYA3P"N%&"Z@(W_+-[+U7J[DR)-UU?IPEBW.QAV1P/'5.=A M)%-Q`OUF25J;9[+P(GQ^)Y=)FH?Q3)PDBZ47UQK>IUZ`CR>KQ32)ZGAPKC19 M+(#Z)GGB?^J("?&!N"GR+/=B'+"V\)OKT[/K">`2/DUN+B].Q_?PY7A\.;X^ M.0,\GYW=3X"C/DQ.Q^QE4B^1!!(#:+,QK*/-]E$692*4O8:9I M)#LBECEV@3U)GKS8EP+X5P1),&`CY&01D!IN(4R34RZ_@U87U0#Y( M^!2(W/OL:'J?Y$#L[TA,0"^Q! MR"(;>WD+Y,M?Z(>:$@!J66XUQ47\"#1+:`!PL1GTR"1@NAD9M*UM>]2^U5'H M316>:QMCZ'[IK9#0:G)CL8R2E92`Y`526HF*J8SE0UB?54'K^VD!&+3F=H%' MH@X&!3:*DGC6S66Z`,Q/:VAKZ)!,HW!&,&5@4@1(_=XR1)1$TLOJ_%1*:/('UJO:^3N`NR)D^3*$+E&\:PA<#(R,19,WVAYO4'@[L.``D."E6:VO31P=O<]A MEA5UD[JQ:?)L8V1R#W^NSJYAA3?GXN;V[&Y\?P$-W.L;;6WIUQ2S5F29HA'- M@_6U96P9J.=UC>@A^<2$9=KF8KF,&L3+Z7-4$,O>((0>8+F`)O+(B/01F$T0 MKC]_FR8@5*Z\=!;6YIE(Y@"")UB$,5GE>?@HM4%25WF*5QS/;PRP2CSM1#!] M;>=V+O%7E-Y/H"LE4.$3JOQGJ=-RC`P,2L2`FWG?PBYA2^`#&B-@AY^H"<7VRVE#/E[&U(8$P6#;46.BBULY7$@6;`_M/O2ST MG]T+C*EB@>L.PJAHXK*MY-#)S=7MW=D[:'?QPYFXN(;O9VZ)Q(R+-A;(>MA7 MY"1&0VW5YXVD&"D!$?Q4,"NXK/F&*5HH9:V]8Y"?1-`A]%P"_GGHV[0QN M#,4&WMU+^S^Z-(:PY%!=YT>+'*[)?:E$FXM&+"M)T3UZ*T3-MD8FG M,)^CT[J`[TFZ`B[.GV7WVHK7:-$F7P]C.`%:"!N@M&9Q'X(HCLNL8^[#-\HAO<`=&99I2USHH!;,_*`>)]IY^E! M-EMY#:YQS6A$2W#WV:9@V4U#T1RJ86E/_("8"C$O4-OVN1?/T)F*;232<&1I MMH5Y[EX4272%E4#H+-#/4$&X5\%:0&)3D(G]ALT1HNN-E-,<6=M`7;?>BH@( MG5NC(V!KM@O>W::)+V60,5";B(?H(&Y:3@ID&RXI M/+)B;L3H5FLHK;E/>^RLNO#J^.+!0/I"1/I;A>EO[16VQN\J0:K4V`(U;]^U M/0\-J*\%1Q\>R-$&&$K>U/)!?N8?!1"M5.BM9R=H>FX7T%YMF?UER@`7#TG&*<@$P2]"6+.*'E"W>Z#Q"\:W#2:BT1,`)(:H$)W M@00H;^[7$,?VY#`IFS5*JEAR'R8;R^P%V4T5=BG' MJU&)Z97**`0)&9"UM%%PV&'_9W8]199\R6QV\/%Y_9&0E4I^YL0G%]A#DA6M MS`6EA[?J;R53?LTPQUX64C@,]&&&U-T87TMG7JQB;QUPSN(LB<*@C,W9?7$L M);_18X4?)8NN'\=3C);Y>R\^Y.(Y`!*[/A>46;[(E>!-_ M_'J)PZ:/\NOOQ#78_V+0$XW8`(XC'DR68:P@6'BQ-Z.)._0(0\24L$:^*F*O M`,E,SE$E#0LB.'4$GYT"##JYD61'SC MW437>0![$G;$W__RG]RN2#])F.>_=H$RP>#/ M@`01NB7C5SP`8-%J<\0#('7AD!0FD0KMG",'@RN`.8N(@[^80U6&%3IE*%>Q M13Y/)9MI,6K9!8;+E>S-4#_`Q([QT1WJB*=YZ,_-/!A7`\_2K#R$E88Q!M+) MI:,8M((("1W^'\-.AK_`+!C"RWH6+]!OY#0)*@'">#C9EKSJ6CI)S#V88BIE M##8%>-&(,M3OFC2;:+`G[N>P+2\DX&R>%!'F1P76*9%:3^*?BICSTZ0YB%5: M`##[L,)*$\9W?64@WJ(B8#F[3LR#?O<]#!UI'Q^?3ZJT?*8-%#25P/\'Z/3" MG[-""&KA?F=F]T>W]V+FQ1H*$@ZXO+RA(?A'[@) M0K$._YT7A"A69Q(XMUP#=!U/[B;GS$8 M>DFND6A1XVA:_%S(%/[A`AO&&[]]KP;\WO,_94G\&$:1J_'WJC$3.@C@\A%^ MPT<]%N`,S*#?1]+7+(3R+REF`1]G*A\ M),A\A2DP+8&7V*1`J]-;LJ<(YAN)&5GN)PL7'70&_0_D%K0[CL9ON3&'),3)O9B$%&M$`?HB)/\E,RZHHPII0J2P+BR4$\C%!Q5S9,3H!7%E0]4P9 M\O.2<^5$J=,B"W&S.)`:>YQ^(&6KUJ+@>`\]`E2":%3"X'\0P*WT38E!-DUH MM_`O["OH,V]A,W["^4@S8]*F$*/`A?4"&M`>M(,H:S)(#-D7R&!;?&XKO M\1S@\WIQ:3#2K$-/R&]I`]U$S&.(K4,312VPJB&,WX M_"DA"C;<21)PM`7! M9B5V0GQPB&)(YQA/=(SSRLM)9HV)ZKXOP"8:8&\,^99+(!25'BN;\&$&\@T].?B" MJTMBO79@5U7(_$S8)Q\`+LHF=OO[@NN@".76JK1\M9)-]U:RJYUB.XFS/L)E:$\S/:ZS6A];:O7Y]])+] MFYR(X6$?#(X9C5SN#8KC%$A#DT;!OX2,3?_MW0=$M,NS81[?\&HYB MW0-/@W4"E).BFWU1NOUDZ=_?7Q"E6GMFSP!?ZP,?J.+M86B"XX>2"1@`Y@CI2MK`]QD15XV`%S3&('J#5/EJ$OAL/] M[K"_^P8-H"5H\15;76LC5N)!TY4XB\#UB#DMPY0`BUU2?*4Z-4]W81LFS>N% M=6P5YP)UKWX0`7;8[09-KLJS8>`[PKC(G!M.-E M&D9;S3GJF.CVW_X#R+`HUV2**,H=.!SM=T?K.X`3K..#&`")C3B&"_D`+N1> M#K^T0`5R^:@#),M&!BFQ$TS!@\YBR21T?B_3&#KH']3+%X#-R#$&S)'NK46] M=?%)V=(=^&QJ_.S890TDD`,8Q5*UGDU1JVL,;K4\)W>,A&'YZ0L4O8$.WAN1 MZ`!EK#_L##JOCTBP[_*W_J#/WSZNFR]VP1K'BJC2S90]ES5S8K^S=\12:K\S M5'H??CO:+3+'X:#W7*Q+Q[AMDB1 M^W+<[K?C\6U'+!/P3_.0W"TN''Q<*SRRLFP=1VH4>0-*GW0LTDQ$(7'L(8TI"\,5E+\W_<#'D+Y79+*B MWDT_CWH:BZD6(W8R$XNF1EPQY;&9MP0KX'.X`%F/OA1O_U!IX-?TWQ%3`OVW ML2RKRV59)U995BU+5F9*E*5I"KCN5"B"9*LZ**=&-"EHMSC[M0._+&TSZ@G7 MRL5-S&;;D+:AWZFY'O8I`\8_1LHQ%F_.EFH1H$T!E4+!`[BJ%!*L!=Q7V,Q; M<`%-?)=:X"\<=@/IC/8D66IH",\RE3MRS@36NJ=C)&8PK:?+22LKKD"@)]<. M9*K2A$B[!1$H"CQU`*&>&?*KM02$=B@A2GF'M0AE$86*AOVD_)(P!M.)"[.5/D+UBO(A92GB ML=JB\$U9\(C9_D49<=-?`[M-PW8S4&*F*R6MCHP]&Q"D`A/'`:--=L1C@BYC M!!Y$!]:/W@PL;A7**.!U`J8^=1_0-#&5E!3YX:092FT,/R`.:2,QODX(?\DJ M"'YU9`3Q_:BH5,EI%?90,\>&:K!7B@HKY>B4#MNI4!W%;'3H1&L!@E'L4#>* M?>K&/-=N1Y#C$:VHM2[%X(<]\@705YAAG"=S\02>9*D?E-!6BR(OZ^X[^UB1ML4C8->9P^ M]6$);*U#FV*UX=;7<;!_I`8;]08CL=_;?VV6,BSGV3LD=U*F?IC16LJEC/J5 MA>SL[^MG^[VCUULMZ$#9DK2B`^@W.M"3<<5@8Z_#LM/K/0!_V!3CZVGC#CAT MRJ3JO.X?*2N[K\PK.Z0X]U#0IFDH.2E;K9"XDH]4;9`S5[+2?@SE$S3DXDJ[ MW@+C6"JD#A*`TOH=C'C!%)0AR_"+'Z9^L4!202]I@02L"P70$E7A7`2)?..* M[+.`6X`C/,6D/U:FA513@F*#:UJHPH"LCRZ,&'=S$R>RP%5E!S8R)&M(,AO" M"B[6EMITJ-7"#N&2^!`-,COI%]%ZU7+`3YB!LL=OH0EWH]F,XICE]<)+/X$S MREC`O:(J!UXUKIC-JC)ICZF0T!03Q5A:0`6<(-PIWDUDQ+O:,:>)U22FKZJO M>63"IEKA`G:1JL96RK[28*9T$H4:K*'+TPHH*_"D?Z@ZT$T+W`"!!'LB7!+* M,=3ZB(EW)>+MI??8ND5/X;7V,A1M^DA(4:3(=PF664R1Q3"G@IEB&H&83]!" M07*B?.#M39D.C#EV1P'*<3$K@(CVU'81,<(^SCTJ-I))(5COS',DRV#<>0S6J, M7U_5-=F[^'^#6^Z)$CG`4%X:`+Q!?D-`V1TX\V-5LE;Z M/N1"V))K;:>:#95J8*FD$`3]&XM.^)>',`6)?W7VP\7-M9@,P7,78+7IQ/*Q ME\8RZWXOG\)L7L9X,0$(R+A,"JK!N:$M:V[+12IY*CU-Z#PC,'&H;"9C2`R. M^#`DHUF5-;A`0^2,_4^PBQX>.@6F2^F.*SJ(WEQ&P2G!M&(B! M!769JAR[2HKLUP,:M>T5V0I$SH(8.I`1`L3>[X=S\4YZ$>9&*LB$M>AZ&?4< M00;12UMF[+Y2-&>,1O)[&7LFVL'0Z*(3(&HJ(:F=:5-G7DX:S[Q07LBN_W9' M*-=;OBSD"%BM0J1\D;K]>V0C7>"3W!RV\RN3F M!5UCU7AXW^IB5TNX-]C5X=G[O`6P-9%1>?,0U!9 MJ3]?*3L.]AR7!DM2>7HD0J3 MRH=(!W4K@HR#6HYE=:DMXB$*HD@:E&C%P/3&W157&AKRW!^D)[ M*OI#"&3<*"&)DDKKA`(:Y&40G&,?M"<5;2U(?^>_M?WHXDP'^X?E M!_BS?S0PL.G^ZJG"TA%`=\@?1J\'M0BU=5$)9XO-W3*-B6US%9P*!),AYC8$ MW'U^E?GG!AJ=[,'1T9$Z#89U:91MI#(V*N]$-9'8:688-HG4M2!>`0(@#7\I M"\K4B8S$.L6MXF@>_`<1#Z,.C'W)R1>N+W3<_73?"O#:'_AJ9-8D[Y(G##-TN&;%HQ/!U.5%$/@8B,6T'^CS M0%+H#Y."A4(,Y2:I&(8L+NM4N)7LAAU$3\$]B5Z,=3;2.A=I*E^LJGQ<:C=/ MNE0!;>K$;UJW"DS<>3B;TY&,!U"M%%V>KOCHB]4!K1"NS2EK;M3AS3*[2>4+ M6#(>X-VWB%YGWG2]AD#EMG&115J-G=@57W,P'A*L94-R-($;"T6ZRCRQBM+' M(L-KK*UK#4JC@O<;3[TB2JIE=)C2A[V$Q<`B[3("L$+2D"*J.L&[#=7,X$<= MIE047$$=&H!8D]I#G]53BR+BXK(&IK!@$XE]F1.S5#`"G+5RTJM>5\8>L:82 MA;LF^GS.(4Y]WHT-1$W,]8N@2KJ7ZHKO73ZJ4-1_!F,,5,"\J"L M%;)U&]>_B8'Y;3AL##/4ZV%W[ND&H/J]9]9M&?52W(ZJM^2C&EPY^2.-))Z- M30JKDK%/A$Z#9,I9UDF"I%(G/35SMQ2.?ADF?/-;P?!O!H90W$%^72R8=^Y7K`CK"L\ M,$;+-T&0S4IF`=C^";X?Q=?V":>7U>5B%8-&W1YHZM4"[55T7E"5_.;_5RG8 MRTB'Z>5&%V3^HXG%EA;Z!J;5B_;NM\JWYLJW;2+WVTB;OC*V]5WJWKN+NVT@:/&.\`1'4Y9M^CZQ@)/+6- M;2KOA-CF95>N-VL4LY[H[[DN`T;4WZRAONU-<2J<>[5>(_U;3&^M4/]^6-!G0)0D?7W]_7;\FM7NEY&E*1?Z[.05U8KTNI MWF_0OHB%OU3J'QFFO&5P5T1.,]\%9V ML/&T^26%\#IV+7B-C+DV2;]69$(5*'B:UW?>KEZI+&_,\SO`M0_FNP8?]-&! MJ5'%I'+G7?L0:]L^L>]+HG>*T&"DRQNO;";:F51NARIW:HL@AQ)5N^Y[KXUU M<],4[U#>XM@.=[3PX*]PMNN8>[Y/_0)PW`YUDT1J\9N=\&_;P;U[I:)QO:Y3 MA_V<+U.(\]`<+K5.2YQ]5K?FJ;/OE6A3TT'TEKW_0G-TU/+7A_^@'6J'6^]: MNGEIF^W3N=\"X0Q%6)SD@&#G;O*AY544%?7[C7BEMK)Y0VVN-(RX#M.6`8Z6 M/=O@$_ZK@]RT7^AZKOQZU^/21W2UV.PIMH)6=7W%6'&_[;RUO.=SVR$4%E[: MG9'TTMX&AW6-J.,TFU=::^M84JU=,^RU9DX@-[*9&.R2A?[*L\DOG2;7U',U\=@!/<2[_/;P?MSO0[8;[C>U>!%O+6D=JWJ&!;]@X[V:.MHR8-N>SKZYE M<.MQ=9+:';W%5S;ZQL2X,Z>J]'NV^9*@5ELFTB7Z3N%RYGJWG_L&!I=E<%)Y M$;5^,99Z(?6=?<7">4&>A+[NZ"63@^:\\CZ'BV+1XE1M-PR05?LP[4=UGTL9 MKE<`V?%9QZGC%P4.FM[]!-OQ4,0!><3ZO_7X1!6M'14+JCE43NR#9`O5 M':ZG#7/JT-[OOOJJZ75?6V5:ZF$)L/5"O(U891AJ`IDBXITRL4`S-+Y>98N` M^?HXM6$:X^6;>FT(G&_J3F&J38TN[8,![4W=X?5-/=>CZQMG4IM3;OW+-Z8< M8]M-8=_<9OJ#/ MJ.7MF\["Z.UC6U8JH7_8K+N!0",OHTS-?4KIUY5^(>E&7\^"\39-9JFWZ(AK MN5^BY1ZV-,5_W01DDM8G:`]JV2.*4[[JB.UA=?-:@[GS M@FJ_9Y@,-W[N?FND;?'5=0S6H9:U\^YWM3Z[)'(CN:AK;1L1R&=RJ<6&%\:9 M^TK5!:;UUEP/>6M><=J^M\U0*6YU`T5''_B5!8RC)I2X,AOKEA?:6@[O<7MD M-)_X>)5E^7?_`U!+`0(4`Q0````(`+>-;$?U42*BIP$``&<4```3```````` M``````"``0````!;0V]N=&5N=%]4>7!E&UL4$L!`A0#%`````@`MXUL M1TAU!>[%````*P(```L``````````````(`!V`$``%]R96QS+RYR96QS4$L! M`A0#%`````@`MXUL1Z^6X@AN`0``-Q,``!H``````````````(`!Q@(``'AL M+U]R96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0````( M`+>-;$=4X:[[9@(``$X+```-``````````````"``=0.``!X;"]S='EL97,N M>&UL4$L!`A0#%`````@`MXUL1\)LSCI:`P``YPH```\``````````````(`! M91$``'AL+W=O-;$=)O.584`(``/(' M```8``````````````"``>P4``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`MXUL1]JA[":X M`0``D@0``!@``````````````(`!+QP``'AL+W=O-;$>'R@+T8@0``#\6```8``````````````"` M`1T>``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`MXUL1TU:`#FL!```R1H``!@````````` M`````(`!524``'AL+W=O-;$>X.DJJ/P4``+`=```8``````````````"``3&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`MXUL1T=L/1VD`0``L0,``!@``````````````(`!A#$``'AL+W=O M-;$=/67W+I@$``+$# M```9``````````````"``5XS``!X;"]W;W)K&UL M4$L!`A0#%`````@`MXUL1R/85Q.C`0``L0,``!D``````````````(`!.S4` M`'AL+W=O&PO=V]R:W-H965T-;$=CK#MTI`$``+$#```9```````````` M``"``?$X``!X;"]W;W)K&UL4$L!`A0#%`````@` MMXUL1RK0Q@6D`0``L0,``!D``````````````(`!S#H``'AL+W=O&PO=V]R:W-H965T-;$>"XE;VHP$``+$#```9``````````````"``8,^``!X;"]W M;W)K&UL4$L!`A0#%`````@`MXUL1_V\VC*F`0`` ML0,``!D``````````````(`!74```'AL+W=O&PO=V]R:W-H965T-;$>@ MI%VCHP$``+$#```9``````````````"``2!$``!X;"]W;W)K&UL4$L!`A0#%`````@`MXUL1Z6@@/0S`P``2PX``!D````````` M`````(`!^D4``'AL+W=O&PO=V]R:W-H M965T-;$>3:%&UL4$L! M`A0#%`````@`MXUL1_7#3Q%X`@``50D``!D``````````````(`!@4X``'AL M+W=O&PO=V]R:W-H965T-;$<+L`;99@(``)((```9``````````````"` M`0=4``!X;"]W;W)K&UL4$L!`A0#%`````@`MXUL M1Z,A%,8"`P``8`T``!D``````````````(`!I%8``'AL+W=O&PO=V]R:W-H965T-;$=M]ZBYYP,```T8```9``````````````"``11<``!X;"]W;W)K M&UL4$L!`A0#%`````@`MXUL1P46QG;Y`0``K@4` M`!D``````````````(`!,F```'AL+W=O&PO=V]R:W-H965T-;$@`A ML2(``"N+```4``````````````"``=MD``!X;"]S:&%R9613=')I;F=S+GAM 7;%!+!08`````)P`G`(,*``"^AP`````` ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-based Compensation (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Jun. 02, 2010
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Allocated Share Based Compensation Expense $ 58,000 $ 7,000 $ 152,000 $ 53,000  
Incentive Compensation Plan [Member]          
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Common Stock, Capital Shares Reserved for Future Issuance         880,000
Incentive Compensation Plan [Member] | Maximum [Member]          
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Common Stock, Capital Shares Reserved for Future Issuance         1,630,000
Incentive Compensation Plan [Member] | Minimum [Member]          
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Common Stock, Capital Shares Reserved for Future Issuance         750,000
XML 15 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814
Per Share Amounts
9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 2.
Per Share Amounts
 
The following table sets forth the computation of basic and diluted earnings per share for the three and nine month periods ended September 30, 2015 and 2014:
 
 
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
 
 
2015
 
2014
 
2015
 
2014
 
Net income (loss) attributable to American Shared Hospital Services
 
$
43,000
 
$
13,000
 
$
(1,799,000)
 
$
(1,010,000)
 
Weighted average common shares for basic earnings per share
 
 
5,494,000
 
 
5,261,000
 
 
5,485,000
 
 
4,858,000
 
Diluted effect of stock options and restricted stock
 
 
22,000
 
 
43,000
 
 
-
 
 
-
 
Weighted average common shares for diluted earnings per share
 
 
5,516,000
 
 
5,304,000
 
 
5,485,000
 
 
4,858,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic earnings (loss) per share
 
$
0.01
 
$
0.00
 
$
(0.33)
 
$
(0.21)
 
Diluted earnings (loss) per share
 
$
0.01
 
$
0.00
 
$
(0.33)
 
$
(0.21)
 
 
Pursuant to GAAP, potentially dilutive common stock equivalents, such as dilutive stock options, are not considered when their inclusion in reporting earnings per share would be dilutive to reported losses incurred per share. Because the Company reported a loss for the nine month period ended September 30, 2015, the potentially dilutive effects of approximately 25,000 of the Company’s stock options, 200,000 warrants, and 7,000 unvested restricted stock units were not considered for the reporting period. Because the Company reported a loss for the nine month period ended September 30, 2014, the potentially dilutive effects of approximately 38,000 of the Company’s stock options and 8,000 unvested restricted stock units were not considered for the reporting period.
XML 16 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814
Repurchase of Common Stock (Details Textual) - shares
3 Months Ended
Sep. 30, 2014
Sep. 30, 2015
Dec. 31, 2008
Equity, Class of Treasury Stock [Line Items]      
Stock Repurchase Program, Number of Shares Authorized to be Repurchased     1,000,000
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased   72,000  
Share Repurchase Program [Member]      
Equity, Class of Treasury Stock [Line Items]      
Stock Repurchased During Period, Shares 1,000    
XML 17 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value of Financial Instruments (Details) - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Assets, Carrying Value:    
Cash, cash equivalents, restricted cash, Carrying Value $ 2,234 $ 1,109
Certificate of deposit, Carrying Value   9,000
Investment in equity securities, Carrying Value 605 2,709
Total, Carrying Value 2,839 12,818
Liabilities, Carrying Value    
Advances on line of credit, Carrying Value   8,780
Debt obligations, Carrying Value 10,246 10,591
Total, Carrying Value 10,246 19,371
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 2,234 1,109
Certificate of deposit, Fair Value   9,000
Investment in equity securities, Fair Value 600 330
Total, Fair Value 2,834 10,439
Liabilities, Fair Value    
Advances on line of credit, Fair Value   8,780
Debt obligations, Fair Value 10,088 10,658
Total, Fair Value 10,088 19,438
Fair Value, Inputs, Level 1 [Member]    
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 2,234 1,109
Certificate of deposit, Fair Value   9,000
Investment in equity securities, Fair Value 0 0
Total, Fair Value 2,234 10,109
Liabilities, Fair Value    
Advances on line of credit, Fair Value   8,780
Debt obligations, Fair Value 0 0
Total, Fair Value 0 8,780
Fair Value, Inputs, Level 2 [Member]    
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 0 0
Certificate of deposit, Fair Value   0
Investment in equity securities, Fair Value 0 0
Total, Fair Value 0 0
Liabilities, Fair Value    
Advances on line of credit, Fair Value   0
Debt obligations, Fair Value 10,088 10,658
Total, Fair Value 10,088 10,658
Fair Value, Inputs, Level 3 [Member]    
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 0 0
Certificate of deposit, Fair Value   0
Investment in equity securities, Fair Value 600 330
Total, Fair Value 600 330
Liabilities, Fair Value    
Advances on line of credit, Fair Value   0
Debt obligations, Fair Value 0 0
Total, Fair Value $ 0 $ 0
XML 18 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note, Warrant, & Common Stock Purchase Agreement (Details Textual) - USD ($)
1 Months Ended
Oct. 31, 2014
Jun. 30, 2014
Four Directors [Member]    
Note, Warrant And Common Stock Purchase Agreement [Line Items]    
Stock Issued During Period, Shares, New Issues 100,000  
Proceeds from Issuance of Debt $ 1,220,000  
Private Placement [Member]    
Note, Warrant And Common Stock Purchase Agreement [Line Items]    
Stock Issued During Period, Shares, New Issues   650,000
Stock Issued During Period, Value, New Issues   $ 1,600,000
Note and Warrant Purchase Agreement [Member]    
Note, Warrant And Common Stock Purchase Agreement [Line Items]    
Debt Instrument, Term 3 years  
Proceeds from Issuance of Common Stock $ 1,000,000  
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
Basis of Presentation
9 Months Ended
Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note 1.
Basis of Presentation
 
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals and entries to record the impairment of the Company’s investment in equity securities and the sale of EWRS Tibbi Cihazlar Ticaret Ltd Sti, “EWRS Turkey”) necessary to present fairly American Shared Hospital Services’ consolidated financial position as of September 30, 2015 and the results of its operations for the three and nine month periods ended September 30, 2015 and 2014, which results are not necessarily indicative of results on an annualized basis. Consolidated balance sheet amounts as of December 31, 2014 have been derived from audited financial statements.
 
These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2014 included in the Company’s 10-K filed with the Securities and Exchange Commission.
 
These condensed consolidated financial statements include the accounts of American Shared Hospital Services (the “Company”) and its wholly-owned subsidiaries: OR21, Inc. (“OR21”); MedLeader.com, Inc. (“MedLeader”); PBRT Orlando, LLC (“Orlando”); and American Shared Radiosurgery Services (“ASRS”); ASRS’ majority-owned subsidiary, GK Financing, LLC (“GKF”); GKF’s wholly-owned subsidiaries, GK Financing U.K., Limited (“GKUK”), Instituto de Gamma Knife del Pacifico S.A.C. (“GKPeru”); ASHS’ majority owned subsidiary, Long Beach Equipment, LLC (“LBE”), GKF’s majority owned subsidiaries, Albuquerque GK Equipment, LLC (“AGKE”), Jacksonville GK Equipment, LLC (“JGKE”) and EWRS, LLC (“EWRS”). EWRS owned 100% of EWRS Turkey. The Company sold EWRS Turkey on June 10, 2014.
 
The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to seventeen medical centers as of September 30, 2015 in the states of Arkansas, California, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas, and Washington.
 
The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (“IMRT”), Image Guided Radiation Therapy (“IGRT”) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.
 
The Company formed the subsidiaries GKUK and GKPeru, for the purposes of expanding its business internationally into the United Kingdom and Peru; LBE and Orlando to provide proton beam therapy services in Long Beach, California; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida. AGKE began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011. GKPeru is expected to begin operation in early 2016. GKUK is inactive and LBE is not expected to generate revenue within the next two years.
 
Based on guidance provided in accordance with Accounting Standards Codification (“ASC”) 830, Foreign Currency Matters (“ASC 830”), the Company has analyzed its operations outside the United States to determine the functional currency of each operation. Management determined that these operations were initially accounted for in U.S. dollars since the primary transactions incurred were in U.S. dollars and the Company provided significant funding towards the startup of the operation. When Management determined that the operation had become predominantly self-sufficient, the Company changed its accounting for the operation to the local currency from the U.S. dollar.
 
As of June 10, 2014 EWRS Turkey’s balance sheet accounts were translated at rates in effect as of those dates, respectively, and income and expense accounts were translated at the weighted average rates of exchange during those respective periods. Gains and losses from foreign currency transactions and remeasurement are listed in the Company’s Condensed Consolidated Statements of Operations. The Company recorded a net foreign currency gain of $161,000 for the nine month period ended September 30, 2014.
 
Based on guidance provided in accordance with Accounting Standards Update (“ASU”) No. 2014-08 Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”), the Company has analyzed the factors that define a discontinued operation and determined that the sale of EWRS Turkey is considered the sale of a significant component, but does not represent a major shift in the business, and therefore is not a discontinued operation.
 
Based on guidance provided in accordance with ASU No 2013-05 Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries of Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity (“ASU 2013-05”), the Company no longer holds a financial interest in EWRS Turkey. As of December 31, 2014, the cumulative translation adjustments previously recognized under accumulated other comprehensive income (loss) were released into net income as a component of the loss for the sale of EWRS Turkey in the statement of operations. The total cumulative translation adjustment of $779,000, previously recognized under accumulated other comprehensive income (loss), was included as a component of the loss calculation for the sale of EWRS Turkey, reported in the statement of operations for the year ended 2014.
 
Based on guidance provided in accordance with ASC 280 Segment Reporting (“ASC 280”), the Company has analyzed the factors that define an operating segment and determined that there is only one operating segment. The seventeen locations are aggregated into one reportable segment because, in the Company’s judgment, these operating segments have similar historical economic characteristics and are expected to have similar economic characteristics in the future. Furthermore, each operating segment utilizes the same business model and technologies, servicing the same end users (radiation therapy patients). All significant intercompany accounts and transactions have been eliminated in consolidation.
 
Effective May 31, 2014 (with closing occurring June 10, 2014) the Company sold EWRS Turkey for EUR 4.2 million (approximately $6.0M). The proceeds were used to reduce outstanding debt and the excess was cash to the Company of $768,000. Cash transactions were recorded for the time period June 1, to June 10, 2014, the date of closing. The Company recorded a loss on sale of subsidiary of $572,000. The Company was eligible for an earn-out in fiscal year 2014 based on future revenue derived from the units sold to Euromedic. The Company did not meet its 2014 earn-out milestone. The Company is also eligible for an earn-out in fiscal year 2015 based on future revenues, but does not anticipate it will meet the 2015 earn out therefore no amounts have been recorded as of September 30, 2015.
 
Based on guidance provided in ASC 320 Investments – Debt and Equity Securities (“ASC 320”) and Staff Accounting Bulletins (“SAB”) Topic 5M Other Than Temporary Impairment (“OTTI”) of Certain Investments in Equity Securities (“SAB Topic 5M”), the Company analyzed the recent events of Mevion Medical Systems, Inc. (“Mevion”), formerly Still River Systems, and determined that these circumstances indicate a decline in value of its Mevion investment that is other-than-temporary, and determined that a write-down of the carrying value should be recognized at this time. During the three months ended June 30, 2015, the Company adjusted its investment in Mevion to the determined fair value of $600,000 and recorded a $2,114,000 impairment loss. The $2,114,000 other than temporary impairment of its investment in Mevion is recorded in other income (loss) on the Company’s Condensed Consolidated Statement of Operations for the nine months ended September 30, 2015.
 
Recently Issued Accounting Pronouncements
 
In January 2015, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items (“ASU No. 2015-01”), which eliminates from United States Generally Accepted Accounting Principles (“GAAP”) the concept of extraordinary items and requires that an entity separately classify, present, and disclose extraordinary events and transactions. This ASU will also align more closely GAAP income statement presentation guidance with International Accounting Standards (“IAS”) 1, Presentation of Financial Statements, which prohibits the presentation and disclosure of extraordinary items. The new standard is effective for the Company on January 1, 2016. Early application is permitted. The standard permits the use of either the retrospective or prospective application. The Company is evaluating the effect that ASU 2015-01 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.
 
In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis (“ASU No. 2015-02”), which is intended to improve targeted areas of consolidation guidance for legal entities. The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB ASC and improves current GAAP. The new standard is effective for the Company on January 1, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2015-02 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.
 
In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability, be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The new standard is effective for the Company on January 1, 2016. Early adoption is permitted. The amendments should be applied on a retrospective basis, wherein the balance sheet of each individual period presented should be adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the effect that ASU 2015-03 will have on its consolidated financial statements and related disclosures.
 
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), ("ASU 2014-09"), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. In July 2015, the FASB voted to delay the effective date of this standard until the first quarter of 2018. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.
XML 20 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 2,184,000 $ 1,059,000
Restricted cash 50,000 50,000
Certificate of deposit 0 9,000,000
Accounts receivable, net of allowance for doubtful accounts of $100,000 at September 30, 2015 and $100,000 at December 31, 2014 3,451,000 3,192,000
Other receivables 131,000 131,000
Prepaid expenses and other current assets 405,000 448,000
Current deferred tax assets 367,000 367,000
Total current assets 6,588,000 14,247,000
Property and equipment:    
Medical equipment and facilities 83,120,000 82,151,000
Office equipment 721,000 721,000
Deposits and construction in progress 10,544,000 13,736,000
Property and equipment 94,385,000 96,608,000
Accumulated depreciation and amortization (46,136,000) (46,572,000)
Net property and equipment 48,249,000 50,036,000
Investment in equity securities 605,000 2,709,000
Other assets 444,000 536,000
Total assets 55,886,000 67,528,000
Current liabilities:    
Accounts payable 454,000 421,000
Employee compensation and benefits 156,000 179,000
Other accrued liabilities 1,370,000 763,000
Current portion of long-term debt 2,781,000 2,005,000
Current portion of obligations under capital leases 4,254,000 4,103,000
Advances on line of credit 0 8,780,000
Total current liabilities 9,015,000 16,251,000
Long-term debt, less current portion 7,465,000 8,586,000
Long-term capital leases, less current portion 10,310,000 12,190,000
Deferred revenue, less current portion 749,000 874,000
Deferred income taxes 3,581,000 3,473,000
Shareholders' equity:    
Common stock (5,364,000 shares at September 30, 2015 and 5,361,000 shares at December 31, 2014) 10,376,000 10,376,000
Additional paid-in capital 5,660,000 5,508,000
Retained earnings 3,743,000 5,542,000
Total equity-American Shared Hospital Services 19,779,000 21,426,000
Non-controlling interest in subsidiary 4,987,000 4,728,000
Total shareholders' equity 24,766,000 26,154,000
Total liabilities and shareholders' equity $ 55,886,000 $ 67,528,000
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Sub-Total ASHS [Member]
Non-controlling Interest [Member]
Balances at Dec. 31, 2013 $ 24,055,000 $ 8,578,000 $ 4,990,000 $ (442,000) $ 6,494,000 $ 19,620,000 $ 4,435,000
Balances (in shares) at Dec. 31, 2013   4,609,000          
Repurchase common stock (2,000) $ (2,000) 0 0 0 (2,000) 0
Repurchase common stock (in shares)   (1,000)          
Stock based compensation expense 373,000 $ 0 373,000 0 0 373,000 0
Stock based compensation expense (in shares)   3,000          
Private placement common stock 1,800,000 $ 1,800,000 0 0 0 1,800,000 0
Private placement common stock (in shares)   750,000          
Fair value of warrants issued with promissory notes 145,000 $ 0 145,000 0 0 145,000 0
Non-controlling interest investment in subsidiaries 517,000 0 0 0 0 0 517,000
Cash distributions to non-controlling interests (951,000) 0 0 0 0 0 (951,000)
Cumulative translation adjustment 779,000 0 0 442,000 0 442,000 337,000
Net (loss) income (562,000) 0 0 0 (952,000) (952,000) 390,000
Balances at Dec. 31, 2014 26,154,000 $ 10,376,000 5,508,000 0 5,542,000 21,426,000 4,728,000
Balances (in shares) at Dec. 31, 2014   5,361,000          
Stock based compensation expense 152,000 $ 0 152,000 0 0 152,000 0
Stock based compensation expense (in shares)   3,000          
Non-controlling interest investment in subsidiaries 27,000 $ 0 0 0 0 0 27,000
Cash distributions to non-controlling interests (388,000) 0 0 0 0 0 (388,000)
Net (loss) income (1,179,000) 0 0 0 (1,799,000) (1,799,000) 620,000
Balances at Sep. 30, 2015 $ 24,766,000 $ 10,376,000 $ 5,660,000 $ 0 $ 3,743,000 $ 19,779,000 $ 4,987,000
Balances (in shares) at Sep. 30, 2015   5,364,000          
XML 22 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814
Per Share Amounts (Details Textual) - shares
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 200,000  
Unvested Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7,000 8,000
Employee Stock Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 25,000 38,000
XML 23 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-based Compensation (Details 1) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Schedule Of Share Based Compensation Stock Options Activity [Line Items]    
Stock Options, Outstanding 659,000  
Stock Options, Granted 20,000  
Stock Options, Exercised (2,000)  
Stock Options, Forfeited (55,000)  
Stock Options, Outstanding 622,000 659,000
Stock Options, Exercisable 82,000  
Grant Date Weighted Average Exercise Price, Outstanding $ 3.13  
Grant Date Weighted Average Exercise Price, Granted 2.48  
Grant Date Weighted Average Exercise Price, Exercised 2.3  
Grant Date Weighted Average Exercise Price, Forfeited 5.97  
Grant Date Weighted Average Exercise Price, Outstanding 2.86 $ 3.13
Grant Date Weighted Average Exercise Price, Exercisable $ 2.74  
Weighted Average Remaining Contractual Life (Years), Balance 5 years 4 months 10 days 5 years 6 months 25 days
Weighted Average Remaining Contractual Life (Years), Exercisable 3 years 2 months 12 days  
XML 24 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 25 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating activities:    
Net (loss) $ (1,179,000) $ (853,000)
Adjustments to reconcile net (loss) to net cash from operating activities:    
Depreciation and amortization 4,659,000 4,808,000
Loss on write down of investment in equity securities 2,114,000 0
Loss on sale of subsidiary 0 572,000
Deferred income tax 108,000 33,000
(Gain) on foreign currency transactions 0 (161,000)
Stock based compensation expense 152,000 53,000
(Gain) on sale of assets 0 (1,000)
Other non-cash items (43,000) 0
Changes in operating assets and liabilities:    
Receivables (259,000) 431,000
Prepaid expenses and other assets 113,000 141,000
Customer deposits/deferred revenue (43,000) (37,000)
Accounts payable and accrued liabilities 535,000 (573,000)
Net cash from operating activities 6,157,000 4,413,000
Investing activities:    
Payment for purchase of property and equipment (1,517,000) (338,000)
Investment in equity securities (10,000) (4,000)
Proceeds from sale of subsidiary 0 768,000
Net cash (used in) from investing activities (1,527,000) 426,000
Financing activities:    
Principal payments on long-term debt (1,417,000) (2,457,000)
Principal payments on capital leases (2,983,000) (3,240,000)
Proceeds from long-term debt financing of property and equipment 1,036,000 0
Proceeds from certificate of deposit 9,000,000 0
Advances on line of credit 0 640,000
Payments on line of credit (8,780,000) (1,200,000)
Non-controlling interest investment in subsidiaries 27,000 102,000
Cash distributions to non-controlling interests (388,000) (748,000)
Common stock repurchased 0 (2,000)
Private placement common stock 0 1,580,000
Net cash (used in) from financing activities (3,505,000) (5,325,000)
Effect of changes in foreign exchange rates on cash 0 (8,000)
Net change in cash and cash equivalents 1,125,000 (494,000)
Cash and cash equivalents at beginning of period 1,059,000 1,909,000
Cash and cash equivalents at end of period 2,184,000 1,415,000
Supplemental cash flow disclosure:    
Cash paid during the period for Interest 1,251,000 1,604,000
Cash paid during the period for Income taxes 1,000 60,000
Schedule of non-cash investing and financing activities    
Acquisition of equipment with capital lease financing 1,343,000 2,732,000
Equipment relieved in sale of subsidiary 0 (4,921,000)
Other assets relieved in sale of subsidiary 0 (826,000)
Debt relieved in sale of subsidiary 0 5,181,000
Other liabilities relieved in sale of subsidiary 0 14,000
Net equity relieved in sale of subsidiary 0 1,351,000
OCI released to net income in sale of subsidiary 0 (779,000)
Investment released to net income in sale of subsidiary $ 0 $ (1,360,000)
XML 26 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Allowance for doubtful accounts (in dollars) $ 100,000 $ 100,000
Common stock, shares issued 5,364,000 5,361,000
Common stock, shares outstanding 5,364,000 5,361,000
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Per Share Amounts (Tables)
9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table sets forth the computation of basic and diluted earnings per share for the three and nine month periods ended September 30, 2015 and 2014:
 
 
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
 
 
2015
 
2014
 
2015
 
2014
 
Net income (loss) attributable to American Shared Hospital Services
 
$
43,000
 
$
13,000
 
$
(1,799,000)
 
$
(1,010,000)
 
Weighted average common shares for basic earnings per share
 
 
5,494,000
 
 
5,261,000
 
 
5,485,000
 
 
4,858,000
 
Diluted effect of stock options and restricted stock
 
 
22,000
 
 
43,000
 
 
-
 
 
-
 
Weighted average common shares for diluted earnings per share
 
 
5,516,000
 
 
5,304,000
 
 
5,485,000
 
 
4,858,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic earnings (loss) per share
 
$
0.01
 
$
0.00
 
$
(0.33)
 
$
(0.21)
 
Diluted earnings (loss) per share
 
$
0.01
 
$
0.00
 
$
(0.33)
 
$
(0.21)
 
XML 28 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2015
Nov. 01, 2015
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2015  
Document Fiscal Year Focus 2015  
Document Fiscal Period Focus Q3  
Entity Registrant Name AMERICAN SHARED HOSPITAL SERVICES  
Entity Central Index Key 0000744825  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol AMS  
Entity Common Stock, Shares Outstanding   5,364,147
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the nine month period ended September 30, 2015:
 
 
 
Restricted
Stock
Awards/Units
 
Grant Date
Weighted-
Average Fair
Value
 
Intrinsic
Value
 
Outstanding at January 1, 2015
 
 
3,000
 
$
2.43
 
$
-
 
Granted
 
 
31,000
 
$
2.87
 
$
-
 
Vested
 
 
(24,000)
 
$
2.84
 
$
-
 
Forfeited
 
 
-
 
$
-
 
$
-
 
Outstanding at September 30, 2015
 
 
10,000
 
$
2.80
 
$
-
 
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table summarizes stock option activity for the nine month period ended September 30, 2015:
 
 
 
Stock
Options
 
Grant Date
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Life (in
Years)
 
Outstanding at January 1, 2015
 
 
659,000
 
$
3.13
 
 
5.57
 
Granted
 
 
20,000
 
$
2.48
 
 
-
 
Exercised
 
 
(2,000)
 
$
2.30
 
 
-
 
Forfeited
 
 
(55,000)
 
$
5.97
 
 
-
 
Outstanding at September 30, 2015
 
 
622,000
 
$
2.86
 
 
5.36
 
Exercisable at September 30, 2015
 
 
82,000
 
$
2.74
 
 
3.20
 
XML 30 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Medical services revenue $ 3,875,000 $ 3,982,000 $ 12,386,000 $ 11,425,000
Costs of revenue:        
Maintenance and supplies 252,000 382,000 866,000 1,320,000
Depreciation and amortization 1,521,000 1,478,000 4,619,000 4,695,000
Other direct operating costs 648,000 519,000 2,048,000 1,673,000
Costs of revenue 2,421,000 2,379,000 7,533,000 7,688,000
Gross Margin 1,454,000 1,603,000 4,853,000 3,737,000
Selling and administrative expense 904,000 933,000 2,704,000 2,792,000
Interest expense 235,000 396,000 900,000 1,376,000
Operating income (loss) 315,000 274,000 1,249,000 (431,000)
(Loss) on write down investment in equity securities 0 0 (2,114,000) 0
(Loss) on sale of subsidiary 0 0 0 (572,000)
Gain on foreign currency transactions 0 0 0 161,000
Interest and other income 3,000 7,000 14,000 22,000
Income (loss) before income taxes 318,000 281,000 (851,000) (820,000)
Income tax expense 92,000 29,000 328,000 33,000
Net income (loss) 226,000 252,000 (1,179,000) (853,000)
Less: Net (income) attributable to non-controlling interests (183,000) (239,000) (620,000) (157,000)
Net income (loss) attributable to American Shared Hospital Services $ 43,000 $ 13,000 $ (1,799,000) $ (1,010,000)
Net income (loss) per share:        
Income (loss) per common share - basic $ 0.01 $ 0 $ (0.33) $ (0.21)
Income (loss) per common share - assuming dilution $ 0.01 $ 0 $ (0.33) $ (0.21)
XML 31 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Line of Credit
9 Months Ended
Sep. 30, 2015
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
Note 5.
Line of Credit
 
As of December 31, 2014, the Company had a $9,000,000 renewable line of credit with a bank secured by a certificate of deposit. The line of credit had been in place since June 2004. The Company’s earnings in 2013 were insufficient to satisfy the “profitability” covenant in the line of credit. The Bank waived this default on August 8, 2014 and agreed to change the maturity date of the facility to December 31, 2014. The line was paid-off using the proceeds from the certificate of deposit on January 2, 2015.
 
Borrowing under the line of credit was subject to interest expense at a rate equal to the bank’s prime rate minus 0.5 percentage point, or alternatively at the Company’s discretion, the LIBOR rate plus 1.0 percentage point. The weighted average interest rate on money borrowed against the line of credit during 2014 was 1.40%. As of December 31, 2014, there was $8,780,000 borrowed against the line of credit.
XML 32 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814
Investment in Equity Securities
9 Months Ended
Sep. 30, 2015
Investments, All Other Investments [Abstract]  
Cost-method Investments, Description [Text Block]
Note 4.
Investment in Equity Securities
 
As of September 30, 2015 and December 31, 2014, the Company had a $605,000 and $2,709,000 investment, respectively, in the common stock of Mevion. As of September 30, 2015, the Company also had $5,000,000 in non-refundable deposits toward the purchase of three MEVION S250 systems from Mevion.
 
The Company has carried its investment in Mevion at cost and reviews it for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may be below its cost basis on an other-than-temporary impairment basis. The Company evaluated this investment for impairment at December 31, 2014 and reviewed it at June 30, 2015 in light of the length of time and extent to which market value has been below cost, the financial condition and near term prospects of Mevion, current market conditions and events, and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value. On July 27, 2015, Mevion cancelled its planned initial public offering (“IPO”) and announced on August 4, 2015 that it had entered into an investment agreement where up to $200 million will be invested by HOPU Investments, YuanMing Capital and existing U.S. investors. Concurrent with this investment, Mevion and the lead investors intend to form a joint venture to produce, sell, and service proton therapy systems for the Chinese market. The Company’s investment in the common stock of Mevion, will represent an approximate 0.56% interest following this latest private placement transaction on a fully diluted basis.
 
The Company analyzed the recent events stated above and determined that the cancellation of Mevion’s IPO indicated a decline in value of its Mevion investment that is other-than-temporary, and determined that a write-down of the carrying value should be recognized. In assessing whether the impairment is OTTI, we evaluated the length of time and extent to which market value has been below cost, the financial conditions and near term prospects of Mevion, the significance of recent events and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value. There are no current plans to dispose of this investment but based on the extended period of impairment, coupled with the cancellation of a planned IPO, the Company adjusted its investment in Mevion to the determined fair value of $600,000 and recorded a $2,114,000 impairment loss during the nine months ended September 30, 2015.
 
In determining the fair value of the Company’s common stock in Mevion, the Company was able to obtain several common stock estimates based under a probability weighted expected return method (“P-WERM”). The P-WERM analysis considered the probability of several potential outcomes in its determination of a fair value of the Mevion investment. The Company reviewed certain scenarios from the P-WERM analysis as well as additional analyses and estimated the value of its common stock investment in Mevion at approximately $600,000.
 
The $2,114,000 other than temporary impairment of its investment in Mevion is recorded in other income (loss) on the Company’s Condensed Consolidated Statement of Operations. This transaction is treated as a capital loss for tax purposes which may be deducted only to the extent the Company has capital gains. The Company is not aware of any event or transaction planned where the Company would generate a capital gain. Therefore, a full valuation allowance was recorded against the income tax benefit from the impairment loss, and the net impact to the income tax provision for the three and nine month periods ended September 30, 2015 was $0.
 
The first MEVION S250, located at Barnes-Jewish Hospital in St. Louis, MO (“Barnes-Jewish Hospital”), treated its first patient on December 19, 2013. The second MEVION S250, located at the Ackerman Cancer Center in Jacksonville, Florida (“Ackerman Cancer Center”), treated its first patient in April 2015. The third MEVION S250, located at Robert Wood Johnson University Hospital in New Brunswick, New Jersey (“Robert Wood Johnson”), started in May 2015. The Company’s first MEVION S250 system was delivered to UF Health Cancer Center at Orlando Health in November 2014 and anticipates treating patients in the first quarter of 2016.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-based Compensation (Details) - Restricted Stock Units (RSUs) [Member]
9 Months Ended
Sep. 30, 2015
$ / shares
shares
Schedule Of Share Based Compensation Restricted Stock Units Award Activity [Line Items]  
Outstanding at January 1, 2015 | shares 3,000
Granted | shares 31,000
Vested | shares (24,000)
Forfeited | shares 0
Outstanding at September 30, 2015 | shares 10,000
Grant Date Weighted Average Fair Value, Outstanding $ 2.43
Grant Date Weighted Average Fair Value, Granted 2.87
Grant Date Weighted Average Fair Value, Vested 2.84
Grant Date Weighted Average Fair Value, Forfeited 0
Grant Date Weighted Average Fair Value, Outstanding 2.8
Intrinsic Value, Outstanding 0
Intrinsic Value, Granted 0
Intrinsic Value, Vested 0
Intrinsic Value, Forfeited 0
Intrinsic Value, Outstanding $ 0
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2015
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
 
The estimated fair value of the Company’s assets and liabilities as of September 30, 2015 and December 31, 2014 were as follows (in thousands):
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Carrying
Value
 
September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
2,234
 
$
-
 
$
-
 
$
2,234
 
$
2,234
 
Investment in equity securities
 
 
-
 
 
-
 
 
600
 
 
600
 
 
605
 
Total
 
$
2,234
 
$
-
 
$
600
 
$
2,834
 
$
2,839
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt obligations
 
$
-
 
$
10,088
 
$
-
 
$
10,088
 
$
10,246
 
Total
 
$
-
 
$
10,088
 
$
-
 
$
10,088
 
$
10,246
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
1,109
 
$
-
 
$
-
 
$
1,109
 
$
1,109
 
Certificate of deposit
 
 
9,000
 
 
-
 
 
-
 
 
9,000
 
 
9,000
 
Investment in equity securities
 
 
-
 
 
-
 
 
330
 
 
330
 
 
2,709
 
Total
 
$
10,109
 
$
-
 
$
330
 
$
10,439
 
$
12,818
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Advances on line of credit
 
$
8,780
 
$
-
 
$
-
 
$
8,780
 
$
8,780
 
Debt obligations
 
 
-
 
 
10,658
 
 
-
 
 
10,658
 
 
10,591
 
Total
 
$
8,780
 
$
10,658
 
$
-
 
$
19,438
 
$
19,371
 
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes
9 Months Ended
Sep. 30, 2015
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
Note 8.
Income Taxes
 
We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annualized effective income tax rate expected to be applicable for the full fiscal year. However, when a reliable estimate of the annualized effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the results of operations reported within the year-to-date periods. Our effective income tax rate is highly influenced by relative income or losses reported and the amount of the nondeductible stock-based compensation associated with grants of our common stock options and historically from the results of foreign operations. A small change in estimated annual pretax income (loss) can produce a significant variance in the annualized effective income tax rate given the expected amount of these items. As a result, we have computed our provision for income taxes for the three and nine month periods ended September 30, 2015 and 2014 by applying the actual effective tax rates to income or (loss) reported within the condensed consolidated financial statements through those periods.
XML 36 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2015
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 6.
Fair Value of Financial Instruments
 
The Company’s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Other than the methodology used to fair value the Company’s investment in equity securities, there have been no changes in methods or methodologies used in fair value assessment, which was consistent with those used in the prior year. 
 
The estimated fair value of the Company’s assets and liabilities as of September 30, 2015 and December 31, 2014 were as follows (in thousands):
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Carrying
Value
 
September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
2,234
 
$
-
 
$
-
 
$
2,234
 
$
2,234
 
Investment in equity securities
 
 
-
 
 
-
 
 
600
 
 
600
 
 
605
 
Total
 
$
2,234
 
$
-
 
$
600
 
$
2,834
 
$
2,839
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt obligations
 
$
-
 
$
10,088
 
$
-
 
$
10,088
 
$
10,246
 
Total
 
$
-
 
$
10,088
 
$
-
 
$
10,088
 
$
10,246
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
1,109
 
$
-
 
$
-
 
$
1,109
 
$
1,109
 
Certificate of deposit
 
 
9,000
 
 
-
 
 
-
 
 
9,000
 
 
9,000
 
Investment in equity securities
 
 
-
 
 
-
 
 
330
 
 
330
 
 
2,709
 
Total
 
$
10,109
 
$
-
 
$
330
 
$
10,439
 
$
12,818
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Advances on line of credit
 
$
8,780
 
$
-
 
$
-
 
$
8,780
 
$
8,780
 
Debt obligations
 
 
-
 
 
10,658
 
 
-
 
 
10,658
 
 
10,591
 
Total
 
$
8,780
 
$
10,658
 
$
-
 
$
19,438
 
$
19,371
 
XML 37 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
Repurchase of Common Stock
9 Months Ended
Sep. 30, 2015
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
Note 7.
Repurchase of Common Stock
 
In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares repurchased in 2015. There were 1,000 shares repurchased in the first quarter and no shares repurchased in the second or third quarters of 2014. There are approximately 72,000 shares remaining under this repurchase authorization.
XML 38 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note, Warrant, & Common Stock Purchase Agreement
9 Months Ended
Sep. 30, 2015
Note, Warrant And Common Stock Purchase Agreement [Abstract]  
Note, Warrant And Common Stock Purchase Agreement [Text Block]
Note 9.
Note, Warrant, & Common Stock Purchase Agreement
 
In June 2014, the Company sold in a private offering, an aggregate of 650,000 common shares for gross proceeds of approximately $1,600,000. The purchasers were three members of the Board of Directors. In October 2014, the Company issued an aggregate of $1,000,000 of 3-year promissory notes with warrants and 100,000 common shares to four members of the Board of Directors, for gross proceeds of approximately $1,220,000.
XML 39 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814
Per Share Amounts (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Schedule Of Earnings Per Share Basic And Diluted [Line Items]        
Net income (loss) attributable to American Shared Hospital Services $ 43,000 $ 13,000 $ (1,799,000) $ (1,010,000)
Weighted average common shares for basic earnings per share 5,494,000 5,261,000 5,485,000 4,858,000
Diluted effect of stock options and restricted stock 22,000 43,000 0 0
Weighted average common shares for diluted earnings per share 5,516,000 5,304,000 5,485,000 4,858,000
Basic earnings (loss) per share $ 0.01 $ 0 $ (0.33) $ (0.21)
Diluted earnings (loss) per share $ 0.01 $ 0 $ (0.33) $ (0.21)
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Investment in Equity Securities (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Jun. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Aug. 04, 2015
Dec. 31, 2014
Schedule of Cost-method Investments [Line Items]              
Equity Method Investments $ 605,000     $ 605,000     $ 2,709,000
Non Refundable Deposits 5,000,000     5,000,000      
Equity Method Investment, Ownership Percentage           0.56%  
Other than Temporary Impairment Losses, Investments 0   $ 0 2,114,000 $ 0    
Valuation Allowance 0     0      
Mevion Medical Systems Inc [Member]              
Schedule of Cost-method Investments [Line Items]              
Equity Method Investments 605,000     605,000     $ 2,709,000
Investments, Fair Value Disclosure 600,000 $ 600,000   600,000      
Other than Temporary Impairment Losses, Investments 2,114,000 $ 2,114,000   2,114,000      
Mevion Medical Systems Inc [Member] | P WERM [Member]              
Schedule of Cost-method Investments [Line Items]              
Investments, Fair Value Disclosure $ 600,000     $ 600,000      
Investor [Member]              
Schedule of Cost-method Investments [Line Items]              
Equity Method Investments           $ 200,000,000  
XML 41 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Net income (loss) attributable to American Shared Hospital Services $ 43,000 $ 13,000 $ (1,799,000) $ (1,010,000)
Other comprehensive income:        
Foreign currency translation adjustments 0 0 0 779,000
Total comprehensive income (loss) 43,000 13,000 (1,799,000) (231,000)
Less comprehensive (loss) attributable to the non-controlling interest 0 0 0 (337,000)
Comprehensive income (loss) attributable to American Shared Hospital Services $ 43,000 $ 13,000 $ (1,799,000) $ 106,000
ZIP 42 0001144204-15-064712-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-15-064712-xbrl.zip M4$L#!!0````(`/6!;$?IW420;7L``+^]"``0`!P`86US+3(P,34P.3,P+GAM M;%54"0`#?0%%5GT!159U>`L``00E#@``!#D!``#MO7MSXT:R+_C_1,QWP-4Y MS!9MJ?3OB^HAZI1R<* M_-%L'WZUG@];3;6K_-]JZ[33/%6;_X_R_YY]^?^4R_L'Y5!Y>7DYTJ$%5[9P MI%DCY?`P[.VZ>M($;_T%#F'\FGL1&CBS["9YLMM_ASX_0:?@X_JJ+Z(7X MP[UW_H_1HS--O[3EL^K)RVW(1^Q0F([+3"U! MB\B@/?V\<*Q.2SW.>L-_(GQ!YV.;:SBL"]\Y><=LS;8,_F[Z_-.'_CCN=?JO[\[OTRV%7[U)])2@8 MIH"4&;;!=O*?PFQW%3#=J:_A4W%V-%C+YT[Y$I.*Z2*3C>(\0N M+]C-(?;,N3&;_>_-3IT$ZL>@;B"9_F&S$S4?_%*69.H&M:1DXI@I63)JY$+J M*!DU[C3*EDP0J33[M9,,J%(BY-B09&KC$6.8Z6Q',NWZ2::]4.5/1I-H^GYNC4:6>>]:VI]?^.B1VYZ#D_%[%\(':-2]_,L# MSN"IL67"1^?L53A;%G0Z6.)/2%C47_"##H2\C@VA"==G1-%#J7PX"%(,ISEL MA8_-".7G=W.[F/+\;AYME=:;&`;.=%T@:IAQRX1^99ZSL7"907@('\L4T)YC M0].\D6=@@O7&'7(;163S(0KRF5^9FC7BA),()T6%M=^8N>,N$R;7+YEM"O/) M(8"$C\V7S'ZCX9;90")A('PL+H_]'OFOEHD_VY9A`-BOX$&;.X2$"`E9\MDS M9,Q?4*#(LR:19Z675!9`BP+76@>N-805[%)37`W(4E- MNZ"\'L"B#'H-,^A5A58RD4#SO0K/]RJ6,DCNWB7H5`PZV]^G3!.OZDZ\=H$& MFCE58>:TBY&GJ4\=ICY;0P8%F'6($C9[-I!V@-5N_KH3;-!J4:U7BW:!&9IU MUL34TT*RC8K..K8T\S3IJ-NO8<#4*6C&I<<2YM5P%19Q[$W%N+8MQ^6([ M#Y[])Y_X;.E<7/,G9EQ*NNN)!.#A=(8)-G).T\SNF:N87ZGQ^^5H;%@3SF56 MYF:,QG&N&3@WF./<#.1C]1SX&1,PRU+XR$*AU&M1?.4FR@-\J7`-FB*&+I?6^V M$#C-[Q";(6?/'",V$#-#A;LUF/DV4)/#_DY"FN9ALW?8;&TJ6EUG[+]_$:88 M>:/X`W?,?")@1,!8I?^8",.O$H(F&*9AR%X)AEN!85S0>PC#Q!ZUV<#A[O[; M_OO!Z:)0A@#V+&^SL&H#8:`*&*CR#&QFD9D@4P7([&)A\0M_END)76C,N)_` M]'/D@,=.A"5<)L5O`;.3!YN!!Y=%>9V/D_@O]0;&,CQB4),IMCU$3"S((,3L M"6(VO*047;(!LR/,:UDV060QC^$[25GMRI)LZ(J1!2$K690Z6Y0:!;JE`NW[ M[1_<'A5XEU!9`)4EDC:E)39">Q:3S;]X[?O]D-G\CH\]6QLRA]_:UI/-$AB= M_T2](9K%$\(@2RJ[6U&KU'5SO1B<>A&<;FWQ##W<&DR32]X)('F/CM`%LR?W MS.#[L;2_F*5HQ_%P.1+U50-3;#(C49JRD1S-V8-+E9Z;^![/!1+NW@1*> M/=G\C6,*35,AX>P,7KARL7Q9C^9FRGHL@-V8IN??96I$8\CXU]SX[10IYGQIYGU*1XIG"AXF#VZO2 MHSKBS/%L_DO`A7PD;"[\+=X%MK:@_6_W%PL:%X[5::G'I_#$ZFU_!X;]C7.I M7N1".T^+$U_]ZHU@T%W+3J.H,&EQ@:=;G-/A!3>MD3"SN\P3=;K/V4;#7V.< M%Y#AY;>[G/&!)U8^H]&M:J9 M,SPS=?P/IFN?F2$SM>XYL^V),)^D*BN!,MSQP4Q\?B!I_H2I%/V[>J!@Y_(Y MA+"B_-)2^QVP6S^_6ZKS4$IK4CRUZ0F*6YD4J\WNR?H43[.6 MY4J[G4E[MYF@?$DB2N=A@?P[6^3A@H\M1\!CCL-=Y]RSL9)J86EW,RF-43FW MFQ5I62"U7B8M"-F$W`I1=*9IE@="O.,:!X$^&OPK=Y<5TG$F8>U.5TT0EM7G M>O0M$%P_FS[UI+4R?;*`XO1!9P7IG60;HW92>(L[7(>T!8)3FQNB[=;F8R;T MRU>LDX'[0N6KJZFHFNU_.LUN@L@"79="[2*19OL>B.[7I?:"#SC\H#^P5_^Y M%3"I9GN9=N\X96H6=KD6=8MDF.T_UJ!N101F>XE>MY\P*`0T\[QF#RLVTY3G&99#N%?EMM)=W5XC[7H6Z1N+)=0K^E MIGQ6<>IN;0OF6>X$"_^X\:>EYA:77[9;.&ZI*3N1U>NZ-"X*H[/=PVHTXAIL M%+I`L&?!W-WVY#3FRI0GFKCC+(?%5K:'@'B_XT]1BO==!K6+I)HS.VD?MWLK M4CNG`C0T8$/SLE85_&UP>;#0U,]&ENV*__@UK!8-7/$1R/8GG9X:\%0VA=OC M?-%H9ONJ3J][/!-];H3SA0^"-RP^CMF>KM-O=4Z*Z3STNAZ%B^2=[0@A%DPA M;1D*_;UM7[@[M'2_?@$^N(0ARG:*O52HNJ"[E:E:)+)L9]@Z;IZL0E8L4L5= M\$O&5*UL_]?I=&:G'NG.5J1H@9C:V=ZNF\)5(8K\WXOG?K(=61<"S=Z<**]H MKXL8SW9(O>-N:UY\NV@J?\LF.#M<-LANY[B0;F?N)#[9VZHT+9),CG%OS4]\ M9-,4%M4.MJ=="_8H#.$*OO2\I)UMK=5N$BRY'9=`Z2)!YDQ?CD_6H]171DVS MO?4$FFV_(31KSK$!B[I=E\A%LLPVY\>]]AHT7EOFTP.W1Q?\<>FD0CO;I+>. M^TEUF=/72N0L2D)GVW.(RKK+DA/W/B4.+D;=`15>185X MC*4I67!E8NRUXE+*=AO=7B]I1?*[+H/818+,=B+=;K._)K'I6XL3:V@9.K<=/Q576)*]G(60D^/4 M1'NVKU6H622J;-?14CNMWI+4?!&F973],=+4_((J'D MI)2.4[FV/$)BKN',U-?!3K87F,T]YO6\/J6+1)CM)6;SEXLK,Y9YYKJV>/1<3/,]6//O;"XN^6S/TNH<]_+T9!7ZML7UHE',697HJ:DL MR(:XYO+GS]SD-C-P\4T?"5,XKLWPJI]@8TZ2J_DU2Y/<9?NTDW;2I16CHE3: M$X?)D]O]LEW<2;-3`NWA>*PJX.-L5]<^2:I,JKO5J,D068ZK:W>7H>9FC%OH M)6CQLN;KF=T%1>23[?!:J7G;G"YGT,8,[@3SNGMN/PM-[@!=!)/QE! M+>AW/?(RAC+;#[;[Q]U5R//+&D9B_@)!HVVU([Q_W4+'YAW^N3F2'8G`1= MMY7.BA0F,[A3WG%O!M%(!/A?6IK]G-F4FIRN9'2]/I6+A=G/]C6]U)[>):B4 MN[=N;6N0GH$6D5W./K)>:H$FUM?R9&0()]O1J.F%^PPRBON]#')RO$MJ`:2` MW_MDV5P\F?Z*A!:O,?,9[`^^\9$/X)D']KK\&!8^?[($%>4SD"'N;/=3#@-A MN!1NC_?':GEAYRS\S`W1DGVN15F&%'-.L*Q$68CG3[8U.@>"A.D!S@/`8X$D M*6[_.1`Z=]*I!N@@V4JAC6A%!B)GHT`J8[]%5JHGQ<6@.L1E#$>V.TZ=02M(G.\G5YH`GN1,`%.A];2G MI6G(D$FV,VZU9K;J+J`!)E13Y"V?ABHBKFQ/W&HGP;4T09OB*$/X.8MI_?8& M.5I>_GE;[Q83NPHA&6++]L6=)0@)UWQNN2W+,GQDCM"6ETS*6\;*/"P,MN;V MO`YYB^4%OKH(?2V@[PA+'*Y%XH4P/)?K2\M0;:KK"S'H?#T:LP39*D60"\A< M*5FL%I!L7J(QY?FVF.J>6W@W17V.ASK>0K*[B)!SMFBD]T6LE>XN(K8BM0I* MS'<7$5&V`SGLI`^SEY7Q+D);3M)0[;162BHO1V#6>.:D"UOMU.+O1K/>!22: M6[D@=?IXJWGO`@+/*6K03ZWX;CSQ743D.1O">R?=S6>^BX@V]RQJ>C/E!E+? M1>29[7K4WO&<@QQE)[^+R#-G9M3<1/J[B/QR5KZ.V\?KY[^+R"?;\73ZW<)Y M^.*.,(N>'&>3/L*[T11XD7',\3V]I-_>22*\@-ASBB5L,1->0.8Y%1-:Z615 M:;GP(H+,6=?JU"H;7F0PLAW68;^5CJ;?8#Z\"'"R'>IAOUNQ=86\I',1[.3L M5DDO'968$B\R(CDNNC5OB6+UI'@1>>7,$M/.>H6T>!&Y9+OH0S5]('ISF?$B M,LO;2W*\P43R&BQE#$!.K8=>RN)N-#=>8`1RZD(1)+=6^+)=T&;H*C*LVJBB&SRQ/&5[::?,A7@;Q',QJP#??#+!PZB;V5*@Y MY2B2!WG7(6T[G&9AJ?`^R.UQNL)X+;4)(Z/K]:G,DO52.S26H#+(7,\\+R?W M"Y-V9Z8N/QG^"H+^;\]7OS6&(=<';I;BG-'TAOI_C/.X??[*9VZ=3S''[[>ZRN2_S6NWN7N?)> M*;];'&#+E%?PX&5P25GE52E+'8.LK:@65,9956PY58]/4J7(ZBNV:9F;1<9B M11'F%.`Y[*0*\-16A.G*0:O**^_PZLE6RFQL7EZW#*NBK2JEG$T')^DEH=J* M:?XKJXHM9Z]=I[T5CREOBKSQ7+P%%-O:L/-+U'`*+@V-,7[U]1-N,TQ5U9\A M5K+AN54%Y-%$9K; MY:=<;LNZ]/*MRW&WT,#Y=&_,T60$VSFUS-K'A>SC+KQGZ<-9 MQS@JY3Y*G83D5&.K#31*\C8Y5=_J((FU?%1./;G:P*%4QY93SJZ:\LA837R=3Z[B"G)%_Y0E@WB58&SQO-O"V:T:R^]CHW^^H;N:UZAK67H#[EC?78WEI?*J0>Y M>]9+\A$Y52!WS^=:MCBGC&092W9K,UBJQ:WSHIL&"L%A[99(JK MA`QEBMB<6F,[R*"6,`)YQ3"WSU2YCB^G?N9RK$W/$%V9T>$UP9V/D_FJ7TB/ M4O3FW%"G'D?CL30U&V>E#$`6.N=80=9+A6TK73RT/F+85!S72I'L M7'D,;,[,%M[V5AHS91G(G.I!)^N7]M^$@#9'=:D&*J?N;#MU?J.L\E'K MB3ZGV.SLR;[2R"Y7]MF!07J'?FE,K&_YX%7KV`# M6*YWT7G!7_T#ASL..W+J6L>D71;#.Q5D22%/3G'L?9/:6O.\G`+8^R:K4B>7 M>86T^\EZ%IL2X'*YC10+.;.#;J]HAF7#PYC%0W96[B15PKVF."X[SLVI)[YO M`BLY.BT\2=@/X6TLP,DIJKYO@BPIP,FI[;YO4ELKP,DI/;]OLBHUP$E7R-]/ MS[KX0$XK77Y_1Q'>5D/D]4.+]'4`>Z=RFUPV2=]1L'WA;;R@5'E^,#OR[W;W MHZ[;NAXP.])OJ9U6;S_$5*[SRZF[>-RJ<[G*4@U^SD47:C-]UW1M956NK<^Y M@:,K;_3="[%M;`)9_*J0V@JO)&>96UEK/,N4!%/4DOP-=6 M3*4ZRYQ;6SHG_>-M2"U_@TJY?J]`#:)NN]=9;H/*%@*E$EC/N?:EYBY_8YGC MG(MHNMUFG:/*K>2,BU]ULQGA33O2[+\DE;.K35J)UDB M>6F*ML)2R9J3Z MK)>LUX6J4U91#!OSX1V^:TNCO+L(RHZU$[?:;/HN@K`)4&:Y(!\NS%^9MS8?@S0O^(#;-N#\ M%=_E9Z9O"S&ET;Y2YCEIASU\RAFKIB>E/OCZ.6@+6&O[3']FIL8=^.J"CRU'K#2(.2?T4U4Q682N MC7*7,8;'.?'E7/8! M5BJYKW,%HC;'5\9`Y%SBH;9344\)?"T^;?T9IMIXD.^;"=[8$/_)FILN'*B< M!:E4;8YEB-D`(UDC4SAEL`X/8?[%\H_YWQ".^4>,KLO MA]HL(>=4"9[QPTN1NVS&=J%,LUU:MSV[FR?_BI%R+HAIY=RZ,'-!S(IIBC`N MO^,:%\\8FJ\@QISY;*>=EY28I:)$RK.$G+,"D0JZ5B'\CH_91";:;@;7EOGT MP.W1!7]UZ0P0YPYM??5CEH>A4&2\AK'X>;1$$^KSOIR M2NJW6YUF+M$+B"F?CRSAYVRQ..FWR^(#YH`:Y[J#QX_"5Z^%R:&E<[#BJ[BW MDVSWUDL-0BX%99&<)?!E"L4M1^V\L5E7P#G3MU8S'^8;H3E+PMD^L'_<7Y/F M^,"$9^RD)QWFG<-=*.8<7WCE*0Z&!*+IZ8T5 M,"!%[D-8(.5V3EWX5"&37`)*(WFQF-OY==M7I_=R,.":>S.X?(5GS2=^QUQ^ M8V*V#G/E\!]<-7MF!K9:2JJTG5.%_3`)F77IVQ*_6:-7>-)8-J_SW_17*-/Q MZ`KCF.UV#SLGR:3>,M1L@).L$ MXYI/FB<%2$]U7Q+-"X&3,SWMJ$7$G4-S:`D?K"#I!;X'%,6=W!K,=*$Y;&J, MCZR`_+RK]/ISG4@^*:4SD07ZG'1O-S7A6IT+N7X>Y"7]+$V0HEE>\CE%TM-U M)>=UNBYU&2+-J8:>2ML6IC#FU.,!5+!J?6->6VSY!%8[I^;Y_*!B8?\ETIPE MX&Q7>BAKY"^(WPJ3C@G:&QM3M#?F/=B:FX&_R6>Z>W2R`N6%MU<5Z+X\BK/P MD>T4#[O'R5!Y!;IG3,H79O_)Y2FK>ZYY]FH;#MHYMMI?,/T"@-1N'C@&F1MGL.L`]Q?/?$MG$_8>XEPE4SGNT;%V8^/9:^=AV3F5MM=GN+60MGYZ-<),Q3CE% MJ3?,1_INQ!5&H[BS+D1!J71GR3W;8:O=_N+<;#[U>+PCBCKON"'X,ZX#!MYG M#6^=7^ZX8-?E4)HEX!POW3EIJ=%1F"4)CNU[+56XA8ZM%>J\+&JS!)RSK[@? M5,5:B68T(:6*MM#9L.Q>UZ8O2YC9[K*K]J=@+4ZE%'ML+VB9$LVO/+L:AV6X7V M6QKK-;A%V"Q*X%7:SQC9GQ;C; M;FV2W?C\8IH_*64QO)U3WC*EHL4I*9V'C.')*36I-F?N^5B1"?\LYA?N#G') M++3&-R\F/#L4XUMN:_"9/64M*W6_7[[8SH-G_\DG_H%/G8MK_L2,2T"".YDY MW]E.E($<>S9/\Q=;BRU*X'([D#_R`?S^P%Y7&)N.EZ)I$PQEC4J!(\/= M5FIL=L90$3-6I%IAI]^M%D-9(U3@?E#@IU\>0W(/`)H+9@0[;^1KR2IRTUW7 M@>4\PR/S3_*]M.4NHEC]?"Y;2>N]/IE;8SQK>$\*#.^<\[/59KR`HB:J_RU@ MO)Y,9XQVHKS?+IA>8!@NA.'ABDUV:=DBBIRHWK?(_G;57A%SM8BJS3"5-6SM M`DRUFX7<_G:8*J*`A6*98IYRNTQEC52!>*:HMRS*U!F$ZSH^*YYC2]>7KUB$ ME>LXN<"#2:"N&+W>#,*Z/Q"#RZ;/1GB.I@BKWR]'8\.:<"ZW)MR,L;VYI6+. M#>8XP0Z&V6E$MT"(E-H#5@J+VY1;LK1.27(K$(FEIO^UDUL2;]_DS!'+C^!% M.QHJ`XKF&P@A4;;J[(79^L-DS.<(K4!@MP6LQ;:0!R=]?+4&SKC]#,U:]B@=CPN+MW\F&O1>53((Q4>^V2!71F&);&0H\X<^)V_K[3 M`M%53D6_9.*Q&!&ED%X@W,@IPIS4P`$5E@,'FRWYQ\- MP[72AR$S?1?H?+4"^^Y'/#F7FN#]C34'G MRO1/6A0L-;R6U(O4`U2W)/8D]]N3^N]RK+@SS%?(I)/MN^@*C5W2 MBU5B[-3B8]?9OJ.OT-@%SA#FE4XE!JY59.":VXT4"@FG'DZMO(%J%QDH56K8 M6_5I$4U7)DC:=(2VZ5`C769VM^JS@/]=!159H[`98]:MTFAD"6-7L<+VAZ17 MI2')$L9.0H#MC\=QE<9CH20JZ#/*&X)^E89@TSXCZ":V7R`_NYZ25X'5P711 M]-+)+5L>2>?PV;:<%?:,]0NL"[9*RCDMIGNY"X&F6PZ\H2Q*YX%3C%>:#]9J4,^A^X=6(>%`BFP%ZW7*E(BN4+6(<`@ M;FA<6AX%EA;[Y8ICAMH-PB,UVPR5]1;<<>8\+R6D0A.%UL$O[2.UC`SQDRG>-D M2I9JH:@;<-H].EEF=:%DQBIC.A?*L?CB6K]7?=-9W+65([YTZ?X,\1V7L5"R M'!]SQ?>8W^WCTJ-VQT=,X$95/.=K@W`\9F`9IM;RFGT"IO"V^Z_.%[5YD9+8 M=DDO6WJ+!VT1""J17%WN)>WI3TFM+[/6^M+K5 MPM[\`\].9EKK"W\6>!)`%QHS[B>.RT?@L[3$!EPN[[#&JZGB9Y#!"<9_F`F2KY8)C7FFCAB;?R5IIAW.+C#2#4N/+NQJ98''UIXV*?#L M(B.MXU0EZ1R)+P^K_O=FQX>5_YQEE\)61C&1PUZ0[6J6QUFQ$@81KREBXR%G MNCY!Y^"7YE&SV>WE45J@2$&,K6C5]4(XFF$YT.O.=#Z[.$@O-4[93,RP/!K# M0U(^@X5`7+""LCF>.WG74:AJZFK,^6S$#1T*POAEPX\ M.CG74,R4SEZ5LMG[`1_=Z6I26.@6K[8HP$\60CNYMA)4)WY/8!$ZBHS/Y>M8 M^/6%<-?*\A%TI]E%OZ-V#M7685O-%GFJL[E+)].K7FYMZ\EFHV2YBC,/_(.- M-TT^6!_Y]&%]<:B!-QPD*"ZP)5]-(V@MVHHQ&D6W*W.\<(P*[(4_GK-@M#:) M.8S/68LJ"_&>"]B M/%T\.,%R5.(O5K%^#L>%UI/G@#^7@X)\2R>R=;9S+MM0TYZO$/'%*D\OO"Y+ M;<8\73.:%WVU7'YFZG\PG#&[MP'0SIYLOC+S>970TC=-Y/&1[1=Q2KXK3OU\ MSB)/B925H9X+^/ED>?:%L+D&\[W$D?@'X1JR,KXNGH7N,6,.Y056IU+DXO+,T?W#+5]>I:/"['P`;'*_ET1K\UCQ!_+2U#%06J&[8QF4=0^;)X?M M9I*S1-/S^OX$`3XS_L69_0F^67YC3D?M^[TG^TTUN[AGG\!5^SXY^.5_M^?U M'&LVWO>E+*]XQY\$&`FP0E_9:`6!MP"]9U\N[Z[.S[XJ][^>W5U>*+_>W-]> M/9Q=*_>7=[]?G5_>^U3-ZW"6H'..&4X#E(F__I,O7P6YTU)AV@#_=]SI]%O= M>->IIN-]^P468T.U,@);8(@/PSE!5M.SK'\2!K?/X:S`I MT(@"<9IE8]UT>F-_C!!`R.I_C-.9?D#9G\U[65"3GPH233CM5 M8RJ[XW7)7)1@R+DIX:37:\[HSOPC-DKU`.564*XV?67 MT^'#4E24S,)"P>?+Y]`R&MM\R$U'/'/_GH>O'!Y_8*_PR?`08[<8]UAFLC@H7M")*^>68<`C M8=IX!<1E^YE.6JZEDKL;:62-;8[+VB-I%-"ZG)L##M7CD[0)V`.!9,`CYQJ" MPU9[QG-L4AY8,-^_V/1".'(SA\#"B?Y-7RL,=^'+_#([+H/*K#'(N6Y@YO+7 MPH3>V$_,%/^1BUKGT767.#:F?@ORQRT+_OO!+1_,B`J,.M.EU`=@YZ,QDR$N M-`(PW?R?AOM>%\^*XTX,_N'@R]G=YZNOITIS[,(_K^^53S=?'TX5%3\_B!%W ME*_\1;FS1LQL^%\TE'MNBX%R\#^?W/=*JKGSZ\NSN]-'RQWZ+1U^.OMR=?VO MTU13[^5O]U?_UZ7?U?N5R3A0F"&>S`\'__8<5PPFDBHDZAU0%5$H81_2^/'F M[N+R[O#CS"7ZYOOSTD/C>I^[PX>;V-$X=3-/U`B1&[\=Z MC/H*VTR1<'?U^=*Q@W#&3.\^P6!*#^/F:X'GZ>LVB&?#Y?_Y^'P[/KJ M,\@UD,Y[Y??+NX>K\[/K\`?7&L?>U<-W_[BZ>/A5]I\WS/Z?"OX]7_;O7'U. M!W'B##Z`WX,N56$NVR6N#2CJT0H]QT&S1(N"H%9H\*YF[Q=F?7PB_%.%@DX]!'*TSJ[ST?NW)92FDW&PHZS(@SZ-LS7/D4[I>U MII=_#2Q;/N$.;<[E\Z8PN0)S>'>HC.72@0/"UZ'C!>UCU-%07H9"&T;]`$LP MGFXD`0$<"Q,W@6$Q8"0CH@BHQ_^9,-*XD4)Y1'-TI)S'67YDAMP!YPPY#`&3 M.Y><@.L+Z,(G2I5$=90A@RX>.3KY/VK++5VV(9P[P_9%P'*!R\P"O.)B+-)9H8?]4 M8#E5649!`MQ&`8,TSV";C&A*2?< M%P.@/U5N[EJ@0U>F=J3\&&L-OXXW!9+G^C7H,+>/(*R9\T;T>_*UVX]W#\J- M#5Y(MQK*]?5YLAO_A^0K2'6:_SNF"YSV/G&(":8RB#5U=G]WGVPG_@W&`B/V M;WDQ8UH.DX;R^9]*=*7F+)6?__DIV7+L"VE9%LHWV;+R[>B?1]"\&$EKE^SB MVS_C?:"``:>N!_$/P.,S&XV8\D]3##A\-)1;F``.A&8I]T=G1^='J:9NN>VE M1?'K7%$HLZ*XMH#0CYQ!3!*M2,Z*Y/KC99+G]YW(9_4$`9 M_9Q]_F>JH]^8]J=CF<_",/)>_BWULF_B(>2R/O%SU3\P8LH/ M*;/S0^,'!PW.#X&QFQHTW^RJS6;"6OYC&C?+./A(>9CZ+YSUZ_%?,>K[S8,P M4_4#R&3Z,< M?P-B^,3_^PM_!2/F__TOR_X3Q,NA%\?AO*'<_&FP(0@=_AH*"W]Z19I0A_]@ MSA#LJ;N-Z*PZB'FSTX](3YCA@#N4.TEA6AQH@J/@ABDY*4<@VVP\D2"Q_1-. M,FL1.`@1KH8HN-9A.NB?OEBZYS]X%S7S$#03]Q!77^X>4AYZA*<;/WM2&W-> M_IQ\61+(E/,'Y5Z,L'NTG89B++"^8,A]`QT+H12,%R6(_&BO$`)M_PALZIGV@>6S\O0+1GOP4A.M^ M4DXJ'_X7S##,\-DH`JP3QN<`QVDX&7*,)7,<:B\6-<0?B MMQ&+"R,'=>3W\&5B>[0X3[QP% M@Z`(!T7.LN(FM M8!K%WTZ""8R`(I._NHK[8LD$2;6TG1SB!KB6)6MP'O`$GD>4(<.L&S,FF+U.9=PP-@8=2)4>-II\.5QG M"&42C:4#DI:#A"L?GF_&7>M%CE\0K]NN-PY7;V*,_C&$\#^;VYA5&C+,S^*> M$5QH`;N/V0H,KQQN#`X=;P`TB&A1*R333Y/ZH\:F$`N]T+3YP+7@Q76QX9'+ M"G)HI[(@RT7)UW62KVT'?TT[#M4:(*)@P?8MB6`[&@%+-!H'5CI0O89W\F=*( M,]Q3Y,\Q@#Y#8(7KK,64\RC)G5AOG.Y40M)O(HN:S&KYZ]#(+$0O[BR%3[CH M#>__=YF9-[6G-IJIY%MDL&:6;A>MW.YAPHVBKH2$S1XQ1/HP$D>%XXDMP_XF>ZA=S_@D&@ MS9.[3%@B.-)")ALPQ042+.[/GVP>;AQA?E(5K+T8N*%1"Z?#C3`$LSG:H7#V MM8B%2D4I&\JF4-"Q*?,`&O;50B5K'S:[4TV_97C8+.%?SV:#ZG-/I@K1Y3\$ M\0/JU%FT,4SQ0!&4"X[N]"VW$5V'T\@P?>?;L3:7EQJ05WT8']N%96)YC^!$)B`R-&LRUH#$8.K\!'%ZT#M+. M1+OLPQ#O1XRT?O*#.IL;7,)!)M0PL`GC0.0G,E/AC`W?C,9VK@&,+;/S$W-'+8A*]8_LF*H.]'KC'/ MX8VL">2_/?TIVBSMS*'$\;>C.F(DZ[`?;=!-@YK@$0K M+",+-^G(N))K0],RK">Y[\5?R_`G\<$[8&$4$!6,Z(^S*W]C^(B2^`E\G6$D MHE[I%+5P731,+L@NX]/[Z8Y>;@A,[0464(L?/'H+,6V-F"AHHBYE0@I=YQZ$_5%:))P2RM,!6G@F()$8^REA9&8V&:$/O/QV5^[&I\Y1*SEI`)4TY`($ M&X-Q?14C`">8I5+CE-Y1,D;Y\I-OX,9!F2@_<2Q"C,#0:# MWT""$SCPG8U,3P#Q`6@6YNIDP`4#%L97T[U)I;/>/6[-83U.%PX"V+0G@8X' M>69R>=4\A-%#"S>098/\,$XJQF/HTGTC'RVE)HXZH#C\S512*4!>EQY\CWNI MDMWK0I=Y@A$FD/%YV4=$`&`;:WB;//D6N%ZYAV4)PKN+"'=2^0[P"N!;QCB6 MPH6X!!R&)`Y9DNU@)XCM6+(#IEWAF9"IIYB.^((M8Y7R%Q3^;CW\Q:BUW8J% MN_&"XH&\NLWWRD5H._U"[;'#%AGA,#0\LU/JWF6#03PE\M$S#.[B:D?\]?NS MCXE7'ZPQA'K=+U-"Y66>"M[FJ3QPF$[::+NF-<63>],?'JX2S<52*7&&,2M1 MD#\@,")J<]R:ULF M_.U7CG9JPD]EYKZ;/WC_&S,]5/ZIS8XJI4'&%#E7Y\=Y[=*6[ M;[6ZAZWF3Z>XW7ML`,O^'O14B_$R$LKC1+D,4C:A_P+KHX$%D:GM1->RNXSE MEQA'R7C`/WL>I8:"'2/)_7:?Y=Y3W`8'LD4#EM(5,*-B;*1.XWT^.[M-R%: M#@*G=&(,W18X!12.G"G)69E$I8))/SD5QLZ0C]!13%<,QO&!BD)DF7B)\"*/ M&$3;K.?BQS[&>IB9>_-G_\:>0)^" M+5T2:L$J):J(CP@Y'T8J_3H<.>=XXP=.]-B.#/P><_@X09_`9!Q`Y6>FF0]' M?Y%V)*^PJE0L0-/JS?BN3_S13CLO\$7S_4\KYG\2I<*4'_UI9%]%IQ+5AG>F M&!<,\Y"'MF,23AEC*JUHP:P^3>$5+J'K(MS'++/#H>TP_6OF9UB62S_1SDO/ M/];U8C6"HQHQ"^KXH8`(5I`D"C`!(C>0^@)V@BV1KO1#)5IAW1HO,,'+6LL6 M64NREANSEF=C6QB%3&4[$:K[&X;"5*3Z_FHT]J9!4U29 MTP&7S&F&%XLH6'0WRZP&M,TSJHX8)'E%3SUP+\7%M(5*RCH.H8VB,9 MZ\K?Y39)7$'P[4=\[QFJ<(=S.,X+'[%I*G!\E43OS+*U,%)_OS(?2OV M,-;U--DH8TP_0(B^"+T@G%OIJ!;Y=HX,EF[SO75Z;_(54Y!S)@^HT[9/R@M]?L_12?X_YX,-VY?G(P:V"G M682@!**THX%A"0U>N!H,CP0A;W@"U_'/\OIM&/$%=@Q)!GX0".':2&"&^,G" MLG^XV3P\MPQO:R$+TZA7*A6$LWA!'02-CCL]U1^2$C>ED>D$FR)S$B]XR$^X MP=&]F-E;VRH>+YBKHV$N:;X>VZ\:&IV9\`ZC[]\\8V:B]&P%YA#B;#:)&2YL M+=S)(%U$1!WF70Q_?Y>P0=+AX6UX$!KOKV`7$6D5#7S##_BWOROO$=<];%DM M.-#>%Z&[PU.UV?S'>T4^N?Z^4)5AV;X=_:5'Q,3_M*=_AL5N MIU6SRRZ$';\$^D+@*I#`_1(W@^E-@/)J';P.4-[*F*J]&E]?YEP=> MOMB.OSDJ?G\=UD]GSO#&QFN4@P^QGIV/DV^F^,OC>&'7[-5VG?C-%Y??[A)W MLW!$N@U5Y7`O.L`$PV$1J]`W* M)O?^CX7W'B[)Z.REY>A2L)X]-A9_,KQ58->BR;Y,I)NZF#B?G[6O;>]%7)=Z M;7N*[>Q;0]:[B7VZ"08A,]W=DASI=F`4NK'+=C?*I`79:Q^U4)7?:-7+>S5K.9! M%O[!B^-D3!B<=?!K$P>%A'$K?BS%A&D`+5A MC!W^7KGY_?+NT_7-'Z?*LW!P3W#I=X*$\L?[->9=$/)K`'BU%;_F8_Y-&7XU MR7#?UL._KB]#14F.D-Q\Y\AIJ"V'2/EX=O[/SWG"K_-9#_-[/]:_9> M$AA[F#D'#X::"2;_0)%SF`\'7?4?>69QYFJ2Q=C+ORJD<@)XZ_RWVO\X0'4" M!0",=Y<5!LS]P?A.1?)%[M>;?I;F=_HQLL/3K\`@[X,<"4?KX>@KN&Z"T>9@ M%+\ZB7S7?NC<%OA/17'_Y6>4%'4:5E5;0FK<*K66%1=.%`@H!)0B0.D04`@H M9%$(*&11:A+0^A>FKBDI3>-\9^'LUVF1K.`8'HM=4(VK_/FW/2Z/L>W*;21T M';-Z%31%;3!%NN7)I./N@15/>\XQEB7*[[\W(S8;2_C.E]OMV<7%U=?/8?*V M&V;1*R?+YM+"[+2CL[JDAJ2&I(:[44.5U)#4L"9J6$FY+:]R/ZJ-XQ-9!_4G MTCO2.]*[[>E=4VV2WM4BO[#3Y;(_TK>J:-9HA!4,,9G@5^KQ=VK-[L[:%;(* MRZL*%GWW:)EG=N*6L2K2V=RD9(LB6]Y4=QN=D\XN)R:D3J1.5179*NK4BMUB M565`D3J1.M5`G3K]+JE3Y;DG=:J%.G4:_6Z?U*D.L_*=KOI?A$>B_(/U>).` MBZ?K_"(LX2EYQ[6%/`,O?Z1$3^D[CBH&I,K)IT+KB&5:Z5:+%@I)GTB?:/]+ MQ?%"^O0F]>F05(E4B52)5.E-3,2KOCR^N'P))7DJNN6IE!SA9K8\;5I^%4^\ M;F@_5+?157N4=R65K*+\WJI*MINT[X54LI+R>ZLJ28O]I)(5E=_;5$G:,%"; M/,5.-PSL?JM2#1):5>!^CS9J55,\R]O8&J&'=(=TAW2'=(=TIW+B(=W96^Y) M=TAWZJ@[%9D8[W0!_V/R\'I00X^6Z/=7F MS37(NNQ!-<\-)35K-R&H=`ITE_-N4L/J((?4<-=J2$?;20WKH(;5%%S=YOVD M=-7!#BG=-I5NAWF#&BA=/&_P3M[.-OV8>"?X("4F+W%[M&R=VQ\.@,B`&DGK MJ=IL_N.](I\Y--C$\MS3@7CE^OL#1>,&7CNHP>1?QTS7@\]1^W;TEQ[^ M]2[^ISW],Z3XYW>><_C$V/CT7AMRW3/XS>`RR`/<,B=7U<],/<@3/."[ M#_S5_6A8VI^__/UO?_^;HOP<-G-FND(>DA?/_)YKGBU65+*IB$KA;7<"^V8^[M"\-?PO&GA)HQ@HL8RBM`CSO5!S>L8H^.7Z\M-#XGN?!-\CQ$AXM`R] M`!W1^[$>DUYFEH1@3A?]4,@VI9*K<7?Q;\]QQ6`R:]E=:SPO\?K'U<7#K[+_ MI>WZJKXLZ%(5YK)=?K5')4PA[ MGW;9*VO)@<(,\61^.(C+`HD:@.Z&5"7\OA]H!#)+>G%\9RX(2N!0CMO5UXM+ MY*MYU!5FJ%C;YCK!ZGZR5_9S263,_4""W++`2?H[?>[&5'[S3*ZT&DH+KQ53 MW"&7WH29$]^L]EOJ\7O'7QH<0JS!;4=AX[%M/6/I+%-A$&WI&'%%E:N#J!Q+ M6V-K$%?W%.FLE"L3;SB'V%"Y->#5'_'GL)=6\[U\$G^)OE/?_W2D0%1H/BD` M`FY#@Q@O^F0N[MGF)ORH3[N7W;F6_&)*1-QKSJ);;*$2L-"8C%(5FRKWV]&9]GGZW985PTF`97E0CGN%F0# MP%1JQVJCUY[M.NCM2'D`0`0]P[\68`=HL@8#H:&*)E'8"-3G3SY1^&AL6!.. M]LVTS,/PHZ(+FVNN9IG$'?@Z5:A[:QS9_ M%I8'LGJQ?,P'T6K4I197P#%T$6BV>G+2E42`\JJ![;@91VJ:E$X[^Q'#^P`[-6L!^N,5$LSP6;8LIWP_+\4_T, MFG_A,!ZN#7\/.+RHAQ)!0GU)FI8R\&PI_R?,84#OP5:+:.@Y1X#JP4"GS"&>!E M%<>?';<7H2:XAA7DS: M^X?::(/IT$-#Y9L>:,E\0L)- MW_CY5@YC'V&./1<%XXT"RP;-@_7!7ID!W3#_?A)\;<"$+;GB"A@*@0\%)CC\ MJ,>?R0B`?.)",PCBG#;@2S-.$/HV'$%Y#XHA!KRA/%L@>F$(%SP:0%WH:)(F M@ANZSR]([,_#@0I*4KNF.0\5=__*0D M9,2+M"H_RM<%U-`"3FYZ%!-O]=9A04JX<4634^A=^ M(5?IG7=R]9Z0\2:0\1G=ZE0H%S`QB2,BO+[B,`$3_RJ+Z5N?8"(3?^!WG-,0 M@-X$@*Y,L"P0PVD$@/T^!3@OD+B)Y:Z9J_S&(&BW)XKJ!]$K`*!B/)>A_[O? MREI2#>^UN:_X`9]5*G#CW_MY.67-L+[VP,YR7W2K_QN`>.NHTZX\!`CAA/"5 M$;Y_]SC6+U;=;-)+SG3]!$BE"Y?4,RC=6%V6"D>=FRO#(\-*=2^O;:D97%?1 MQFJYU1F<0J!7*?R@T@8?=,8I23=[@.YS2;I/EGV M@`M*T^VP^E85)BT5K"%)4]0ZNE[*H1!`":`$T"J,X/['AEO=;#A[:*?RLX.] MC1E+V9*X2L76>L>4NZO7BG^K3=JXN'OVZN_7-YZ7)(P21BN-4X)9>QWSQX=Q-XDR-M':O5+ M#9`])WN^/M2[1]V=G9VL@C&O2.1*90?J:]*JL/EJO_;1M7:Z*Z2ZXUE];:Q6 M$+GIL@.=_EX.8HTP2B:UZMM#JC"4%0GR-IN>#!<^J`3!_LY6ZER"@"H05("] M^L=TF][IVZY^;IOL9UUB.MKRN^\Q'94BV/W6%2I%L,*QL+T^[12?6KC-8S-*RN"M85K)3NVWUH2)4(*F"KJ!+!]D+**NR# M6;D20:_5HHV-NV>O_E'HQDL1]/9R$&N$T3V*0C<+UNY1N_I@W?]`=+,YRF#= M61Z)KE0@6JU)6:G^:AGV M-Z2"=05K^ZCUI@UJT?)8X0><_C$V/CT0CB:83F>S6\&Y]9H MS$V'8;&0.VXPE^OGEN,Z]T-F\X_,X?HMFXRXZ3H/_-7]:%C:G[_\_6]__YNB M_!PV=Z\-N>X9T-CTI62SCFL+#5J614J^F<)USEZ8K9\%19H>D,2H>46S3!<^ MW/'!AX/;IOH=_H>1\(/5//G>;LJ_#Q2A?SCXA%6>].^=;O?@EV!<9^H*+5M3 M3$G`9*/EN4HI=T:4ED]I3J$QSWR6MY4I=@3LH/@80U1#TX!@1T![\/;8%OB> M,5&L@<),TV.&PCRPPJ`:FO*$9\L<^%Y7=#[@M@U-:3'545P+S*9YR$=CPYIP MKNC"YIIKV=#)JI7-YMFLV0_;'2BJF258(_6CXN&E2IMR=D]>[0E)W=K>/4/*!)&WS1&Z5SB[F.[S>8A?Y<;"RH? MPM,OI[<9V'L@X5AV>(#S=RAATI'5BF M&Y*:$)@_0H&@DM+!=\+W:UK>HN1Z%,N6NY"-WHSQ3Z>T"A>]6E2XV!R4MUJ; M0)A(M?]?_&$KBIA3=,(O,&%)6"DL@-7*-2`6:OF6$4%U'ZCN`]5]H,/9>8>S M9RH\!/Z5AO]-#/\ZQ1UB7X67O,:_NX5(\(V?\'\S,"J*DSL^8@)"JJ?XE^<0 M,MD0>'G,B']]+0:Q`B(_"C/^X[\XLYU5=DQ63[2TI$/U(^J:]J/Z$5LY>MSK MGM!"S.[9H_/UFP1Y^TBM?@4)LN=DS]>'>O>HN[,CL54PYA6)7*F:1'U-6A7V MU.W7]LC63C?[5'<\JZ^-U0HB-UU-HM/?RT&L$4;)I%9]UT\5AK(B0=YFTY/A MP@=5EMC?V4J=*TM088D*L%?_F&[3&[C;U<]MD_VL2TQ'.[GW/::C"A.[W[I" M%296.`U8F9GIC]WN3D/#:@UPO32X6J'A9G':/3JI?O'8>H:&U57!NH*5TGV[ M#PVIP$0%;!45F-A>2%F%?3`K%YCHM5JTL7'W[-4_"MUXA8G>7@YBC3"Z1U'H M9L':/6I7'ZS['XAN-D<9K#O+(]&5"D2K-6FN1>Z2`M&5@%-J(-K?:1Q:A?E[ M%=BK?QRZZ-^XD``[%R9VA<9!WL. MMG_'#>9R_9;90(C-@$Q-$O=Q$O_E[%4XJ:)@QP>*9PJ__V_W%P>*SC4!('10 MF+^T5!4@TIP*9@$;(;=LY)S^S@Q/"ND,"U$Q4^,KU"KK9Y(%!,WO*2WU"_[H M7@A',RS'L])IB4I/J0"U.3UR%_QR??GI(?&]3X(?&"Y?$2MZ/]9C M,MB<)2&PO]$/A?0Q-4&-V\"@&->LN7*M\;S):U``JQE,;9R68?HPZ6,^OQ^F)S.[G&0FO60#FW0:/=@GUEV%A]PZ7LJEE+ MLDACB1;V3U9%GSMS$&YSGPZ#C!]25/[0^,%!^GZ8B2QDBQ=<"Y(P?GF23D+2 M#5E/$/TE,R?*D.D*4_Z[S.YEC8AH&AL-L,TA2I(6U0A43),J!A&..P0:'IGY MI^)P#5R!KCQ.X!N-VR!U<*NN?%SG8\L1[I&"A113;2`;CYR;BC"5L<'`JSD" M?=MO'CS6:C8[_EL!USZ*^RWU^+VC<&9C)2`'7P5AM947;G/XX'@#Z%N``P5S MIV!DX0PF4G;AZZWF^[%M#00HO#`@QHB^5]^##WOF)H-WH55WAEZ?FH_(\0L3 MS\"P.Q0.<#A@GN$JEJF<>4^`.:7O#Z#"3!BF)YOCDY:B#9GYQ&6[(^9Z-A:* MU`,IX9<#,/A($#X[`X:8_%Z8HT#$H!]:@X'B.;(L)?P&3&G0DZ,,(*:5W\P? M":0S+(33\M-]1[-F86N5*&M=B+(2)NNC9=M^=5+/A,A_#G`E9!SO\=]7T&(Y7N@YS`R MTAS@*)0I5N"GDS37_SA2?,)3J-_J-X_X?,U*^%[Z(%=[YPAK+5;\P[C#50ISXR1SCK%O#NJ54MX%WS M6MU;#]JK$K%0L));3AWL@1AA`@U"7F$KSZCT81`\SZTS:1!D-&U,30)\C2_- M+E[+!V<=GS9??[V>$:Z?@*%2Z[M<\FJ?_"// MM?A_8E/#/&34O\KM)OC?XQ++!<1US2$4G,I,)=`0:)8%38M`0Z!9%C2KU&RM MGD@(-)L%S8/E^M7]"2F$E$QQG3/;GJ1NB)!))4)/]3>]A_O_84IX.KDL:+R_.;N[.'JQMX5"Z18!YZG=E5=3;,;^S(Q*;GF+6NO;]IX>RH.EQ9 M16> ML$_8K\[H$_8KQ3YAOW89D;`6ME\.5FWOK!;V"EF2<^8,&XH&_\;J;>*9&5@^ MN*%@W25;:%AG!7^D7%NEN=^`57TKEQL4$$6KT6I7__(#T@#2@$UIP/Y=+TOH M)_03^@G]A'Z*?D@#2`-(`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`JO4E5:K=W-FD@ M92)E(F4B92)E(F6:([56XY@V$M4SH;73C40/ELL,2H2N;F;B-YWM?ME@WEUL M,4-8HOR*;N)<4FP56F]8698K;`-M[G(?**EA9:!#:KA+-:1](J2!I(&[U,`= MY@1(!RN#&]+!'0>CG38%HZ2&I(8[5<-6HZ_V20VK7HF:KN>J>NZW"MQG&9"X MW:N*='94SG]U\=2QN!WI#NE.%<1#NK.WW)/ND.Z0[I#N5%(\I#M[RSWI#NE. M'76G(DFEG>X)NQ;L41@[/=!8@_1C%;BOPO9;NO*`L$_8)^P3]JLT^(3]_1U] MPCYAG[!?C=$G[%>*?<)^[;(B=2X'=:8_,U,#ZBQ3,80I:W%K-M=W5XJ[!BFV M*G"_`4-*MQI$HN@WCOMTMK_:W),&;%(#J.92M;DG]!/Z"?V$?HI^2`-(`T@# M*)U2A8TG%_S15:Q'0SPQ5U@F[3ZI:'FX6N6KJU(>;J=9;JIL0JI$JE16>81> ME\YEDSZ1/I%KJBA42)7>I"J1:R)](GTJ59^Z)RKI4QT363O=%[33JMHU2(#N MMH):*: M-#IM(>MR4Z*Y@O?N0P0.?V8>"?X(`<#'P,F;)W;'PZ`_X!D*893M=G\ MQWM%/G-HL(GEN:<#\*Q@W#&3--F$_R/?P\9KH>?([:MZ._](B!^)_V M],^0XI_?><[A$V/CTWMMR'7/X#>#3TS8OS/#XV>.PUWGS-1C=92^<.9X-M=O MS#NN>;8--'QDCG`>L,4'_NI^-"SMSU_^_K>__TU1?@X;O^..:PO-Y?HY/F.#SXUM%4CLI M4MO9I*IJ\V0M4L\MQ_W"W:&E7YG/\.YH25%VLNGK-;L)\N9VMR)-"V76S1G> MXY3,BA'%;5<,A,9<[MP,+OC8DE!C"[YW7I7"3`XV8>G=T3=0TZKX4)UOY M@BHUFZK^<3^)_G@W<7#%G,J*4#_.\073@NS+'G.M?\F1OJ%SYZY+;G MH$9$#WR<1'_^*KC-;&TXD8^?O0HGQ7R.S]GIB.4PWUJ;^1R75DVVVVNSG>-` M=ZZ?&X)ZGGO>I9[G,+\VU/LY/K^:;*\-]7Y.4+$.VPNB[Q4\4#\GWH@"_R+= MED7B9I2PGQ/&5(?5]54N)QBJ`I/K*UA.\+0DDYFS[^CI"^%HAH7IHN*A:3\G MT.FEY]8%*2B/\H76(2=*:;=W3?FF@]1^?L!26>;7-R,Y84N5F5_;O)SDA"U5 MTMK-8/\D/X*I+/-K8_\D)S"J,O/K8S\G5"K+[OL9TK6WJ>?6CQ9V.<: MQ"WRGR=Y^9UFIWVR<>HV[2-/BB9R=LCD^O8@/V&S0_;6U_B<."?M[3:K11O" M:>XB27KU<@=9$Y2D75-A'G%-QPD7==:Q^MUF3N@P M=SDIJ^LR2=V(:G6;.0%#]5A>7\_R(;MKX[B5NP\X[21WRN_:.&X5CY>68_22V28X0.>6V_=# M9D^/JR1Y;*K?FY*_[H.UR+FU6@>_I,XK?3F[^WSU]51ICEWX)SAFYI\N4E+G MD!K^%PWE'D\C*;'20O*(T/Q#<,WI*;+@%[^@4.Q[GP3_\%F,A$?+T`O0$;T? MZS%YH&V6A.!87?1#H<-*J2I+\:-I__8<5PPFLZ?(7&L\KP+3'U<7#[_*_I<^ M0[;JN;F@2U68JW2YF;-J7RV7*ZVC%7@*!+XL*Z!"BM0AY6QD>::;7>$\X[3< M_.X2!Q%3@GF?/G&XLN(=*`RB8//#05P(AEP96(9AO8"A4`([R%T'OK3=H>(.T1&- MP,G(20M>3_@(\QA-8::NZ,+P7*XK/+#ORAC0Z4ATPMOR77=H/N>CUWIN91VLZ&@R9?/HY\[W?@(+QC-@I9[_I`N/JM>%B1] M&W(MS6(2HXC0T%`VXT>;2_%PLQU$;YS?7%^?W=X#F1J@B8T=_EZY`6?RZ?KF MCU/E63A"GAXOV:N%\D/K3#]+\SO]&-GAZ5=@D/=!CH2C]7#T%5PWP:C* M17`K)ROR756KL%T]":EQJ]1:5EPX42"@$%"*`*5#0"&@D$4AH)!%J4E`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`_S%Y>#VHH4=+]'N7Z2Q1 M0+6KNE6BL)8WQ&DIJUFQ!4.@6ZRWDWJ6%UD$-J MN&LUI*/MI(9U4,-J"JYN\WY2NNI@AY1NFTJWP[Q!#90NGC=X)V]GFWZ,OS.P M3#?L-2&!'QZD"+Z"".Y0!#\T?G"X+08_S+#MDX4-8V,Y["3$G.KB?5J>7\[N M/E^!&.%O^"<(T_S?E-2[#?^+!MXS)P8'"C/$D_GAX-^>XXK!)")QAMUP4'P4 M!(.1%''(U8SL2N!00O/JZ\4E\M4\Z@J`VFZXWL@`5HN](L_=>K;C,7C.M93/ M9V>W#65LN=QT!3.,B5]=03Q/"R_(.HC\+T\\,P.>`E(=3QLJS)D^FJB5V%"8 MS:$_%UHP':%SO"/Q9/EBH;GP)/PEV+SL66[PGR:4\U!>;$\0U<> M^;0CH-A_`YK$!!E($IKS;.PB>N](^<@UYCD<.U3.K=&8F9/I>TR^*2M)X._0 M*5>`47>(+0A+5[BIPV/W?.SRT2,TVFXV%+QCMB&?GRLKOVRD@W4CV7AL6Z]B MQ%P.3Y1I?Y36]*Q@A&+H,<:EK];]EGK\WDF/2KFD-)NSM+PPVV82(5@NL]3^ MCF=[\\QG[N"`INMRPB\"QN*%S\(P'/0I[/PQWQ!D.CN'3+N_.F3*'\4YQ)0Z MBK.^;*%CF_M!QE3RFM='RX:^/AQ`&!,P+J.94[79_,=[13YS:+")Y;FG`_'* M]?<'BL8-O)A8`WKD>_AYS'0]^!RU;T=_Z1%E\3_MZ9]A3//S.\\Y?&)L?'H9 M6,E;;LO;9Q_XJ_O1`'']\O>__?UOBO)S^."YY;A?N#NT]"LIX1&:[@ON:+:0 MHQN]B()UX<,='WPXN&VJW^%_:.T>K.;)]W93_GV@"!V&GFFNT+]W6^V#7U+. M?'A+?^R3XH7F,A$<+7$@^'='[L1Z3X?XL M"4%R+?JA$`12JUSQN#WP^;,AMFN-YZV`_7%U\?"K['_I`'O52470I2K,5;HL MS8XD5/LK6%>E<[0"3_$@:PE6I@J%$!;M=PH+;SOOLP)<)E2B9[3+,,"9_M? MS68?_E_^ULCQY1&FX@';D&&L]M]E\MQKS@FZ<=1*[:75.&Z>S/8C(DO3P/AH M#`$CA([&I(&&!QE/S-$`85_X,_CV(V41WAH)<3'#L:3,2N5%RFL>+S#TYJ'- M!YZI2U>O0_CF8(SG6C!ST/U0V;.U(8,X7`:I-N?*E\O?KVZ^*O>M;E-Q)A`J MCB`0MZU1R&M!G%0IS;$A>[Q7EO4AH=:.HL'<4D#LCW@1"0?LXT!A:$8<-[BI MX5GP%WC0E7,%`0RF=3;,M?"F12`7GH$N^#/&R/A!$[;FC1R7 MF1JP-\)<,_2D"PUF:`!+Z$HJ'Y`TP=G',S,\'DZK8L2-V`2S%X_Q(G5SY[I,2%P;$WAM,D=R@2LDBQ"E0F/`MZ M@YATI"SQH=\\F,U&#@D$:DA^`W8,;C[!/!<_P=#*]V&RP/WLT.3<#KI%CW^@,A`GBA$DP3CATX*]6>G_I#Y^0;+@U%\%`9&8_A9F"&9-G<9\(4/I,3%P@F\XPT& M0A/!"S!3!]KE`TBD"[^,F3])U:QGCF/DV]\XZT?*C0G"!%2UCD-K&V!30R`9 M1@#?L<%,$_^&"2[*8^P]&D(#I@=`"\#IQW!*WFJ^O[J]B3ZI[W^2C,';E@<- MZ@BB,^\)M$OI!,,GP0GCBE8=F)'391"$A8S$>&=/8%KE7R]#G&![8V2[7)>6 M=@`C81@HC!?X+ZJ%"&?^CQ/EUYO;;TILHMI0_N4Q\PM*XYR-A0M2\I$G'#G? M_W9T?Q0T8-F@(.>6&0+E10!<4ZH1#00VXJ.:Z=/W?:CH*`(8\Q&@XM\6?*4@ MN#Q;9AT!F[JG\8;BP#CZ>`/FGX7&\2?7DG"PV7@R]5%!DN)\*$SNA%!)Z'(B M]9(T:HN=>\,7H,W'$!'(L33C":1R$S;@`GJ)4?R'E!7F:H!!U!(<#2EM`SJ' M;\>V>$8R`.2:CS#79J:#J0/@19K?@1'><. M.M<,S.Z""D9>'6UV8#]B2NI;6F>N"V_,)8DI+[9P^:%NO9BA>TW%$,XP7/)` M3_-D"N#^"`PCA"<.=QQ\$`PV]NC'&E-O#Y3+"\5T' M@"/`P^*(X&_)T:R&^WZ0KM!?O(KB#G36.$,!>^7`="4(\Y*!UZ,G(S7?(6.[ M4KZZOR:%Y"&(HJ&"F,;RQA@,!*YJ%J@LBA$`GZDYFX[:EQ4(`ZWX0@Q]`^AY M"N>2I\=SIGI^D*EA"KWT^7BKH:J=.;/+J2;(I1K=LWW/%%^M<18N[2VSO_%<,H76\&2J8Y8=WC?8$!JM%@(!L\%NN42M]3V4'(Q,S$K MO!E'E9P]1G,_C=N^A,`.,S!205+%G4,WPU4X"#E1O+IO]V4\CC_S8!X6B-3G M+.$Y4R,W?^:>7`'=N(7:?+BYM=!RK\P#(G4;WL(*(B@(#^:F70+HSD4K*$3D MVT20P<%-**"IX:&M(`J89\=@HJIS$ZT._"57#:76W&,X&W9]`U&#U'&9^8'^ MXC,H^9'[T2KH'H0._O1XND&!O6(6%6,5)PKO9!X**/:D*;-,4+(@3`A#P9ET MF]_L$]B(5`(**,#U>/:"D1):(9F4DK3;"5+#&,9/,20LM8QRG[B)C/(8%]A= M$(@!+S#=]F>+BA_02F.!L9V,(M'<3Z,,2:@;9.#D8*`@'J&+`68!0]N6BA,: M44;`A#@0?]3<4#*Q9L`X/0NY92F#+(XR),FEXGO;9FVGL^AZ MT+^$J1L(&R`;6^!H`"B#F:BK?&2VR9W#W_B+<(;*KS"QDBH"-N<>G/JUY6'F M^LM-(A29_TX\-&E$Y@,MG$\!3(Y$D!R/,L;JB<1LV]=]A^.4;R&IJ!%GVI\0 MG8!%/4?MM)5SF7Y$#L;BH<>@_VI[IO`CMSX;\ M^!L\QB<)^N<9G<2(9N!(SQE-!Y/F(&%D%.49H/G1M(*)?9RF^?E%\Y M,\#T)(4./-[88'UU*_P=68&IKQS::"%@.C4.G(K<2N5+U0GGR#XUP9()VGMX MO9=C:>JSGZKP-JGT_JI/X$9^QSCW0C@:N!+/YLXZ>ZHZF]]35?X.*=KQM+L= M3[TM[GA"L"N_A[.Z3U$>\`I"+MN3.O-F=CW5(@I9Y%KTJ;$*$P;)%,(TQRNF M8XLA?Y3?3"0=A@(B>%L;3H*9!KAA"W?!_0<]BHRAQY[?"8Y_B^;,09TA5O72Y<^I&V`3,,`R8BU_A?10T;QBF(9T8YT;\\"_\3I'6! M&,W/GC"Y;R;XWI\F"1VS+!HF,AR'!SEH0_@)&2')9[/3(OP\&"^!),S@VON MPDDNKF_`Z]XHW$?^"'X])#GZ5K(6#A5$%S(40;3YLT/I;"F!(@0W/!`C`1_)<=?"/"5!L,ZF1MTW-@"-JXUA*_[Z4)0+67"F7U4 M=^NTUIIA&8?W:)Z\>_J7F"=/L\O%%@L66'16>!.NG"')DR?,"?8Y.,J/4A$M MSX''G9].=Y5"KGA8XP>:US)V3J((,11&T\WX<>@YDY39QZ-3%^]""F$E#QQG0?[;_&-1_N=?%LFN@D]!?/Y%:C8 M#%/"F[L(NJM*[AA?E31>7)[?W)T]7-W`HW)S(&X)7V=V-9MS6'D]JB21Y8JH M"K7TJEDHKR*WN5>T&MZ&KF6O$79(L=NX,4?*==6:>XW8%7_NUQC&NI(<$]N=V@?*578A:3S^8,]$XSX#L+T$F52)5(E4B52)5(E6:DU@MN&B5E(F4B92)EJB!82)G> MJ#)1S=E:IK-VNE5HU4+J;R4-FFMD8+05W?(>D;S=KQ5LK\Q7T:6$)<56H=6& M+18%H\4(TD+2PEUK(6T)(0TD#=RE!NXP(4`Z6!GE4J`I_,?'0^>J]Y9YTAW2'=(=TIY+B M(=W96^Y)=TAW2'=(=RHI'M*=?4XJ[71#V+5@C\+8Z5G&&J0?J\!]%7;>TCT$ MA'W"/F&?L%^EP2?L[^_H$_8)^X3]:HP^8;]2[!/V:Y<5J7,EJ`O^Z"K6HR&> MF"LLDTH_T5'FLO=$OJT3S%2FAC2(-&@=#5*;C6:_3VI$:D1J1(Z(-(@TB!P1 MJ1&I48W5J-7ID1K5,3>UTUT\5-:)#O'2(=Y='^*E@C*D@:2!N]3`W8T*N!&E;D"![5=:IZYK<*W&<9$#KG M3.><27=(=TAW2'>J!P[2'=*=JJ"#=(=TIR[H(=TAW2'=J9ON5"2I%*;?SF^N M;^XB:*R:9#K&5R6-%Y?G-W=G#U=1:'-.U1-N M5>!^/XWD3H\CUVCT"?N$?<)^-4:?L%\I]@G[>\L]89^P7YW1)^Q7BGW"_CXG M1/:0G.Y+G^D7%NEN=^`52U: M8NLM5+QOJ,V3RF.`-(`T8%,:0)J==]GIGI8K\YD[[HB;KB),N:W%G2@. MUSQ;N(([E,E;_>:TV!5D>Y7MWK!\]C0Q3@NCI$JD2J1*%84*J=*;5*5V>V>3 M!E(F4B92)E(F4B92ICE2:S6.:2-1/1-:.]U(]&"YS*!$Z.IF)G[3V>Z7#>;= MQ18SA"7*K^@FSB7%5J'UAI5EN<(VT.8N]X&2&E8&.J2&NU1#VB="&D@:N$L- MW&%.@'2P,K@A'=QQ,-II4S!*:DAJN%,U;#7Z:I_4L.J5J.EZKJKG?JO`?98! MB=N]JDAG1^7\5Q=/'8O;D>Z0[E1!/*0[>\L]Z0[I#ND.Z4XEQ4.ZL[?EN&N0 M8JL"]QLPI'2K022*?N.X3V?[J\T]:<`F-8!J+E6;>T(_H9_03^BGZ('+!'UW%>C3$$W.%9=+NDXJ6AZM5OKHJY>%VFN6FRB:D2J1*995' MZ'7I7#;I$^D3N::*0H54Z4VJ$KDFTB?2IU+UJ7NBDC[5,9&UTWU!.ZVJ78,$ MZ&XKJ)5R2I,JJ&U9EK0,05I(6KAK6=9M4D)J6!GHD!J^R=KVI(&500UIX$X= MX4FCTR9'2&I(:KAC-6P?[RRI5PTUE"\-+-,-WTIP\,.#9.$KL'"'+/S0^,'A MMAC\,$/VE()WV)KLI&B^\)W+`)'3CXEW@@]R,/`Q8,+6N?WA`/@/2)9B.%6; MS7^\5^0SAP:;6)Y[.A"O7']_H&C<,)PQTX3Y)-_#SV.FZ\'GJ'T[^DN/&(C_ M:4__#"G^^9WG'#XQ-C[]Q(3].S,\?B$S-Z4=%`FO#AC@\^'-PVU>_POU93[3Y8 MS9/O[:;\^T`1.@P_I)#PY>SN\Q4@"<8)_@D4V!\W)37"#?^+ MAG*/XZS$DK92^//-2W.JG\$O?JHV]KU/@J_6,1(>000%Z(C>C_68-!6S)`0& M*_JA$`Q2^>NXTO_;/A5]G^0`E.N90E>58694.RP MF>ACVW1B/+5"3R5S4-\ZU;PNJF1/`^ M;5X7Z$)!(!XHS!!/YH>#.,\907")SS:.N M,$,=6L$,S.=Z"?:*/'=E*NK)R8G"3%UI-9MJ0W&'7/EH,5M'^%P(FVNN93L* M&X]MZYGK"AA8R_#D_F"%>>[0LL5_0)?E>X"V,3,GH)SP6`1#;XQ?,/B7RPQL MM51U4AL0K.`_R1%UALS&@^$#1;CPGQ<3.D/+#LJ`E%IC;BHC9O_)W8;R,A3: M,,:XS=E@(.P1<"M,%$O_2'D8:9X+^1SC@G$13ESO6CV9!H<7Q4FUBG@8CB4?HB0VC2<@RD\X+_ M>H8![L\!>I4)9_:1\JOUPI^YC7X>G#X#KV$(^RT.U9-@KA M18`;]#TXLGKH6H*QGC"@D)R/+`R`%`C0AB."Z![WYMAS\R^&CC#-01-QT)`,*,.0<11)P.R/R.I/.,PXEL`,,*DXT*P80-?`ZS.S!58= M"F.G0JAY@B_]QR,$)T0'$8QP^0@)=B1$D2D)KB%[CA"FYT$LQ(T[M#GWPSXL MBP3R!#$'J$#5A);N^1@Z?(10JMULR-`UF`2H'<0`:M9D(5Y#OAS4PRE*`MG- MPR?&EP``"053I@;D$`R$";(4T+CCPA5_"N*QH+(S< MV,@Y18_\![-1-\Y,W9_(RQ#P-HAYSYY@D%%BZP1SQY2WHKS5BN'B29GA(K;8 M4`+`-Q098^$_B126$F)?B.X\E(+2GIDKF:FT$L>T#;B>8/,6#'<1L!BY8]`31B."7CX1?? M"/I1;[DYQ'F,)D$%`=T`H\SF MOOJ5><\,?C.X]QX=H0L&<%L^4NP?*)XI_#>^W5\<*#K78)0-!WG^I1E0GM]U M.91V8I1V4I2>9%*JMKLPMLO3&\;O9P;(&RQZ;W5Z^XI\\1?9Q MOH#;S4RRNWU)]')4E$)[`7"TU6R1=UNK$O_S_S@\_&19K@PX[W'Z":8*NCD\ M#'DSA/GGZ0`>00MZ#1^45_F5;:$R#UUW?/KNW_ M-!JU7RFG@L34KPWGM5L2DR=!O&_1DK[6.FN=7=;@A_.+QI=PUOAPWOJI]H_6 MAZL?SZ]:Y_^L_:?]\-_:W>"IUJB]O+R<^<`A5AS.O'!2:S1D/P'CWX8DHC40 MC$>?Z^,XGEXUF[+]ZU`$9Z%X;GXX/[]H+AO6%RVO7B.VT?KE8MFVU?S[0W?@ MC>F$-!B/8L*]-RK))H^N=7EYV53_"TTC=A4I^F[HD5B9RBI73=M"_M98-FO( M/S5:'QH7K;/7R*^##6JU3R(,:)^.:DJ`JW@^I9_K$9M,`RFX^MM8T-'G.IE$ MRLKGEQ?GDOR'+N.T-[H1U&=QO2;9?.UW-J0ET5C9NRG_L[G9O@F][];_/6'B M-Q(DP/2><;`T(T$';"Z2">5QY"*2E<7N4O;I-!'>&,P/NH>32<@'<>A]!/Z1%ZIDYTVFN_>^TW(?,-6XKV3T2>$F@(()9^-N&#O0UIL#27VHA>]EM MU*EU!7H-0F^CIT"N:*'8-%?:D5JV1B0:JK4KB1K/A$R;THY-&L31\B_*LHWS M5KJ$_9#^^?=V%*GQON`B^4/8]C^+DL!.2H:'-?_G/W[X3-2"!'2SN^(4+,(0)5$[,!&4=Z M-(AM^=HV<([J(`:T3V'E9!Y,/KM"6YA354`NK%@^W!\PP'U+IV'$0&;'F533 MOBK0:<3/!^@"`T!MSPL3<*H^]2@XV#"@7VCLL.(9R:H"EUF+?-1^Q(!:+QY3 M\29UY(29B:@JB)ETR,?K)PQX/0HZ)YW*&!RF=*6'ZZ3H1%T5!)V4R8?R M9PQ0WM(1!2G])_*Z$-II[!FIJ@*=48E\R/Z*`;)'$4ZIB.>/L-N-P>-D+#65 MVVZ0WSCL3&1H0-,/-)/XB&-&K>"_BC`R'1;8"!%`YN**SD"F:B'>[3T0;\PX M%?,B,)J(,$.XH=-ML+*X51$.=S[\F0BK4U]T$90CRE3P<\!50APOST) M12>VS%.MCUZ;#1R.Y^R@6+-K83H`?*DCMG^0KG2 MW-4[W7%;DAW:ECBS-SND:TKU8`L@13,TJ$/Z&UC#V(@!?QKU1FFH5""CZD1> M'2S=]$%\7'(31G&1U5W3OD*(Y2O@O,0?V4+2963(`A8SZK2:Z)N7X[[=C?)2 MK==V,1KPRT=QFHYF[*8!%TJ:UB'`7M>5@D:\AMFPHH! M9E/'>3FH[ERSSPJZE7RW+/*",$J$*<(PT.SEW,P6O:UZULR@!>C1;,H,"*P? MG!50[2"S6"Y>F@C-!I.=K&KHV#6J6IA:;&)P9U$E9(MK=P*1[KYBR]6R7\S3 M;(3EA%+D'/<&A8\83&(1O+GQ-1Z&@:S=4'Q@/!8OG'1Y3`?$/ M[#XVN11/9'Y7*1!X4-;KM]WGNUH$L7^F^O)GIRDMMS4"O$L899FL;IYI$`.O M*G\6X\0`^$8K!$`;W'4;D`W1$0,Q(`&-^G1&>4('5,R8IVYS&$#14B``*,>M MMH'1BH\8)'DFT1NE0EM.9M;:50.0+:$QUW#=,D&]>#4+/!`&TS=7=_>3Z320 M:0U0QIB@<>6``+MSXNGR0+I;/Z$<1;%4H4936\BF@(/1P8(@"P0 M*+IJA7E=7.YB[!AF6E8+K(SX]O%6(BJ3*6%"W8D9.1[4Z"@0H(1@DZTUSV'& M9FX6_E<(L*3X/2XW,KW1(!E&S&=$S#7Y=Q/!:<-JLP[BM?0>+,*>^>+6MS=_ M$H1'1%VN6BJTL!K8RY2C*L+EM'WE729#_'+)FCU4/+E\K\^Z<&\3_-\M3-9! M_!;*RAII+',-`:CY-%9+@<`'7%,N.=)C#JPW`E<' M*P4J=%TXH&M"V(T7`F"=LK'O4,T==215!WG/JY90?I`C!EB_-S)'&D:JLL[4 MM2+!;T$B'U9_E*=AX/"[#;R]]X1@6#JX0?:IWH M:G6L`>;JY?LRPLK<>TZ/5#"Y__:$O/IW2Q?_FIRU$)O28@,I'^Q89PS@NYY_ M!5`Z?)6%:,-L-%OT?IK ME_>L'$M,].1'"[*;^HBCLN/*P!X&Y())513I-YGKZ8F-O*'\M%B'&[.QA:B/ M%F\G[>V9LQ*+0-/GMXLG4*R41PNZ57/$B3)[ROE6Q?9W.T MGE#,#/8/$)0W#PS&1-!KHG;4$^G-MFA.1W"T6.L41OR-@NU-9H=G/TYC3I$[ MD!\MX&[JY\/_$<6@SFJ0?BAEN8+E?C"ED$>X,3PA'W$S2+[77"+UFJ4R:6&^ M/--*HAAB']'V9_)VC'P4??D^>B'W*SJ#P%\3R1 M4'_MM8UW+4QFAB?D/FX&T7@-BM/&MV+F6Q8I-PR/K&F6A.UH?L.BM@1I' M9:!:&V7N$76VZ9LD:<""IS;HN*I0[?*`Q:)F,L MCK$+U^-UEUVL@CCM>3<:R;<^1G>OWICP9]H'Z7L\?S4N&)7LSAJ!-^TC+MG= M$(@=2#/*]Q_4.C,^$N?9U0R(+ZSVZ31=A'NC;LB?GZB8R,]#&)Q"3X(` M[OT,A>P7L70J8PY/\Z0N_NV30EQ.R@-V^'X*CH"U$T6)/,!7[S.`E&`BB)L< MIX&BC([6-8H:`G$@L=R0W8=B(]A>)'=ZO!L24R6&&_GQ.H*3^IAK\-;%7CIM M=_T#!([S@8;V>)&WZXZX$B]O;7-%W8'V:%%WT!USH=VZT[Z=Q"V?<%%%9N,P M`(%=3ZIL3([6$8H8`7&1WKH:.[C!"8-?!/*/*"!_"UE@-DN$-Y9[&?DHRB3D MZ@*!6[BG)3Y>V!V4QUQ;E[]K>11L!CN6QX!XU);)=&1PO![@:`#W@K@2;ZQ? MDT`]+CZFLD:GW(_9M;FO!E`Z@2[>C#-XHIVTK`_:O7V65]W+,'\!.ML8P=!Q MA27[V;JL.H@O%&\5*=KATA'@@FQ+CVV0=$H@!NIN,@W".:5]&JB3M2)#S(&V M4O`YZ(.XG&IQ"R%3"FR'T498*0QMRB`^+%X_U798W_):5PJJ7`T0IW8UZ2D[ M5#;"2J%F4P;QN>S&6:)+!)G7O%)@Y:M@/T0M=Q%;GQAD2;S;"J:CP@58H:#? MJ!?B4$0S1SAAZ4!;840=M$,@PQ!?,LI5YVXDJ!Z:(0XMW-]L>V#-!EFZ($:I^K M7U9EYW&9GX;_U)3]#&$CK$SW/U!+`P04````"`#U@6Q'5WU&WAPM```JW`(` M%``<`&%M&UL550)``-]`456?0%%5G5X"P`!!"4. M```$.0$``.U]6U/DR)+F^YKM?V!KGFE(**J@[?2.)5#T8$N1&%#3N[:V)A-2 M)&A:*>4)211YUN:_CX>4%V4JKI(BPS-/OW07$!'RS[^XNGMX_.U?/R;QP3NA M690FOWT:_'+\Z8`D01I&R>MOGWX\WQR>?SKXU__YW__;W_['X>'![R0AU,]) M>/`R.[CV<_^9^L&?V:+^P>"7P2\7!_"/X]/#^_3]\.1X<';P?P?'MZ/C@\^/GSYR\AM)"7+?P2I).#PT/VG3A*_GSQ,W(`@B79 M;Y_>\GSZZ]$1*__Q0N-?4OIZ=')\?'JT*/BI*OGK1Q:ME?YYNB@[./K?W^^> M@CJ4LIU("S!?CI< M%#MDOSH#G[YR,*E7%`FS)>?J3=P=E3]\1.HZ^#@;S2-R2,9'Y2R_IK/ MIN2W3UDTF<8,8_F[-TK&OWWR)UE)R/'%Z3'[TK]_3`6OVQ^/M&E`_>RNI.F)_/)+7/P+INLEWZ6=1-AH_4)+!5\IFKTGN M1W'V3#[RPH]UA-1HI+ND5VD2DB0C(?PC2^,H9&/DTH]91WMZ(R3/=$35::6[ MK`^$/KWYE`PG:9'DF;E&%0UTE_`I3X-R:(`B)E/02$OJ]=KI+N]M\DZRG(V$ MV^3;WPL8"$\D*&B41Z2%>DU:ZR[[7920T?B*DC#*S665U>XNVXT?T7_WXP(^ M<1,E,`HB/[Z%Z9N6L\Y"&3IRZK;47>9',BUH\`:=#O223B9I4O9"<]5J-K2- MN>L!!GN2OY$\"O1D-V[2$HHGF.])R?!H/)JRG0N,__93L:BY+4C/)C!*WJ!, M]$YN87\V(;W`X+9K&\]H7*X?;VDJM69Y M)1UT7D,'UF7L+&(?$MZG.?G#I]1/\MI,_#"?GH>OE)3DF<_Q+1NVM0=LO_FK MR>338"'6_)_U!I?'F"C)C\)H8B>ILQ)?V5I7D>#? M;%Y,D\.0C/TBSGL4D--VC^*F$S]*[$@[;[JSL&4[AQ,R>2&T3TG7V^TJYAM( M1(/BA1PN5="CL-S6NXJ#R8 M&UG^!7[E+;Y>^R@[S]S"4IPM6H_]%Q*7W_145;S/*QUM6>QG_V5%KUKDLKAW MNB;NBM0A71<<.M:BZ7D?,YK-QS2=Z"MP_N%43_XB`UG2*?L=6Q=3"CN_WS[! MKJ3JP[\&:9)#E_P6E\LHC`/RROZQ^GN;;X3;D`UZB<_]I;[OVN8C^#_5^Y!1A^1+PNJ*SC#0:G9Q9YEE5IZ!^;S;Q#31\*FYV`XUU3']D;Q&6<[,EO?^1#1[\8HR"#;/)U8(D0`1 M'$"/MTG&%8"AS)T9DH__1692-C;*,A163R'VZ.`C$?`QV`X?5P6E:S.J?'D7 M%6=8ONX:*PHP`F(Z'M_-!LI-%!-Z!3*]IE0^3-9*,@3GNT:'&(>`B8XG=%TF MGJG/(@N?9I.7-!9PL%:&27VQ:]KG(1#H?4LG[/FDN7(REDZ\;%3D+!J2"2M? M-R05F2%AYT[CVK`$M,TW,0#V:-T=TK^31!W`:.0I:?B"X1<>YQLR5XBJ"NBN MZQZH@T$]>"-A$9=A4S$(G;(XG7UH8!]<.\S4-QK7H"K<.MSRWF>;FP\MAXYEJOG] M2JP,9)Z@)GR?C_C[V@K&X=^P)>^SU8V1M@=)S!2?V38PD;F57'*.RQUEGWS+ M/JKVG8!-=+!5&]$'G^;S'ZXC%KP?Y06LHY>S'TGT]X(P>Y%BYC=MRCNS:6_& MNRBTTI,5-YNU;L-$5WJJM=OPSJS:O[77B%;$M>H#&]BM./MVAWQ?38/??M+LN:!_DIEP\1<7]LX6 M'\%ZS"GEG=GTD.!;:D4J0.!V%,Z,FT6\,ZO^$^6J)]*AR`Y9DQJ#1]%$SS@6 MF-8*5RT-;5R'W+5! MSNI_41S3]!OQSFS:9O"M&BTU9,<9V4\O4>[#FX69H=QJB*3V>IB+\%7F%]5NP_OB M,':@D^/3#**`Y(YASNU)ODDIB5Z3*FPKJ,\QOX/&+LD8_O[L?T@HUFS!^^+P MTD`G@DT`"NCM:-AH3^\#30-"PNP&5%$SW8S&MTE.0!/Y;;*6@*)XR:(P\FE$ M9/O?#JUZ7QQ&R'?J!EU!"[I&"\L)=Y%=$VGY\=GO-,TR9H@KTQX)%ENMNMX7 MAT?05LR901.$$SB+7QKE;X1R\O*(IR,XOI4_Q:5NAN%_%-5:=$_RT1AFJ(>4 MEG_(X/C8H>6[TP3A0E&"3MLQT+U]IZT0W\'@ M8M-D?0Y<8)+T-'5EAMKA185.W4,;G8!39R:SU:8V6^;/NXXR%ED'LZJ43UE% M4-;QKJTH1L@$/#HS:MU.IB!KE2*M!D!&(+\&P^F&9A[ZO-:"K' MD1]9D&\EX?Q2M#8C&^6]^$8FN9:3P(""+P649EH=)R/['?#CO?ES&0.17 M/J6S*'D564R-ZGOG#MT>:DKX%.HCLY*TITL``&"+`C@R=277L"7O'($_VI3F M-ABM!.ZV)_R:3-,L`E'KT"6TT!@)L`<$/-)T2FL\>8K]Z70`V MM].YAUWC-*Y3W3M'8#71/IQK(^HO)+@?)K_[P5N4$#JK"UU&\4CX$U?R+A"8 M5+3)X'.I0(!0*[B:VAMT+87^!N M;P:58E*45T^@3U(21/-D@-.8S*,*AQ,6.5CYJX0(Y<:77C[A72`PU'3L(;WJ M`EN0L4PW+3?&W@4".X^M66&!#UO<+?\2DFQJ%]3P+M"8"#2.,S(0V,)H:T8G M=LE:SY*Z6=Z[0&,GT*!'#`%;;&PEI-):XUWLTF&_)K,\L'7[^KZ+_)^>-*.X%C-H`FZ=F6IJTNL'OH@K`4@$)WPS2I2T M MEJ`)6+8;5-4%R`@.^^U(U`0GX-.9U:;:/04!+0S)E%<$L`@.:.V8U$$FH-&9 MN>8N35Z?"9U$<`B.$^WXTX'F8!&9W80MKO.1N,K2L)(9[1QBGM.KZ5V'&Y"/`*B MG%E#C!8T[E2/X"3>EB0^&@%%SFPBY6);G\#US5;\6M[F:T"N26M]DE."%'#I MS-XBF,NU&%76]2QG.]P>KYI0!>PZL[@L0N0>R3M)"J+%JK".=X%L:FW-I@*B M@$5GYI9:H&,-O1&9HJKL$;O]XE2.5$"M,]-,*P.W3$$#!'[U/NA48100Z4=3K72;PCJ`%(']2C1<^'PIP&!+X/C3IZ%&$N*U70+=CXV%,#LO23^]*_<.T*W'\J7IYV9O?[PV5*4*T_D:^48)@1KJVRT\!GBH4"73K/;`E%YQNRYDZKVO<$I M`F?W5CPD/>I+GBUT&_[3]&7=K("'V/V,-OW%US7$I0JOF1!.EK M$OT#]LR$1BF4R_),QYO:\Y>\P6=WUIWEIK(?4/JNU1Z_Y]E=2J0>5BM]0>5G M[5UW^^!N;6EU/K7IG&]YP.N=7RWC\ZDX$?B2.U.BMJ`0`$SFE[,T#3X*RE M$&0.[D>F!\4V8UD&$"!T;&]IB[&A!62^[5(ZI=VJ5@JVYU9O:F@OYAMZE2B_ M+C@RUV\K]>-:[=KP8,$SVM=[(1_1I)@H&5DK!X@0F/$:79W/!$=R9'[,[Z`[ M+0[JY0`)@DLDNAPT)8UE?B%&OOCK-0#@;7H; M<>\,3%2$S6\IDYUM?I5'0;T&`+Q5%YGV;L.$*W.V-P%C\V]ND6UX`Q!YH`M=@\3MX?Y:LO']-]X$$;'$Z[;!$L!Z"["7"ZDOLM:7!TZG#,/M"$'*M^R"N0^ MN(KG2>T??`K;$.K#Y%$^2YA=SNI_41EXM1L!Q2%T,JN(%MBR#%$C]MR?WXG[Q&[A1I&`>S19QE;8FZ3 M0.K\E-8!X1$<=41#HNFXU`"#S&U9S?,I51J7UPNR[-P[PXP4`C+W8\\)0LYL M1@YL=9.A`(G,C=DYI<29U>2,?:3].!,^NR?"@\RUV0-'N+80/9*EVC&XN]-9 MO&3D[P6[1_4._]&([174\`9?;/JHMSLWRB!B':NQ[^(%0,F`$-6"Y1Q`XV8L'3XI00&`+DPEW M;-RGR2,9%TG(%MMK,DVSB,N&L*P'1`&%+:PNW'61]9ME M\-M/06PHOR`#A>'INZXKHA"90/4GVXO.8\(OWOUV'XU7E^;&#]A+*K,[C1`\ M:3UO\-79=,033!5K)ZP#VUB;+FAI@)V&AOESCP+-/D32\2`J#(NB*J`4-`YL M!7/Z=*^`(0N$XW9J-GM2I?%)517PXG!HRPG1)[$)#EF`G&4R<=D2;;&*]O4+ MGO#SB\Q59L!1D6>YG["G]JX+RA[<*V]5&+*NTR2L=@A.\;TNR/JPD47S79.7 M_#;)8/6O+IA4#R@^^CEY)E2Z9534!+0(SO&M2=9"ARP24"RSYH#6:P"P(SC7 M6V"V"1)9C"##ERU`7Q64$FF"75YQP(4@87*GN9A-D)I-.$V##Q+T^UH?!,E?A)$?KR:/Q8W,%T8>Y:2#;., MY.R]W-KKN=^)SZS,X2AY9+=%V[3A"Y^O/2S2.M^9J_?\0;GSO;`?0!1 M&9]Z^P:,'IN6#*FQR@+C_&F@9VWM@S%LJ9++V?*?_Q81"L2]P7'SG<0*TYA> M`Z`P-`D%>^X%BJZFH19D9K:EO'-=K+L4ER"49AJC=F#8XLA2:$*<@GI]W,AL M<\YZ`"ZKG8.N@-:@MQ3Z-ID6>5:B'R@O94IJ`5H$9KD68U7!M`@I,DL<3]Z3 M5GR>+%$BL,!9Y7,-*3)K'$_>TU9\GBY1(CCQ6^5S#2DRX]M\;_H")W\_D+YK MM580L""(P-G:@8X''IEI;O4HZ96?O0%2]C\6COGNQXI0-U55P&LULXOF:V0< M#OALZ>%!=J'WBM`\&DX`)!]LZM;3"$&L!VP;;NX=)T]0$0!"=PH8;5GKP*`+;[L@ECEY+5Z,JQ$5<$<`B.%\;LJ4#R?(=V)K$.@N1J#C(BN`X MK*E^-1!LMV.K>9QS;TG[!"RI"Y`11*%L^5"LU(?E^[6JP]Y2/L%`U*X/:!"8 M/#25WARGACC[NY'+94UPM%.1I:H&LJ.Q5+3@2`\>MCNSW'.?V>U9W29``6@L M&(;\MH.*[1ZM$'J;=1,@HC%PM&13@:V_.[2]'\O;[8'T&@#P"$PJ+@[O2J7( MK_8Z#KXV&]>JJM[),0(3C@DY8E.`&J>`6/>Q-?).7_9R/;M!RQ9!/;C,/RV[ M02?X@M[A\-Z<3!VM%P``B\MXU'K(JU$**-WB$TJ/9%K0X(T9N\:UM\'SQ*5=!0Q9@SA=7G:I94@UP M6C5`Z*?95E!A0F`=&K((<4L4XHK_ML/EMAX[XLLAS08KJP*B(S`*J0=*TWJK M1H4L-KN<]!L"WQ=,X-&X>EMV6.1O*67/D3ZGES5TL@OWG=KU3@8(K`8=]T8] M:`!9W#@A?7D%!4>_2["J0R8 M$=@?^J5?"%,:@+X-^\-5"H63\IGI)$OC*&0)U2_]F&6R?'HC),\>?);*XHWD M[!U`)^\X+YZ"TC$\-`M[)Y_=O?"TD$;Y"/-:01#9YB%3_MRR0(&B?MZ4>R^L M!@M<3P%)?!BUNL\6ULN#.FP>-,V>D>$0I:"T"06;;6`NX(\DFY(@&DV4-[Q7N9[?HFI==I\9*/BW@8!"S' M8/9(`A*]LVE&G0C,J!WOY`S!L=)L@6P!$)F%H>:5JG:NMUE62(^!@AJ`#L&Y MSHP^*11DQ_N&K+5LGR9LU:H!3@1GL8Z4-?!(S]/.#EU+E'#@','.;A[+L8L' MKC-G-ZA;'[C.G+EP10K4.W"=[8N;MI\#UQD:YRR/**,#UQE"9VR_>_NENRA/7`]^3&!`\,[20KR1.A[%)#LGLB.5H(:WLD7 MI(`BMS%O2D38 M4E[5`>HNC\5/QDD5AY-,91_OR"M[) MUYTQ&.D@P9;.ZB:E)'I-JA"`8/9,_22#C2B(MT!R2<90YMG_D(P<@U9`#3MG M7#*&UU_&JG[W#K#C*8]XU=RML858KP#@$%B4VNTD>$CZ2U'5%TV+)?4&4%^E M":RS!2RU*X=\U<^JH"$PK,D5KT=6#8X\791[IJZCN,BEH?F"&MZ)W1HP^I#1W>`08FI'/J!$ M&J/4BM@*CORBAWL#Y3R5Z%L:@V!9%MOBEI:IXL%:AG MGI2\$;F;YLEYTE88RVG"C/:Z9DI>/5`/VEPB%^I<(F)(R,R6&X(JK5_<\H`, M62X1L?X%?DPQ+&0FR]X(0VJJ[(TYM.;*6H8TX1,/PK*`#($%2S)Z1/#'`@,%L8D]*$@,R^Q#>%*:F150.<""XM&5.EAH0MG4BY7UJS*?7LA.CG M`Z`\G-=FI,:8_I"CRW]BD'ZZF:/YU.H+FW;(Y(/`EL!$]BI1^3ZR:J3*Z@)D MG/$LJD&H!H4M[8GM%[A.43S?V!N3=538/"C0ZW^+Z"7/Y3-A=5U4: M0_/&O%,,;^VUH+H%ROY2KEBEONJM?7$O:PW4@N#$TPOY:IC]I7WA)MQYH-$[ MX'B(_:`$4[,WQ>YPW!%D?WE,N,-PE3?E-EEFW8I(=CGC M'UY%P]*X'>C5".Q!^L.T)4!LR4TVD^HL0GI9/IUKEM*362]8.AZ1]>+?*O.' M9#3W]0E0X,Y9B/K%CBTMB\C[TSZ>FVLVJ\SCDAZV53F`"ISYEB3=T(&"L*62 M, MZ,:YEG+O59QKIVOXIRS'S!EWR;+?/E#V)V^@_[9 M^U7-G+$:][_[^0#H$.E95+RD]HD<6;^!,'FOD\^U`>"$^&!P%VL;=T" M^DA@^Q9$,5G+3_&<:JI(8^3;^!SH%4'`A/V>9$]WR**#ZV_NP;]C,C>&M'B$ M4%0=<",(S;#'*+\'Z6L&61ARKR_@(+`<;IMXN3:0!3JSETA&=.WIF3)8(9$^ MOF-0&S2%("Q@VWU`6S'8@J>OR9A02D+SUQH4-;W34P0>Z^TO`AI*P18)K7ZW MZ$="B1]'_Y`&-9@TXWW&<(]EV[W#7$/H@K.-(_X$T6ZG_X3TRW2!+7I[]4#= M=91-TZSD9C0>9AF1;@VE]6!+=(H@DM?%YD"E$VPAWZ5#G45L@!HJM:@?E!76 M\2X&"(P(VZ9=H0YLD=Z;.0]KN.?!>AHF*/U&8-K[9SPK&NH'VSN@3?F'09`6 MH#Y0'HG>%H`'('GP90H7;I%>/$]!;HI^0,E4S\*%R><^5RV>"]3N3%H MUR`H!X$CPU9GT-<`MF#X)I8%B/GC*0#B"F96F$/I,'SWDP#FQP20EML?LWYB MU#*H"\%6PU:'::$*A,^""J;$!W_&YD-F,@\"6I#P+O)?HKA<6UNM*;(&03D( M?!2V5QFU!K"%ZW?S]%D+BP!E(;!JVW>#]J$E;$'\`DR5J\9BQ(WA![S3SP@, MYKU$W+1"CBZ>WI\M[JX%?R\B2@`EB)[/'F(_86]SLX0HTXG\XH9^(Z`$!*:Q M/@D5A.P8:@3;*[$-^;_[]$]2W@]Y(D%!5=L5K?H`'8%]W$%G$"L#VP.TH)6` MD#"K+KJ5&LD+2E@(0'6Q[399NQ-2NT$I#^%KVRJH"<']TBWTF:XJPO9`;C>5 M6=N7@+(0&&CM]Z<^M(3M#5\!IILH\9/`XI;7\`.@/`2FWEZVO*V0RQ\4=I$Y M=CI?D$?CNS1Y?29T9!U!5`4`(C#<]DD6OSO(\0L(=F:VY4D[-S3=,^J6#869DP>C6'S!)*!FF`CI3DA MF#4$RD!@AK7?/]IH17#]T)EI=G%8NTGIVAZ\,DKO4ET6"Z53W!L?'>#>= M??8'?64(NH$SW-!](%"'@WIE-E+?, MZ7*OK.N=GB$P@+O9*W`4(>#>G>&SUF57=KM%_J?ZPWZ:$X"\$9C]$-L?+$T% M6BH1=`P4EM`.W8&+^/0,KU/$4A\0ZT%`O+M+Z:M-S"JI-4QBTJRR^I4!-%Z# MMIV]H%03`OJ=&1GY9YK-[*[&1\7-!@#\/]TZH-*&H"LX,QQVTXXU.S,H"X%] MV7[7Z4-+@B[ES%3Y;3PF03X:?_N`^3!Y)8\P"D8)@\FB'N%_+$[@W8_9S&G8 MJ;HV#0I#8-LVD0)LV`(A!8M,W(-\X3S`-MP(.D7+5H#M2`X8O=#KN!PW58I@K[2UV->RSCY1Q)'Y)T=^.>9IV29 MO#1K`@($1UP;M!HI0$!A7T^"U:[Y&I.H51=0(#BLVJ+10`4"(EM8M[A$LJ`= M8P;EE4!N!(=16]3I8!=PUM=#8&7OJ=V';3<"M1H`/`BB6JP.0P,]"%)KM[`M M<7F])WGU5+DQH1HUO=.O"$P)MIC45H"`PA:F)/[0#"*0@%DCP^=TF8Q'?V!J M5@K)R*:(ZFC%O;JU:ZKV,^R>?9JW9>[-NN`6FQN=[5> M[^J!5X%C1HX:V4-?=2&5CT4U"\.(L;K=-7_:BZ]U@PZL*\K?H6">W295"-#O5/ZNF(6O@58=NI)1]T"AMI`] M;E8]<))E!0FO"PKCI1*XQ);5M??M`[9K429].\*\,=")0Q^TW1[44AG(7AKK M.A!N4CHF96Z?Y6BP.$EQO@9:=>C;1CU)";6%[&VSKCCG(XP="JUOTQK?`HTZ M]-ZB[G\"72%[;*W'S>@?)'I]RTDX?"?4?R6+F?^!1H$L[GE+$H#V'3JK4?=4 M(PUB>QU."3XSVLS:ZL3]20$T./34N^W(?6L1VS-WG16PP.B\/QL)XIVY3*N! MNTNW4.1NO,AGH`/.5MY5OS84!0AQ&+^!NV>W4B6V1PA[/"4XVC]K2@#J_\L< MVH,&L;VB6")K!+LTP;\8'QX>":.4O1.3)F684.''+)'4B:HS;U<:H&5OK;2N MM(GMX8'$@#M.RUG=B%-N4/7SH/5-Q"G.(CR7)8V=@3!DR2 M'X`J*U7;5]"B_@>\P?'7%FNH'=A=XAGU&O?.K.8+:!W<:$S8^ICN6T%_Q3TV MPIN^V#R/]A;W:$*RR$,M5<&^!4':34W11Q#D%^$*+L*S;T&07TYV)@C2E"RT M09#EI/$,7U',F&OE`)%-6P>B69(#>]?B"(5FQA6V)&0O]]W[$Z(_]-@'$1:G+,JO!\YN?S"U9]VEYWY:$]N(`366` MH8_]&B>0G/H!X.ILO5=5E8K_GKC&Y3M8+NOGL95PRWFPCZO$P@ MQLY?YW'K^A7T_CWT_:[O&Q'T?IE`P,[Y7Z=KZ_H5]/X]]!*O725VWO6%TC!> M_CH@VU6N(+#_>'NWLN[3G/SA,Z@Y@)_,K[8]%#1X`[3#5TI*#R6K0$VK]H8=GN"$1VT]\X.1&57M=KX^\UI#W MXH[4\@V)^9L2.G>D1'5`+2CN2+5B4S`=R[$BNPQ5DY&%@8[&SZ"#S`^8?.H` M:V5EP(SDLI2<%0&5FOB079[:`J>X(N`MDHOVLM4#C=[]G#S$?E#.2\J8=GX% MP(CA$6?-@<9G4H:LMQM6PMT3K!?SE:.Q5@@YT:[KG5]@>%JY%3V&()'=57HD M,?2ID+WR.ZO!S2YG];\H]CWZC8`";1+M8B-D"A[=W:&5D,I5LUD8,.&XAVA* M@YK,.D!D%WYZ(`W7UL8F>ZJ]C3/CY7.4LP7G-@FC]R@L_%@QS7++`T*;[DX7 M,ZH$)[8['0U1_XCRM[(;LM[[%DV?TV])'FF,4L.6F,'&ZI9)>^*5L*5)KQ92 M;'2A=03>-M[@IP3SLW:4&O(TH"*)Y)SS:;+7CKO.G"^7A^@ M._:P;HER'FQL<<`/-`T(";,;4!"3TT\"F.>NR4LNH5E4NX-C;-DD#>@4[4GE8)$% ME'3-W`J@<)CO5'KGLR5$A"Q&I`^:<-G:>N4+;=C'/8$-,&Q&R)W\D?:UDV\)&%DD!/ MI>7,Y,?S$TTI_##/:?12Y&P'\)PV0_1KF3PEW:-[XTQI:.[']=)G>M,)LI`4 MP5B8ZZ8Q),PG%5%+;$U$N)B2L<\LS:&@N2O7"K0PFLDB7 M35'G.`TXG-=@\-`DN+#"XCI0>;P+UQ#XMR/VG1>8\4LE_1=02P,$%`````@` M]8%L1\#4\XK)2@``\RX$`!0`'`!A;7,M,C`Q-3`Y,S!?;&%B+GAM;%54"0`# M?0%%5GT!159U>`L``00E#@``!#D!``#E?6USY#:2YO>+N/^`\UQ,=$>4[&ZW M=V_;,[,;I;>V[M0MG22/;\.Q,<$B41+7++*&9*FEN;C_?DB`K$(1Q!N+!"#Y MPXS5$A)$`D\F$HE$YI__[6F5H4=<5FF1_^6;]]^^^P;A/"Z2-+__RS<_WYT? M_O?_V_;C+\7CT??OWO\3^O7]]S_^\.[']^_^`_W?^>?_A\YN[]`1^OKUZ[<)Z:&F M/7P;%RMT=`3?R=+\MT54840&EE=_^>:AKM<_?O<=M']:E-FW17G_W??OWGWX MKFWX#6OYXU.5[K7^^J%M^_Z[__/Y\C9^P*OH*,VK.LKC'15TTT?W_N/'C]_1 MOY*F5?IC1>DOBSBJZ51IQX6D+>!?1VVS(_C5T?OOCSZ\__:I2KXA@`?JR?U_@OWU3I:IW!P.GO'DJ\[!]%5I;?`?UW.;Z'Q8(O?(0OO/]G M^,(?FE]?1@NY>COBCK*!HV;IW0YXB]XV#SOZ)S.+U&:>-C\WS106;4MUV0P=/._^;.6G+ M>LO\WCA+7!6;,L96C+,IW1]2M+`8$MGO""%LZS@_^OGVFW]MR1"A0XP0<93H MUY;V/_[,/M_A:5[N3W]4QNT`R8\:IIH6W\4%V8S7]=$>?\NR6-G.>#.2PG9: M^)4RP5/#$>6FPO&W]\7C=PE."5?O?X`?`&P_'+U[W^SG?R"_VHZ$&\!=M-A) M)@UD7\V_PIK7IP8T#C##PFX^\BB#9! MQ1+11D3WD&8>H6.\!"U^+.??'8A.TRK.BFI3XJOE2;%:X[RBR+[!&=@2)T55 M5[(J+M,U-?4-%+A%'\XQ:L.?8'T3 MVJ,5)49[D.7H`U.]ULO91>O`M71HA^!%O=L)3"QR"8%[JT$V)2F9!<]6@5U\.`?<;DHMLYW+SSXDP&]W6H" M(G=2%IBOD$L_3ERL\%WT9'7Z4%)Y\-BH M>!#=--`:D>:AGD8,UD1TQQ@NB%=DF6R8:K(0L*7:+B7@"FJW-%D8`WSYWROC M!YQL,GRUW&[E\ZK"=37/D\LT6J196J>X^HPC&&YRE=_@>%.6:7Y_'%5I1:_[ M31`Y\G?<[\0CSY.P<3?]PQW/SER<(?81%.4)XCZ#VN\@>@O4?`G13S5A)"@H M<9D$9H)Q,!W&W`GD57D?Y>D_Z/7529%7198F+`(K3ZX)LG%>TW\2)M,\RN,T MRK8A%":']9'Z=RZ`8\U+5_#X?F=HKV5D20#1#S),O9)HE?[XC/U6$`<)@)8M'G/)C'G>]$6=, MM?7M?0;QWZ'"2+YT%,N:(/YC_H,IIT>=?/^;!G+N)/6.?.!JR8U,$\0I:>]< M7F3C[D(>V@'<>?2V^(ZDB`XDQ%.Y.%U,&JR,.UB)DA#U@_\S7BUPJ0"<=4_. MH6C/:Q>DO=I7CL[38A6E>0#X'+C*7>0>M,3N,`WJ/*H>KLKKJ*R;?YRF$)^1 MUN"-/W[^.4__OL%?HA76:%'[KIRC>@"W75BS!@A:!*-2ARYB%[.'K6`PH(7A M,74R'*U\'Z'!=(^_+CZ;YJ@H$5"C]M\<_:Q!;S`JUWH]+8$K6\S![QEO(S"3 MS[Z6U=VF_`T_2S=\56.G;Q:E(Q:.4Q$[2IW]M+YEX@F M,S[5V\-+?!]E[/VC9+_L;>7TI:$XQBX*:(OVD:KO;4XQK?QS0N6<3K7<['O2 MW49LXG2A.Z/KKG*[OMXW`ME,\LLKG\;!:MQ0@7M6W09*.SQE;:*FQU70P\W) MYID/V`[/_,GL^)G_B^;T8].)(\YD7J$]FRC_&2_/TN>E)@U;@']R&[QKP) MP;N,$K6DO-L3`?$,+2@Y!"SYAZGE(@H!O4-6T!U$K\LBQCBIS@G?G'_@:GF1 MUYC@IK[@KJ5Q%YLJS7%5?>LYAYH-(O>2J-G#T4."+"X^Z[JH4DT:/SMR?VFSU%R);V4: M,G3%A_6UE$$%]=DLG#3#EO&J>0"D-IRNT]`?R*1A;%LXA1-ZUCN[4GQX#?G: MG8@A9$CCJ^MK[#''#3=B>3X;1(.^0O&^R:=;GJ2F?ZY]0>2$H/:^*)M@9&W$ ME@FQ9PA).%*D2`K@YL=^<=0`TZ^,A]WIDIBD%^1'HT2B7&-_NQ0_8L5.!(]V5,SG=GKRK&C'^_M[=G= M[42#K+F4\8=.Z0R=1&7Y#"_TZ.GO1_^BU@];(016@5G7(L8\TK6QI`GM/0F< M.&XI2%C+P`10/_YVW!%M'PRX)8#IQ[@2+0Y3+D;5PSQ/X#]P6_@8933ZO&[U MA\P/:DGO/M6B(5\"M"#P%9X>T!\XTAF*ZHY6G2%:1F4JORA>ICEUF7S:I$E3 M$&DR=FG`+]Z13L346JB7XXXE6,`%OD_S'%:P6"(VF$DYW54U!8$1_IS&D?#Y0DUKWY"$DS)97,2ZL[0$I%&VS-?JU149E M%D34OQ0.Q*H8!'<`4%TF6%W#E4.U9VXIY$_2WD-RU?YQBVE)63O4L>9]IU4U M&_T)+NMTF9+5IW>P"2/S+R-*U(C)5+60<7AHC>-B0\3O!L>8B.(BPU]PK8>] MFLS]$5;-A7"2;9JC7?L9(A1;:9C61C?SV0QDJ>18RG$-8A)E6?$5C@)H690H M*3:+>KG)4-22D";__?V[=[-W[]Z!%7A+`$_=V>C#NQFBI5YAQ^6;G)*/L!;O M:8L?_(N@"9"%,[4QBAWF58+J"KL!54;BJ")RGP%)Q8&0UHB6S>!:NQ1$P]UI M`$,[*92!VER=D3U,S!Q'RD0S2UTHRH/03(FO`D MAGY2*M204=W,0!>427<8!>4NWG/?^I$Y5#DR0!YXDG*$':>+@%-+_]\7_KI+_LF/A!Q=>4'CY@.,+A=PF@_"$+S M7Y?%&I?U\S6955I:^^^;=`VQ*T2H#&ZSS65TY,855`+L//1H- MV7<:PG!VG)83R[V&D@4A-M:<72V7:8QWDN-?5,Q@9KRM]&!L^-O2]EHH3^`5 M:UUNZ'/VBYQ\_9ZL:B7;*VR(W;XN->5(?DD)-_T<*;K(44OL4R+&X8Z&X?#< MI3E:-\0^G\T.96P;Y\9>S<+-TXK=,-60GJ'U.12H?DC+!*VCDM8(@4NI"BI< M0)J5]:8D7R>_K1\BH@I+3%V!-!R"$"XP*G&]*7.H*%*B:+W.4OJ7KU&95*3' M9[9!+VM"S#815P2B3-@GPXR?8[@E2Y:,[`.@(PS%O9%I!8]Y0L@#<2X/YVC]`!VJA';(X`5MMRD..C>@X#;C9 MK#8T[1M1626.4[H7DY^))F<%:N:K@NR,[&&AE`EU<,Y(G_`1R#/6[/1$R+1= M([[O&=KV3N'/]S]#'0&9[4O(V-+^D8*KEK6%J16$ M7<*!S.:*(JSTKZICB90BD-2N?;:N+)&K9Z^J.0--N>(Z0$D;F>0M)$D1B^3==)&.D,4>A0+._27N#S;R!3^NOC4Q?F[K(O[MH<@2 MVNVT"D(844:'<'8Q/[ZXO+B[.+M%\R^G MZ/:G^7IV^?+^[^W;_HV,*S*US#L.E%_,P3 MU:B(?(J8/N4+USB\O#56G+2#SW9$`<3JZ>&D$)!`/0IF4@3X3LQ[]F+?T#7PT:V3M3%6(<>GM6ZZQXQK@I/B1*I,KO MHZ=U[P$RX$?P!34T1VW-J;Z=PK-?Z`"V:&0(SJO=GG(E*3B1^)0818!"-)"AJ&&(L[;\"XX9S/J=3V88,0M'#@@#K$DS!.UVIX[/4=WXZ8-X.&K&3#OX M-=STDIVD#7.D_"6$U+]4*)`DG#UT,'*90)-&=U[BJ,)7BRR]ISNUP9:A(_20 M,E/#B1@ES`);*07B2`+9,NP9$H6DV-&U8<`-UQET&\!F8@9`,:FB.?I<.K5R M7%TM3TJS=H'(B.'8Y\DC!,I7$,^>-7S$E,9G M9JTI)MZMTTT.=]'=IL.Z3]^SE<\Y"%^SH8\Y@+M*H['OYTP(ZK1C?L()YU1# MSUJ\E6D>1R*C\N,"D/+0?URF9YZ[W9DGJ-@28UXN]TXV,V*J5=56-AKCSK]< M&&"LUP5@`C#OYQ\C>3&@#>44I,2;XB`4B@`-86LG1OMGGE`%RAB*AH,O?UC=^:?:VIG$XLC.(B[+E(DQ9T2)+EJ%-`RLO^0TY MN]%*1.2D/C,=RKA1ICO<.[O0YR&A2<\0SM(\+E88DAO*#C+#N;![H3<6%^A- M7N1'#=';JG*1J45I//8*VJ`W_S3[\,\_T+SSU4-4XDJ1H1Z:ON\T%3+5!R`] M,K0)!J82:@XCY)*$5A2+LNLH32[RQO#EAJ>0%Q-B]Y%S)AR)WNR6"`$5Y")J MZ&:(ES?/074'L@:)J8_2;?X9_])BCCXA[,X2>B[K?]51FN/D+"JAK%RU]]IZ MF<:IR@XU(?90Y[1NU[H'E=E^EB4T,<,63QNHX"N6\RXHC= M-[&7RT?S%2[3."*[)EAK"?JIJ)B_\):E(@M`6.3`$BN]JU'E,,]PFA>02N\B MKS%9;=5.(C9UGU-8'*VU&-P5U&U1Y#7Y9`;9[]K>/*<9UO/V!8[UW,#3IBD\ M\*\VBRI-TJA\]B\(,E`)B865B/*Y(US0K(MDCJ^9,Y5'T%VQCQ\#T1GK`P'L M/`-GQD!,9VC;-VHZ%S8PB>0&N:.--%-L%Z0^BJ;[/_[AP\<_-?NB_QK:DS%^ MS!*G3ELFW*!XMB<&_5HNARA`O;5SN/9S^`"N.9$55O84"]4Q]!O`$6@TVJ]39$\U6G9P3SD^*U7K#Z8$"ZKY`$0=\Y]`NV^@]B,(D(BXSP!1G[S3CTF$W>F&-`G.A(UI M0I`YO([,HJJZ6M)=]K181:F0JI^_3>II[/Y*LF_$PL4>-`*U1K^R]@'@1[L6 MLJ?LFH5P>,4+!33NR%?F3ZDR.=Q^._<7MYUQ"A>9\'<$#8BE2YH$`([>J16N M*N7SZL,4W.*3>>+ICG@<53@YX?)*0$G=-91_N5"+[%#/WCA;P,<1_;89VWP/"W1<1^R2BWPS14)P`A7)[ M<3((.I3?_C&7)0$1IJEUCY]W;:Y9L22J>7;J)T\@,?67:(6UAN$@;Z9[0E`\H\!YM&[R!/\ MA).[@KZ[:2_*FSS@:D/`M`/WV2%,.1,21:R;^LV4$@)_&"V-?*EVV>[#,#'L M%E#(MS!@]<(`)QRQM.=^TPZ"`N<>9X/`.6O;XHL8K926SL;_D[R9MM+F2W[^-Y6R&KR'ZN0`$:2*P22_]ID":E[?2S8,Z MRDEU@Z&$/$[.B_)\4V]*#"H%HB%5L0OV??E\;6W,K_HY=IOXA_6#VH[0LB@1 MZPJU??D7CL'+K7C-/&2M'=Z%,Q'$2;^$GCW!CRI4FW;@_O;J^WX@ M/%H)I6M#O+;7KYS\%MYTV5P^U:*S"V+_)8>1.LH7%Z#ZP;O^#II>U1 M0X`:"GBZ%X#SUWA!^"M@B]5PN+5M%A7^^X8HM+-'\G\&P992"O<;F'3LPIZU M;8EHT[!B,35K(.Q+)@O@MLY!F\O]/(HA>]JSSB)2T'BI>"`;OSK[/FJ;AV/O M:!>C+Q6_P4KXA9-&(\E)@@"31"==8EJ"!8+&@M%$NLDW04]HNHC-L]9(UI,& M`:8.-X8*:H8:M(5C4ILNE0GDY.OD&7H&-ST:NC!`I[B%D6Z)ER%=IABMCA'4 M?%]T]`VJ"3&:KZ">[]6FKNHHAZP'IYL2TX6DH/">-UO(CYR!@@/UW(C!HNW)`@:4WS3'SBRJ2IUX-*D-ILU2]!BAF)@`N\:SE"Y8S6F M34ZBLGP&&:8P]B^VIF`4P^5MD.CP.2DNZW29PI.DZFIYBM=%E=;SNIUV;3E> M(W+WCT;-N!)0R9&AJR5J",GV4QL!\6"^$KQ,[X[*),1")"V/ MH4F:#3*%QZ[6L'3Y@+OGC95*Q/K;>WB(W3]N\;%U5://PE,YGQN4Z=!W?X4" M<*P>%*JVU0L"E!$5EL07X%H@#7ZTQ>Q+W:XA;>GT@5;_6(4GR>S$X43M*^NA MF0^9%C8S`^GA.U41T_MV^FKYH%'?;E:P#]4/F)A\S<@C&HA&SGM5^Z<%*^V% MJ@>,:Y0TFU>49:0-7:CZ(:H1O!TOMVD[OO7[;DXA$_QK.:U`N`RYW1X.#8IR M];;V$"C;-V8Q\G/G-)B\!I?1GF0][O!V'P5+ M(K\_(CA;H9X\TN*,X*O+FD''M'&(R!8QHHJC]AG527T)-*'/ M)8XJ?+7(TGNZ*^M"HU6$7J(XE9ST1F\R3QA+YT1I$$D3)N'4+ M[YRB$QO^L&(F,PZ3Q='#T_::ZS2MXJR`6RV#\XL!K?L4<0;\]'LJ9H@+K=O1 M!7+:&8>O`.H-&P-.2/QFA[;!FZ#NHFD[`LFN:$'O=)NTX4MW@3KON4#E8.;S MT0CBCT;6$O349(UW'#J?TC-"=#[0$[A^IKF0; MN7(?][Q!6XLTOV,/E.?!^D=R]:93.WHRI]K&@`O#RV.X.PY'M1S&U]Y]<1`* M9``_YSO17Q=EFRH]YE=OQZ9GR3<5)E[@[23)\[UWCSUD>Q7>VT48M^/]W!E> MF$L,^B`B3X8SJ[UBUZD5[]?K"L@:W;AK\1K`Z7G(J3FDT[+M*7EB5['*BS:$ ME\:5%I*H:*%D?!X.X/)[F#_)M`.?5^1V'IB]V^>0W4MC<^A?GNS0J+AN']7C M--X-?+5+066S^^A)O=S4:[CIRT-6[2[M`[;T!C"GNN!]CGITIR(0!IE[6/.Y?87>J,T@-.<-<,!'NG,X&=G>GIS/F9113;M MNY)*^S,M@Z=+JZ:@<>]>5(Q?\"="6["ZVM:L\&$XJ M=H/79)D?H@I?E\5]&:UT]6041.Y+RJ@X$.*?:%&^76O4-`\FLYA^/83:,H:+ MX1M3VH1A:K)`<"5-!R9'5C`IP4S6Q0Q=HY9)Z_^$LDJ:FL3I_;IF].8P\9[[ MQG0M^"M:\X5P6/*=7L7U[;27)F7<3:C=EV8WXDDHMTZI9DAJ1UV&E$?&8MV$ MBNBVB^9P,X11"!+R90,20R`"-OV>.CP+2HW&&R--+^? M2F;L/Q"(\`R8&7,IVG;^.N1I*(K,!.LP"'F3L(2O*\"&;"X]O<2^):.?(QWJ MD_T2&;,&Z&.[73\REG)\#_6F[TS"`0:QQXES7*Q618XJRO";E/Q$B=X&)Z8* M*&I$4(O#P0?38Q8^?PO1\]>DW[Q^P#54@E:$T!C2.3VBFO#1Q5!#@R@1VJ/2 M1LJX.JP:KP]_8K5<')>ZF6@%B*N\C7$>$3#KG+#][3UHX/YQ"TJW^7,XKE;5 MA(M*1SO;#J'2C.'GO%KC.%VF1`EJO:MR&O>048Q?!IL9XEJ'Y%35K86`)+.% M.8/@J_P3%.'^&"ZF13@K)4(,RR'_U%5&Z7C0TKAX761;.SB8R)Z=*%-VQ/9#+'F?N7* MFH>*\<#.7BA5L.#V39`21N(3(`,,N1."BYR<;?'6+#-XU2"E<"X$\K&+C\R@ M)=HV#>+L9;@$70`9S;]#(SK*,-'ICSC?X%M,9(LVGC2XT5*;FK'S&"74_5$TK5#(J_X*@@9)P`C#!D=OGS%?+ M9CP&>E32WLM#Y;YQ][Y*OEJV0C#]0R]C,\)\_/3VOL%[`+F#E)#I>SNLP8L[ ML'\JBZJZ+HNE,F7J7BOGP-X?8Q<.]*^(_3F`^'"3P7Z.ROLT]P_;GL7O@E6Z M\@Y3H:8ECNNK-2ZC.LWO/T=I7N.<.JTWZW4&">M`(RC@:]R#^^2HQKP)SWLH M)=J2(HX6M<2(4GLN<3^819XC>"Q2->W]"XXE)(6@;YG3),TPT#$"P]],0$Q(:X_.0XHST>?\)YT2*,MAKDE6:IW"` MK]-'?/:TQGFE@K-I!^[]IZ:<">Y41CA##2FSF/:(44,=A+%T**/,9-KG#S,B M_Y)DAT_!"SL`G"ZOMVH,^7_U0B:T]'"=U1VK>(W%6@0E&Q;##@;R$EB(5VT* M3#@\%[3F%[OZNRPJE=>JM[7[6LG-S>T;Z#AVP`,(MOQI\WX,QB_ M?X`K("/8^3J\.-36JW64EG"K?;4TJX4KI7"OO:5C[S\IU@]1CN[P:EV44?F, M=N0(5H#&Z$Q7*W?_"856PQNSQL07$KU]+=,:HZ3XFA/14&;X]9DFTIPS8*S# M%SD-#6+-Z4:GEBAAPS,1I\$/03Y%:0[S>)7#U?W5\G:SJ-(D)?#OD7`=@=.G M'\J1"Y=UI#%J\0+MP;>UH_!CK5ESL1/E"E@@8*^F9L$DO[\5#W-6R8.,_1[6 MA&W..Y;`75>M"_(/:-)(+SSNV@KP'MODWYZS_^L%B'^B8RH]#C-2%B5.[W,6 M]QL_WY517D7T2J0=ZS%>DC9WT9-BS[?JQ7WF22L>A31WC!JUY(BC1U2QM!;R M@O:"2#<^-]##N*4,$<:6#==QRW6]ZR>`370`;(5$DT,QZ]Y5,L\3:J&RXX"! MQZ1+X,UQ(HQ$,G3V1':LHDS2G9WE(E$1C M/HC4U&1>,N;A8N,/P+D5QBHP:[R9ZL9_5L.W0E!CSE5!_S,/#WK`M<(E0V_\ MZ\%(_:L241B[VD,F MB>X4!IFOG4'%2]9=L2]7K5@I],J`OIRKGR'\:K649Y5D=_4YQ@Q;\+* MWO8O2-!\A_YIZW]?.FZ(V4N+?*!`T\ MKG%)IQ/*L\4*12UI[[[Z@&3<0KV!%OZD(0/,#-&V05Q3F7*Q[^8%26ZSZ-+: M'4=,_,/06Z8\-?OHGG[BN6J8XE.Z[7285X^3*8?T]SL&N=53Z&&GY2U4PB\4 MM-!+OC^U=L%#RFT(&@:IF>?)2;$B MP'W`>94^-G>4!CFQK'OREZ;;F%>Q:D*;A!#JO?.D[6D]I.2$`]=6FO=[R,(Z MS\`@C`LT)3GZ7"WOHB=6(8'\'NICX5/,_FL`[C$Z]Y7/X;`9D:5]Z,%^>Y,% M1VJHM!8]!9-H;L*IB/>F@KD2`LA/-YXX2))+C"8+8:@(>90O47?T7QG+-Y/\ MYX;%WK2\#E0;AWPP*%5RT,P-4"_*.'OP2'+?1+N/\GHI7&4TZF2>]\;F-S,3 M;7L(P($YK63::+"QQ-)I+OPN(^V0MC$E34C)@??>HW_)1^[]D>>J)]^]B67T MLN-]II]&RF*O;15,U,M$%II:ZQCJ&-]IP<>>'XCC MZ6@3R6TO,0VD(3U!ZYR)=,P+U2G#]$58NF!,.0\F7.@0?E]\G(8!8"U$,X`[ M`UH+Z:'($EQ6[(62W4V!BM[G_8"2+_FM`"0+X2C;1XB!7@KH%T]Q%6"ZFW;(R`X M2G/4D`0$)Z/%$0KGFJ^,0YC%\6:UR>"]E.S60P\Y\S[!5_;$&V#;L,!F'KZNV@R MF7N'B0&HHTL+F/UF[I,#[(^R"P[V9PTB7'GC-6.]W2R.V&W=_/:GVX!0W(<$ MX5VZ%`8.WZSV^M2U"%:3N7_1JN9">';7?^\4".3MF3D:P(W3%X(&(!,>#!HC MS*&3#WS[U=6FKNHHAZMOE6-/;.O>F=^#P#G&$2%& MA1C9#%%"O\E1AO"U:[Y]:P:]!"`FIJ`3[QJL$.=8C"ZJ:M,SIO8U+*:O<,BA M75>F=TAG?@3-EN-^R6.]]`K=C`4''"VH6/*];<,GSHMRB=-Z0[?D`-[LCS@Q MC.N8:QI.6:_AB.\5Z@/@[EW*V68^EIBK>PM%SC4\VPAZ:TZ_%DD?-#5R40_, MPATN`H9R;X[_P<61KLOTD1A=UUD4T\@%[I*Q1UZU%$[+(ZG'+C@F66NT;8[X M"V%_Y9&&<;'>C98XHQ%'*U&'"U"$$,K,C,OFQ+#;W M#VC=Y=MS320#N>&+(AD+S12"S-2(O3BW=*$(]98/.]%N=M4@)5S+4K^<.W!1 M'2CS4L9N7Y_`[\N7H=CW"9?+$)[M"]J[0A+]\4M4EE%>,[-$&=9CW9>'4!][ M?L7PGVT?-&9_/QH([:*!9JCIJK'R_9KF8[!^'J4E>FSW[*^L]5:(OZ8UR&NQ M(O\NRF>4%W4(+Q8&8UR,CCH(X(.W]%VME(O\EBL'>?S"%L^RIX(>;8(Q>.[>W;9O_3KU@?E*HAZ-A3$XWE56E;,(ZRU- M;,X;'"5>P]MC\B]F>G@V,`9+.V]P'"CJ[@R0;M&H-L\.U(LZ32OV/`[*3 M;O[$WN\H[)+Q/N'<7!EQ=@RC5V:H_08K4+?W%<5K:]1\R>^5X(3S=1)5#U"P M>7\V`JZ<,+9D=:VA:<3*?R:MX=ES>E-8L/`\A7IR/(Y@\FY--<]^TG'-I"EP MG#Q;-TD^['LA3EC`/LQ_?Q(O_SK3BTXP3>WE0"%X>8`/.^MY5GRM[-[=]Y#Y M?&[?QX7RE3TU*"A%J(_KI0NC>%.O616G991@+-=E\9@F.#E^_KG"R47>U*_- M[^=$% MF:0"=BA)=R>;J]UD1-LN`DBY.Z[4])3O&5UD/-V5W&"8T33#>R6)[@I#_@ST MRS2?\WOC,MZLJ2YE[@JT_1`2R]"1/^]KJ>-62UU(M%0PZLC#9)(33+F=S'Q7 M6Q:<'^1?,4$TB$@;0NH;X$F#B,$<@4?*6,2U]R_'-GCLRJ4]&-W) MV:L<. M/C86PL7?Z3[[O6L8QB2T!^XJ0D'C'C7- MW%<_0KAN_&^Z!#+^!5M2R6/;6E&%=!7!Q/P2^73"L7@<&\P#0^"&;]/U>`.?$U_3RUNZ575`O:+L5YB[R>1Q#>&-U@V.B@>SM_AC`/F,#O*X(V:/. MIT!=EW@=I4EKKC96ZCQGJ2/G585[8^8/[3``H3/DW$0,B478]+8]0(*7D(57 ML9XFVM8.%LR1+TP2#;T"N(`P0C!PKZ.GL%2@:N@."XW9'-) MHT6:T0O803:WNL,`]((AYX;J8&N7-]VQ"U'6(>)Z#.*\.]ID;+E>,%+?^0"B*PWYF+!7(]@,O/U+\\+G:3490<97C2HVA)CE(9%P6\'AN MLX3$?]^D)29\D,'5S]=D96MB)4&-M_5*_2[4IA,/Q3\L.!1+@SSOLNE)3.MRS^&&S0\_B;S;MC-!3>=IC5/M7`..(R;BV M=&`JXSS-HSR>\%1N_8%05(C]S%BJDNT'7OZI_/"YVDW&2SB5#Y0:0TURD,BX MK,BZ;FRDJ^5ED=_?X7)UBAA@6_B==H&X/L*3,'-F^X4N;EC-H(,`K.4!H#610R/$ M.G12E46,<5)!6D7(*@U!-5?+V\VB*!.R[P(6S/8RVX[MT>9?Q($0A$G-5* MZ6@22DH9SAYHRM@VTAP.@Z0M2%2LX,77AJ8$GFH/,T"=W^.AJ2@9T`9Q%-0A M3N948:)43"5*AQ_[M#J"]ZL$)DK&P#,YV`4A2KR,[ZYLVUSZ]&7R@[:BA4TG M7O$BR-RNK3ML0^W2"R#E2ND!V9-2< MG+`H];Y1>6=2/&00>R=\J=IR2Q9`PC-S_"E<'D;@\WU3T"T]:WU#('80R,U` M#V?F-P)"J6B?E7D.X,^^"KQ_W[X,DF8^?34>W8G;V7*)X_IJ>?9$5$!^CV_( MH*YRL"S@%3SY#\2W/T89*`O+J-;#NW8NHB/,1A?J)<<7%G0;I M'^$U+4+;?6NOT!9VW3C7#)9<]A[5^D6=]8%ZV1!O8.N"DB/^[>&.9)SRNA MT^T.:F`^'=ZUEZ//@;/1"U[HY,'2F;Y3U7@"X_#E+QOO57D=E77S#YK3@!4# M.T^?<,)2#S>9#I+W"K4QJ#?W;WH'\=P31T)13S8QZ&>K(;B>9HCVU23L;M-\ M3+5G6]FAX\P!1P&:8/O0`7U-ZX?]-TP[?>!?"1P`>N&5[J&(-Q'U:%51^7WW M\<,[*KWD%W_;9O2YP5F*'^%M<%,,3E7+T)C2F52:\R+XY;=P:\EHR<*FV-]T MI0O-;.0Q^"HYODR+&!ZN1XIX0YT3?16"#F+LCMC^T0J2V.YK"S6;\-N\4:X[ M$X.HW3X+XUM_VL52*%M-,D@B!VL-KI:`M=XPI'6J.4SYZ4*1KZ01K/HXC#E6 M-R-<'3*4NWTM4ICS^I(4B96<\JID@)`.5B;PNM-:B^B(G*H/+0=B-=1%N.;& M,&Z"51#6[.QKAD3/W$O2"&;"QJL"&TD[S*#@*A`,LRH,.W!O6IARUK\%<]3! M*HT1V.3*<(2K30[BL\_F,.?Z):D9>WD6K(\!PCQ8_7S!]1E-+FNM=XPHG2H< M,U[Z@I<86;`J9CAC3>+@8)7*,,[VM4ENRN=+4B,61WGZ M#XJ&DR*OBBQ-6+Q.GEP3?+5(N5HV%SY1=DM^0^-\N`N?._Q4'V?J-U?C?\KY M'=P5 M$"(`-UW!Q&=;\<>]8?_C'SY\_%-CKH80B:U%FA!\;0@SAV%\N]?,=*:KJTU= MU603)C*M"M%3DKD/OU-S(7FM3MO/F!JN9HBC\2L?P[BI&#<5I4"%CAFG<6\& M(!-BVHP1YDY8/D5I?EE4U55.S">:^)":5^S"2R$M&CKGXJ+CHXLP:(_>`,5; M>&/*$;$']DVZ65KNBR_E=O849YN$/M!-,VK9?XJJ77OXQ5VZ6A!3J/V=WZ1J MMO/R!@C>(F)'T[>W"24BIQ0R*>Q..(!T'@-Y*G8^(!4K+K6(D?1UU8B%Z`UV M`[?QR%=+JJF.(?$)45]KG%?T`$:5V-6:E<9@/K+G.[#-),[A`_ISZC(^A&]I M3/?5LCD7T>X0WQ_;L%'38QOU_DQ.4-"IQ\/3*"#@/9$C(<`IHB_3'%_4>-6W M$8[09_#(YOD?%=W0,:(]OT"("Z@X%.822#CT+_0.=5Z6\(0?[)[CYUV3)H?4 M_&M4)@TCG!W[90/&C\HM,?ZWW'LS)IBO7B?!T4*4*>XS4.*,;]?6Z:7?FK5R MMW<,G"'VQ8F.@^PEXFT=E;769>)B$GG]X^(XS/@_R[5V>8C<.W4T3:5R!/_4 MM/KFY2CI3Z1A75WD+#/)IY*<("94T[U?>W&*NG_.IE35[(L0F<"^";\A7_7L MW78SC?OJBA*%D&YS0L$;6UEII<[QG14D/L3)*$+Y:M36A5=+[M1=GE?3/V92:A/MB,+K$S23N*YN&*`AE,YW@C6V5:*7N MY:BK1M^"7WIR3U?/MUZP8M39^9SZ\R=WXX# M-0/9'H@0'C7@<\)>TBYCJ3,GO&,P5Y@![4B5 ME5MRJEUIS%&$MS.-.L=#=J=J^!6&GSUJ+`M]TIFW4;DOYT9D?(5@K7*GT@8O M2.UN_?^^-:_E0%Z>\K6=Z4GU;\^USVM7P8?.OXT6#NG"R8N&&%T5'Z`>7I`V M[O&"^]+'UD-Y>1K9?K8GUODEW=S[N_.U\%P MNB[3)49O_AU'9?5VAHZC#$K6!**=_>B/7DWM4WF\'*TMWY1DK*KJ6'D9S8O3 MVL/FW)_9_%JU]CCK,$AKAV=7^]$A8VON@Q7(9'DG;G!5$_.>#(B&$"':L31?*"'JC>?U&I\G$OZ0(T?&EW)TBU8CX M:]"E6Z]$YS:)VMT00G<>I>5?HVPS2=#HJ,-[1=K7:E6"\#P+E\1<$"8,%M'1 M_BX\TT/63!6RNIN^UY'=X87,Y.O81>WUNP>/N*5R?PW[KO+5=B";K_487]$. M;+\^X?CC/>_&WH]0AZ^=Z2;RN[L`"'`7.4A+O8:M9-_=%^968CW&5[25V*]/ M.+<4O_>MY/"U,]U*?F_7(@'N)`PDW"OY,/<1NP&^(KV$,N5\7Y3LZ%5 MNW_?>\>!:V:Z+H.L-)/S>Z(!:LG=KG&9YOAJ>5+B)*W/HSC-"$MG3^NT MI+,`0U2]>S2B=JYOS7CJ"A900>UL1H=:0GBSUI)2L?,O3Q9KU@6[]8(-?A=V M%:?EE3N[T;9<%5T*8_OIJ:R:2(J4JFJ!Z? MR[L'C*)5L2$;,>'&EF?X;4XD/:H>R(]PU0$O+XH2+=,\RF/Z#(,]0TMQ]:W? M)WJV4LP_PALFPH,5SI>BQK]$L&W7\QSV\E53C?J:H.>!C&)^7V*ZH<\7%7T) M*U$]0SIRJH0&<=K%,'1"3''6#2+](-91\VJT[0IM^T*_MKUY?C8Z?*%Y=!ZZ MR@YP>H>?ZF/2\6\'`Y7K*5"D\KR.`%7H#M'^)&!ULL6,PS[L-J1)6F*4I%6< M%14Y4:`EV3!R.C%?FXF)R,3$;&(J.C'K=F*B]C.>=Y,#H#],="6X=R&[BJP& MUKV$*K.2/`5#Y#6`=`0#%W<@,KTF&-C:7HTM!D.["BV/L56GG$F?$*"%XJL^EWB*'=,+Y$*_+C'4%]!0>7(C\M(.>,"DP&Q.Y1 M9<*1!EZL70@`,UX>`6F6:^,.A5/3 M$&U;HE]9VP`@I9[^+HQ,YMX==.[2&E!]D2?I8YILHDRSVTG:.P>.;-S"&0': M@1[:M0QFKU/.?1LCMH74O3O6V/8]=T.UZ>"%7BJ.R_$(N&`_G>?^> M,1TV`R_ING&@]/,[_T&B[]!]`@KTHJHV.#G=E&016'0IC32JON"O]$]*?YQA M!^[=**:<":X4ZD)AE(B1;L/-&?6,:+BOK$7E?R>U6T+!S3)@_;S#DX:J'8#. M+GTHX!3XLL%F$W#Y`J#9OWR&R%2MG3M@,CU^6535.>%ZJ\=3D)GZ:GD7/2E0 M:4+L'))&'(G6$-WPWP#96P0`0#SEC)J"Q`P@U'[CJ`=Q!\V',.52Q,R!V)4O M6Q2Z$ZYY7I.A9!MB#>);'!/A!YOP["G.-@E.8+00(KUA5N_5\BPJH;!`1?0# MW;;FU%15R-](_3L7T;'FI8MSOE^TZQBU/3,9X/H&]+>]P_[#[*(98E_P+Q2C M`J@K-Q.@Q[%!M>1Q7K-:`//X:5(7^]QM6>LZQY540=U;L^#,*Z MG!M9-DO::VC9K^=@W]K/35Z5ONH7RLL/$T*G'C0C3KHP:XF0I$1*&%<>YHO$ M>SUL5^B`.[3\!B\W>0+Q2Z=X753D"]([L]ZVCN_(^L@T> M-1OY#5Z3(="7E_5#6B&"8$ MP2-G.N@1M5W"@^,WT"M*\[=HVS':]3Q#N[[1KO,`[@\GF1WJN7^S:6>$G@GZ M?/?^+:)QQ*1K)HTI(PX-_FT)LNY!Y#BJTGB>)Z=PEL$)C00V,O^']NC^,#"8 M=VG).\G!E_9';]R;'IM0$P+`CGAC&`,$+!1Y.O2TQ#VTX\%7`TY%!5 MJ%%$;0/:N0#:8,HQVBQL?]E%^U5UIYD[N1A8W:VF4B1?`IN.6:&/+?MQKH5M M^=06^&4]T)`2VL=^T7O:S53&%R[U5PVOB%_#RY5#.3[%>;$B9E0-T2#D?PNJ MF-YD]%()MXJ+F%(LG@T=H:_-%X^B9H[H'R8[)F-BYZ9@QGW:I`FQ]H3M9(KE M;UEKWU*RM=_-CS@Q_BV,03JM:U<5V7Z6)34XNG M$!/V[-+YJ([C8W3NXP+Y\!GIN6!N.]V^WF2"P/<+\6>G[076V7*)XWJK+KOY MPKCO>;^2'G^^6DL.;R>!O<$N6"HH>D0I=WYG^D?_:F,\8>JYY!Y5DKR;A\T" M"\K0WD"4]Q2*B:C@]4"CJ>DY2+-I"-=R6R%I%<++L19T$#>T%\SP/;W_X3+- M\46-5[+KJ2$=A>F'X#D]W![-!-E MXP%_'N!*'NE+'EW,8\V5RO4L2Y0[D\42T$^U5U;/@3NE1T6;W%D]`=3"D4TZ M^";OZ^CB:-)YW/VM3X6CHG.\>.C[$ M*+=>'+\A--7;`$(WK=:GJ\DM%NBC< MJ]*EKV$#VZ\M&<`NIA[0*]K*-#,?4K%=01VQ!X@[W_MK+7!EN4;"//WNJN?Z MUMOFVN,U*._][BQ3=5/M6.ERI+&O= MLT<;B`K:Y\=<$_&%TOSCRWBMS!23=*$S>E6%-)7A4`>#WF,!IU_2^N$&9RS) MRT.ZOBO.\IH8X-K:<]8]^2_ZI.55C);:-88WFJQY0.7I!BZGMEJ4S5H.WG7. MR8J?IB6.27-UXL3>EDYWC?ZQ=O$"K="V60#A=)IIYI68=HY=ODUO:T]4YU%: MTL/]+IVG0B?I"#V\*==P(B_/`LXY0L*\3%SVUFG3LQF__1Z=+__*U`QVX@MM M<\RYC&\FRAL<:V7]S!4>U91K5%)YB&U6\="[5U,_.&F.N/;!%'`T6!,QHMEP M0=P6O<9_WQ"\GSV"#X1\3U^G6$[CI>BU;/S"/E]N%%MZ&GK9P;:?\65Y0!F'WJV>W?P?JG=K!Q#X_"JZOE-?,-T(.$ MSG>D)G%J[FM&WUUZVAS>C_$$`;T&,UD,_BQ@OA(.]YTHP]4-)FH+RB?5\T55 MEV0W5.TZ,@KW>XYT[*(50QNQ&CV_M@VG/O8H:%I32-V[JK;YKV;\=&_D?&0([O MP;#6(=^>C[S(CUB-4%"6_N5`BZ2N)!C":+!A``=D%@N29<77OF24S:;5U]"I M$=`[TNZJ;QNA;2N/MSM&0YYO2^'N!A^U[5'"JC(2%,#53E'2,K?L`9OGVQHY M\Y9HN5-E)P'BHQ6E1AQY(,;S MT*64YQBQ64?O[D*M8T=#%XK+4'W!U^\T#,;)8[0VAH[#4>_OKG_!Y4IY;[?7 MPNG>O3\V(7`(_7)V\SD`1XUD&OG]3#J'MMJAPO&W]\7C=PE.03'\`#_`HO[` MZ0/RJ[^=-G8&.`=[UE5LXFQA>T8G1!@V?Z:>6G_K*IO'=F'5DSC5RL[)YQ+X MY'D6]27<[6GC=&V[XQ,-U^;O"!KX7=W>N>275S&14TON=9MNXI3L`1H1[K3U M(LO=\4J%FC5$9Y!FE30-0[Y[9[M/T!53/34BSM,JCK)_QU%Y3G[3=^)0MO:" M"G',4ERPI@C:(MHX#&1(9KT/&\HI=X,.!D]S?.RU]XB0_7'K,-*HD.!0TC/[ M\DB[I",<-3@>"NC""+X.WS:E$(D]_P MT&GC=.&[X^LN>?-WQ!KX7>O>N>1763&1$]L&NP=0)F6>3`E]6`UJ3F0F!/<2 M<-93OBD$'6&R1CWFA?$".2YD&%7X%+/_7N1-T?+\_B1:IW64&82*V73BIS"A M*8>]!0CAS>6;EOPML6W1M@?4=!%,L-E!W)X\0'H1FC^RV'(8515NGJ-F:;1( M,UKD/H`8-7OH]I8''(!;=^(Y)XHC:4I;WN)X4]+)/WN*LTV"$WC8#OEA-BRJ M1:PM=6D0)#'>)YR+]HBS(UR6<%VC7=^H[9PE3>"ZAVB,GLIF805BC`VGKD!- M@R6'53?9,W3MBEWGRN?2`:RG0M^KSZ\H4@'#".R.]_(_\F_R(_0,8_RN+_!U!+ M`P04````"`#U@6Q'(Q)"4S8R``"H5P,`%``<`&%M&UL550)``-]`456?0%%5G5X"P`!!"4.```$.0$``.U]67/;R);F^T3,?]"X MGUT6M5A2Q:WIH#:W8F23(W:7CP2I*4QM$?'WJ_'7XX(%$0CV@T^>/#]Z?; MC^K_U?KLX M@#\<'G_\%K]^/#KLG1[\W][1[R>'O_<._]_!_^]__<^#F\>G@X\'/W[\^&T$ M/61Y#[\%\?3@XT?V.R&-_GKV4W(``XO2/SZ\9-GL]T^?V/=OSTGX6YQ,/AT= M'AY_6G[XH?CR][>4;GS]XWCY;>_3__YZ_QB\D*G_D49IYD?!NA7KAM>N=W%Q M\2G_5_@TI;^G>?O[./"SG"KEN`Z$7[#_^KC\["/[JX^]HX_'O=_>TM$'X.#@ MX!])')(',C[(!_![]CXC?WQ(Z706LH'G?_>2D/$?'_QIFK-\>'%\R)K_RW4< MS*?_$_O'3_+VGV!T]<;W MF,5!CGMT%4]G)$JU1R9J67],=]$K23.&^BZZ^><<0#^28)[0C))49V3R]O7' M=T\C,AA?)61$,YWQ;'Y?__=O?9K\NQ_.H=-;&L'LH7YX!_,HR35%BR)E%_5' M^4!F\R1X`04![/%T&D>YQNB,3MC4AF[!KY`G_TU7E4J?U__U;W%&_O23Q(^R M$J[A`FQ_DA#"^-<9F797]4<]),GCBY^0_C2>@W(\^<^A'GN"ADVM6OH#D[=O M?(;J#U2SH_HCOHJC$?#`"(G2.*0C=JRX]$.V-S^^$**WK.CT4G^LEWY*T\%X MF)`42,A%=TTRGX;I$WG+YGZH,U2-3JS/G,4/5)@ZJY9-C9#"M='MJ[.QH3JUF M1_O8/X>P9$;9"\EHH#=VXR[W=CXUET/%CAN2RR/L]_GOP0%@,&,F%%C1JA]P M1-WM8?1L24[("WQ#7TEQ6;$"@]MOTW@&X_Q<\1*'(Y*DQ:I='PV_UWW(!D9Y M&\8_["A6J;=&3M`5S\P-G$@KG$%+HYB5!@<;ZU\;PX%UA0#/H^6`6%]5C6^Y M81!^,(R#C=\(F4DR3A28X2\\6??]YY298K-E-Z'_3,*\TID5WG`LJ MPCKZ+_!7J[&4AI#?2SE#EWWN'6\, MMRS'?K(Y=#\)EIW#'W>$N&G=77SQ:99OEA^#%QJNY#].XJDYJ8NAQ'J8YBF, M+IZQOV-;6IS`,O3'!SCB`\(Q2>#4=U\0)$20#S]GL9Y`QW[ZG/KBX!CXTOJ,6%I+W'"CH#&<^T;7L'4H9MC&MPSY M4?ND)\/"E^)9"Z1X2]/`#_\/\9-;^!O55K?U-4/O]!)23Y)\-'Q9GK=&EH5^ MZDNS]#UC`./!Q4B>NWCX$KU`+-'B-OU`)I1=HJ/LFS\5+;&\3QENC!=&A1PE M4`0V@4/T,KP"!A+F]1F1M_]%WJ5"W/J607=Z.:PC13X6@1A=V'9TQ7@U3Y*- MO4)^XA%]S@@X:Y\P%7`$\G1APS&;EKL3AV MAE"^)TH:,F-C"VTVVL`$TJYCR@&./FT[_)IP!`IBW8U<@'8L]->P=85Q.D^* M@);56!Y(R#S&5W&:I;D`\M$._??9! MY?4IX??LN;7`6A0LWUUB@Q[[SM%]+0G2)!,'"\-Z/&D_#`?9"TG*?Z5>`/0Z M\(YJ1A74<$Z"0GTEV4L\*HWKFJ1!0G,%TIG2VGUX;BV!%80B\&D:`6[O=+PO MYUBYV)?)<[9>$'7V6VX#;\O0Y0R!UO[(;^&Y-?-H$"S8SR1P+$V,5Y(\QRFY MW__\4"7\.9@RJR&M2=?9IV3-O"USAF,T.I-(VLYS>]/7IIP_H=30VKO?B%)4 M'V>-;JF`^AD- MI5_J1R/9CRGR&\P[\LX//YO/I9HH9#.F8D^`PZECM0[[FS.K%@'MG6W\HA<. M=JL;/XEH-$E7`U)O5:(F<'`X=6;W8Y6B1O,0#MK;PV/Y:`'HU34-YQD9Y51K MG0VK]?C/I!1E_APE-AZEOY)<8:#FNG#>&K%@Z;E'4B+5+!3,['(,>8 M6M=4=>>,::=G203*J9+`02LOFU!AWEOX'>_$:0*$MDA5D]L6%>T]QFJ4UG/B M>UA565FM/<,XI8H2%B;-O3-W-\_E\$3U+/@?>F`*4$?:0E1XZEE86)OO)74MQ!][9TA\OIKS6(``3R&+ZI)<'.G4IX7-#[TS M%+$Q`L'PI^_<:1$4M4#Y"J"/S5)9C1$9 MTR@_Q7^9PS4P?SS%C5JL+;]U%<2P)^_<:<65JJI2!:6E^AT85I%K,F/7SW2# M-FE\.>=[[QS%Y=I4]&(LELIY8!!P/PCRF(<'$A#0:3C1?B.96LZR9MXYBONV MJ;B5D&Q5`,E(XECH>5+2&F>J)7)Q(^\>!_?P6"K9DD69W[H>!V/9R3)WH=A$9W++B(S M9LD"W=6PWN@T]\Y1V.BTC3G:F&S5,L$PG[_Z0%]$DO!>(3$D:ET\9#(%X6VDS+)E%O\51H.NT!D3](0KAB$0+0M-@TJ;8+>1;O,0J51"Z350O-?*8$"-I3=&C(:)D#= M+EC=&0P"-XK5,P,GT(M6&@1+R/6#^<2-@"`4EB`S@2J5@HM2H`:MM`LN8QB& M_CMS:>O'<6PV`&)06(A4HI,'2+) ME-7%54N>\S7+K&^ON(6`!-E3QJ%[&&1\Y<\HNX@05LCT.:237#8:$UW>$(A" M87NI)GD=;`(E:&5`'[L-I!0 M6&VJBIB/1R!@8^N;>WM.?CPI;UKZQE5^*Z_70V&UL7%O5\(4Z(&Q70_#1!?L M7UKZH&P+='7&FJ,)5J`;K;3M+0.5'\@KB>9$2R>$;;P+=%M"95U0@!3H0"L- M>Z5@]1)S1JH@:LJ>^NN:1LBQ"A2CE4;`2DX@&;D]%-$Z-I1!A5*@!JVT_I7* M="L3^[<^!3)06/A4XA*#X2@N!)4$[@(CT#`QF9`]U:BKS2*$\!U%V4$)".;W=N?>CT< M#QI7$RT?C4"PK0R^V^7E+@K".7N!?S`>EKJ\9@>I,'_\Y-N61EFHEKZ)%=6I3 M6NG?.ZGPA)FES6-5:OT*EBK_.4Y@N*^DSY[NFBQ&&8WRU8S_ST_PI]3/,R=3 M9;ELZS_FG:"(-["G!8+=IQGBNE#7FQ4\'HQ+4!6EO;G?>R"8I[L%BZ`AM8!91=*"?.)A,<8P;)T$^RQ7]<4Y:$ M1S/V6LGE^_>(_G-.OOE3U:,!IEUY.!X5W.NB4XFC+A0[5P!G>*_CJ4^CZ@JV M[L,[1>%_JR3L2GJS!=U2;?6*"L.MR/+HYR]P_DC2IWGR%WD7;COBC[U3%"XV M,U%LBE,!SE+E=`L3/27!;Y/X]=.(4#;'3]@?F%!/2E,;_LJ[)Q,_O(DR9@C@ M[PZ&(,I2=6@$V\-FJ/&YS&?]*7BE[D&Q$`S]\ M?$]9)8:[*)"NZ=(V#"L*+Y%0#+O+O0X@6Z7";0J/X]ZYESS!IFK"D.((*]C' M>JW)AJURX4[79WX]J\&/B"3I"YT-21(P_!.9ITB[#^^S4R72E"M_[38#::L` MN5/=N(T30B=1D8H7E+>]+[!F7I(Q_/N3_R;1#,T>O,].]_A:>F$"T59!@O\E4Q)@_$R;N8N*K]^_3A_3NF(^@DEBGJU57OU/CLUS=?2GKJP M;94XMWGVV,"Q&O%[7I27V1-%Z0K:;;W/3BT%E01N!LY6M7*G"T6>SGL53V'( M+R1*`3R&_HZV1/[VL<+++, MJ>6_UG+D@BI;Y=J=ZGI!TSU,9+:2EY?I)1$2!54W9E0Y=4/4TBIM?+:JM6,( M]"X5![[U:9*O[=7U!"X%9:L>>DG2^XJ?AOO^XPOPUI_FE2<7L=,N@J:7>6^K$:GC MH$5-6'F\$TNW@+6E;OO7F#(%<&ZXIN$\8YG[_#AD\T[8\%%$72CXY8195,'9 MA8#@56#U5>BGL,+DZ18*)Z.P#:O\Y]P44$F4_,53!;0+H;]E:$K_X.['C`D4 MX7,J6?$E+`3D-EJWWH*N&/7#:'1^-;:L)U4(L!28.R)C&N6E5K[,Z^NJS$L.?].F MN.28Q76\YSDTI9@`N?&M9N>,=NU!:\[4])\61/UQ,Z$ MS@,G]K.P*2BP%.V,09NX+!K8;)8KOOO0"W88=T-JR;DHPH69-OE,?I11D=,:^@K>23!/,G+ MN=R\L2)`9,2\D,S)/5_6>=@&HU\:P\8/`67(K=9'XDI+#3#QRZZ]8T(\0I:# M:$_8QI;O(Z$I[")HJ(-1T4$9X+F6'!;RH+K M;?V>!TNQET[@$$X#9A-CJ^GWB&;B*EAZ#1EH'#[SYB2ZZW?5Y@5/L0L+UX\B M:XW1&T=Y*?/R9UPG,E!>2C>\8?A3[A4PZ`B\3!TC?ZQVCJ#9C68$:T=(R8PV40-F7,RZ_!3QO7T(< MYG.L\Z%8D9/UD!95:Z[B-$MS`3R7;D4ZU>_K=>R=;@4YV8@DYM\`>5>TXMH7 M@*["$4`O9:1.Y]ZIVX@;FS+;O0O;Y.B7MV[;\7&**22GOH!-/72GXD"=G\M# M=^HV,$=34MH>NE-Q\$V[/'35?#>GF%++FIK5',A=\-9UPU]SAB)*B*,B>_77 MG`DCA-KE0^1-UH?'[TK3G+0=XP='J%!SPN=KFPXM"-U\M9=TF27/[@\P$IV: M@9O=`ALAJQ.^1-54%LWDY[G%IRD\Y(0F,`[B>9TP2.YMC[PCQ6Z5TTS)$ZF12;0P#Y M.:]HU_HYP:/4DD<90S9;<\3]>[Z2.)T.FT,`V2&J1='2Z<"CM+9C_J*8#Q&9 M,-MX1^?#;9R,"74])79&`2)$5*.CI;-"P*HM_W^W-PJ+%7E;]1;RX^@U;).K,JQNYXMR>"!V1#56VCZ5-.FV]<+-SW9I MQSG9#,?HG9XA*CK3TAE7B7-;CP=U^[RW>87$.>4,QPCB;W_HD.LI5XES6R\S M=7O*+>ZG[#EXG//-9(`@>$2%DUHZV"62,;$)/N+YOA'ACN MTK-M^[J7(I@[L@&!9,]_6?_VP+"MQ^ZZ/7=*UTP$$T$&LN+%ST6R`&]!$& M&GID^4(C9\M2:8?6NV*XUO%?%FJ-('"0L7(O4O3 M.1E=SQ.8K078G)>TS/S-&TD"FDH?L3/O#/A$GY!?7?\JTE&WK$07$B5YQN+F M$B+%OP8209\=[VR!%/)5MQI$AS38]1$5?3([JB.J,$_=.-JAY<%UFSL3N\HV MKKT[OP7R0!\;YTQ[!6PU]WQN^Y2W-,&W(FN7!ZYA0H-&?*9F(P#1H7>48EBF MU1S:JJ70&@.#L-"B3H:BM6E@;Q0@QE9Z>.Q,!=L\VJJCT(K=0$7>DA_GL\%H M(-[I*?I(37<3H@*5MJH>=&).<&[PKF:%X5!`F*UT"^YG7E0B\U=A@E;>'4Y_ M>2&M<&BK2$#G+#^.)H#F"$!XOUR85CCL7.[^3E#Q+G'/QBO'`V'Q6_#W5W&4 M!W_._?"))-,CU538[VA`I!WVK+KBTU;J?1>FB'AM$9'8:W"*5!@-B+3COET7 M?-I*M]^=(B@24IZ@,P#\*RUEG?RP_2[\/M>PU?2YF<["^)V01Y*\PHE&<'`* M\[%0]N#M`PGB243_!D#Y@3U'*\8 MQ8MQ#E4=(6Q["X:D3HKS9)\D+8JZ%/^K MV#[U.@#"G/JXG.VM)O18"MQ'JT_LC*J\UNEU`(2AL#B9B-=<0;;QVHJ-=ZHA M=B;>O:1B0T._!#)`81S8^QK6"(^V`MW=EH2)I].%B^O*G]',#XO,$A&?()OWM@? M90JFUX'7WD7%,>.1!/.$9I2D[EW$Z]&E M():\EF3YK]2N8+T.0)@(7+Y,1;^2[(757EX-4=^#*VX.\%`FM`T@17$- M$,E@U_VH`:<+SL=B!8L3I5E\\T.OUSMLD4"E(+K@2K1;_[=WBB/:H.:.JP#8 M!7]DW7*_O5,%WP<7(`JJ,+16W8SH;CTB03F[:D-T!UP0$IN%!4NS,7A/8.41A3&KHE MES!VPK\H@&ET1]YI!P3U4!SYU>?@G2<2!15M?,!PH#ETZ M;._>BW>1=,)QI5BW=#SYNETPVE#OR2Q.*5>(PF\]V,:0!0M6D)\* MGJUB+0BG[.!'1)+TAJNHK+^B&(=^1_R)C`85:KN^D+L0DD5L>\MJ^8,88:"($1TLQ]C-@U M><[6"Z).>1!N`SA"?W:UY)4)O?4#&DJ>IU6V`2`H+KTRFOE+G`)2%T*Z>!`5 MQFA1$R`%A0U2(35]4:]!=2$BBX?PGJVRB=+VK&H*)*&P:\J%J"_X76QN([4: M5``-ZZ:TG=<[0Q&/;VW2;R'K0J07#^8BU;L_C>=P@%^7:RP_I&>H$SI=`JDH M;"0:DM=7&7W@E@+.,-R*V6GJ+H(SU+S(U<@(2#)[\#/":A7*UA-%2V`*A;&D MLHIHX>O0$Z=BO)J+B5X'P!L*XTD#>K$+TU(D&P;U8-RD2\*NY@GC6+&S;'\. MG*`(<:FU:_!!60I@`UU"(.9M;F[>9C0IBKN"ELNJ$VNT]LYZ[9[_VACMQ[GM MRQ"W<@@,QKC M>^H_,Y6B)/U*?#;0T2!Z8*FS;&^!#[[%4;+\STL_I7F_)Z\D5!@1]3H`PE`8EBQK@$+--"CI@D%R M!7)!X*9+>85<:9TTZL?KG:.P5YD(6Z$N^K"[8,5<(;R+9O,LS:GJ*7,8):V` M&A0FJ0KR5"B&"&L7;)H\D$>5U.!H10T*LU.C:K"!M0O9KSR0QY74X'A%#8I; M9J-JL(&U"\FP-LYG.JXPJ[\#]*.P:NWW<&N/N2YD^R[84!LB-C\$`E!$HS4@ M5;[Z\.!WQG3Z0``6#=@30'[Z`ARQ_V,!V*]^J(@T534%IE#4T>')CR]I/426 M3*3N97]%DHR.*:OOEP[&BR2,?G;E)\D[S)!\O`_JH;*4$ MC\B81I1U\V5.1T5HL*N:K9RP7ID&\+X'6L.ILO*+/`24*,Y^FZ-10;.7?NM^'BUV+XZO7 MMI)(V@)9G;&Y&1A.E(S8RM>U/M]5YH`5,L$"H-T>>$!A4M,4V.[Z8(C45H*N MC9LS5_("(X!*X*IF@!Z11:R"G/4`VLKF16X8,2O3H-L%4(C(8F:H(]7`"@** M6FQ($Y)7Y?P`)"$RJ%74"`4Z@0J8V]F<'R%+9ZEJYTB]#H`V%"8\%P8?)2T" M;3(W##JW'MR7DS?,UA-54P]P8M`@$\&*S4=JI`*E,#8,XMEE5E#E4RZ?8WHV MIXH]`L'8S(X55:D6`0(-,S9:XM$P.:&5-S&@"YOQLO+2H\8I4`MS>^;6V69? MB54/9#9/@A=FJAV77IET7^PH'\9+'(Y6KP)_BS.=(Y:\(4CMQ-E%LWA=XBG) MUYSW?*"J7"EA&P""PJRD0[?@'BF'UH5LIOQAS?44&R;Q)/&GJFI"YA$?H_K1#4DS(`>%R4@E/A.AEY$A?*J./VAI,7Y9$\")PL2C MEL6N35B-JPLY/\6^Q5O5[C5B]S5:`U4H##J5%FYM?%W(^\EQ[2C\MSE3^,&X M>'6]/\]>XH2]N/T47Y9FAZP43:U^O:,>"FN.MB8(-H/Z''0AIXA/PP-AZS"- M)DWIFND/`.$H[#Z-*%TU,KJ0&+3%QZA<(JH@05^S.(V!*!36'[M:(P1J_YG` M?1E^KF+X.`)H\(G[J;3XIE1E2%G\T,8LM.;O`&OH@FR"Z<3%ILEKL>`1#Y,=]T7 MC\O?`QTX[NP<(2G$N0NC$W:9!:KO43HC`1U36-&51AE1&Z`%QWU>+#.!D.6( MNE#$9<6)SL5]]V,@`L4]O<+$W<+0!;/,ZB&1VSBYCN?/V7@>]H.`%4-.'TA` MZ"MC1UWYTZ@?[^@4Q5U;)%B^&E2`V*&2T27'97$XOTO3N?2*+&@!S*"X\YH) M7PJF0_6@=W"62J*;R+K4##A"<5VM*?`=1(V5>=[7]90YD?_TD\2/LA+:X>(^ MWI\D)*>K3IR"X!7/U>^R3`?)3RMNK>8=>>=;3H)]H!!=6ROTXIV[M5+787W7 M\U4)?"=NP//GE(ZHG[P_^NPYN!RTZA8L:@.T.-U0*TM2<-J6X^S$57D-[)L_ M)2QREE^_E?U'L\OJ=`.M.]%@(`GFK%%]"X:T5BCAVBJ-ZE03 M-M\C9F]32S1@]V-&1>=6`R%,6P51$<[]$FO&2T"I+2/*J<]H?RO!+FI;Y5>Q M9!BL`EW2P7@P(\FB:HV#`A-W$8R4K,:C45E"T,([.G564J)R^L$IBFN\E%'1 ML6H72"?"+NPD'IRB*!#!$Y)"G+LP.A%-83?QX!176LFNS`1"EB/J0KA$[<2# M4UPY)?H3=PM#%Q(/6%A!^D!>230GCR1YI0&S[4B+3O%;>$=N+6`J80E$*P/3 MJ;2!-!N,%T`USG_<[X$5M"D#8A%+H'0H8:#P["RN&='D*^PX<(/)DU[GLUG( M'KP`'J3OM.CU`,RAB&J4B%5@EC#!UUA2@0L3%8PYH(5\HE%_&B<9_3O_3ZFM M2M@*&$(1YVBN`2I,E@(>,$A]D+V0I&!HI?(+JB12E[0"AE"$,QA+78G)4N0" M!JEOD*.[O0,+*"PDQI+EH+`5RN"^_OZ7)$[381*/I8_FE;X"`G`91+1.9SL` MK+U4ZER"CR2$/B=?2`2K3L@VG-&41I3I=49?R@,(6&D"-`6)XR-3N:0O.E[D9 MH-BM-`Y=FPV`%A0VSVIG+QX66R^78E@&UD<0%F%T%4=P+IG#T60=BINK.TX_*B)F]C`)$V,;SQ+X)LO5\*X*CZ)*2Q37J M$F[-'63)K;X^_.DZG? M2+9>GOI9EM#G><:"2Y[B;S'\0Y3!0,/\TERL9Q(I&_<%9+;0_%L19NV'4:W< M/AO0&EV-`!I::/3E0+#UFJG[V7_C)^R5A71(DCQ%3B/*1M0$J&FAK5>.QM:C MHACVZ6VD[!G5P$#.^?=`"PK#KUQL>J(N`;+U2BA&.5_3<)Y)B^T*6GA'YRCL MB#9DO0%)(&UCE82D$.>XC%F[,A,(68[H5\878P^7 M:4I_XFYAZ$+&5T5[TSE:>].Y,!F3`\%23I?[^\HBK'WGF,&@`N[!^,E_*\KP MP-^S1R')-2G^7^/P6+]S8!NM"4NL,+9P=RBQ3$:).+($CL#Y?Q55"ONC_Y@7 MKMDEB15UK_H/@EQ0W,IM:9BY_M;EKD,I<1R&EECAO\(Y>UQHR)+#@(UZ;CS+ MO^0=N2T45FU5;80$2[EZ[OU&$G::4SY-GM%&.U92-GW0G4H)%/)1376`(;3! MD)74H@#45.8@#@OW8)S[;E[B$&"E1=B<8_MV7OIM8T!F5FUQ>Q!H^ZJ4X2@V M;L"OG@5;4E^\55:3%:Z""K:E:LGGM@!Z4AK$+=2DD,9PN6+:WT"FM MVMSO@0Y<-C.QS`2>?S&J+EBU2Q5(E2^^[7P+-*"P;TED)#P(\9!TP;+='XUH M`6#HT]%==.7/*!S&E,*5M@-Z4!B.C`6M@:H+S[WU@V`^G>=O5HFL7VH%T.W# M.SY$87\Q5P8SA-UXU2T#4LAH&;^FU`)^`R`$A17$6.0R.%UXS&V8TZ9^J[7T M&8!'8;HPEN4NB`Z5*N,;XI2"E34#CE"$AAD+6@VJ0Z;)NF$EQX9V&VOP5*<)G@]-2!#\-6H30TDF5:_T!FBW=G=A\74ZT6LK9`&2[S MG/Y"H(95N\0:H@19&>1B(E14@Z(Q$(;"DF=/#\JX:M=CVU2$)^=QC[*W!I>Y MB"3/OR!1JJIR;=Z9=]Q#80ZHH"T5<-IZL0W';4/RG*DMS9'U!I2BL#Y841TU M4!R5YK@5`H<)?04.AJ$?Y$3(7^]3M`#R4#@(],2J!<96`;C]BDYX%M!J!TJ+ MPK1O18QE2%TJ];:.34Z?8H&#:_%T9;%D2;U^AGUY%VW2D)HP;15/:V`)6!=Z MNXM6Y4TI22_?^58/T9)@W`_,)Q169?TEHB+$+M54VZXAN$RG8.4#KUF]>68T M8]4'14:S?RNL;I*5Q-9/`/DM-$W:15^[&APBPX7(TUX]$X=KZRV<@Q4RJAH9 M!X@1EU=&2XD=4%2[AAV:5%33LI7'O1::W+?';ZMP'88]LC6NNUY;+;66L-LJ MHE&XBQX;]>HZ[7AO=-WP8MHKF\>2*(P&)E=B"[V_#^$?J./%H-0ZS?*.= M9M[QT:&[%;M:FM'Q$2[OA9!610!-"4VGLHMJU<Z\43C^7 M[]_A3',7K5Z\Z\/U_Y5F^7OANV^8:)PI[/P`$([66'@D//_:Q&XI>PG#!=S8 M@G*$PH)B4YIJJ\N1T.K2PG+3&VZY!P(W_H"&9*-@W5.L2:[&FM/$SX%$4-S` MF]?"YMCK4%&M:P)C#FC.*OPY)`LK>7_*K%Q_JP*J=)H#9R@,@,WI`U__]+GI M4%J8U?=W49RO]ZTV&W;_W1 MIJ9V_AHBI_WU8L#F;RXJ6GK'QRC"Q_:_>6G08BLG#MB$U=%'?+: M>!L' M03P'ZH%X0E\5<3$ZS8$T%"XV4S'K*HL(<>WT/]0KT3`A,Y^.EM?2Q1K,I34;4.@5@4'KNF5$F?@]KIB*B5:TG`XB55]A(D[`BP]B?]T:L?!;"N1\!2 M?FXTTS*CGH%J%$>LIM2M`ADX$AJ;WON&_CM;QYEO*`B2.6"B_C,-\Q-%I=U0 MUB$0B\(=U_3^J.:@2PF3]=SIC<4]`=$HG##-1QO8X*EV&B6:YY$$;!3^S`;# M\0Q_P#L^0>'=L1*.5PF[K7Q&#&L@K/C+B@G!/^AZ$?9;`1L$2N MV52>=JO?"1"(PI9J4QT$\7R&G-3.LD1T6]C!_M5/_B)YUM\C">:)ZI"FU1YH M0^',<:!*8CIJITUBTJ(D#@@9I45YA9S-;)X0%N%39(K>11L)>*6J'_+8XJJ] M`L4H$E/VH'%U2;*5YHEABZQ'=V/G,2`:A2N@>6VTP9-`($VYIY$=! M@]<$PQ\`VE&X%*Q<$RIA%ZA<*T/>'\AL<0@9C._C:/)$DNDU>9:ID:@)D(/" M06!3U'QEDC,@4(]6N@=X2!<&R7MF81P\AW2BW`\->@$*49C]W2B1E!2!7NF; M_Q'I5?D!'GLK70!+*_6 MMW&R<>:TT\1> MFBQK^_"R0FT>\/^B+.>KWPFLVJBM30TM0UJD"-3*N!8,A@6I#+Z&,G'9.C[% M[/IK2(/$3`C4II4F\M+!;_U2$RR^TM=&]!L#89@=+\V^& M?Q'=?OC#^(:_W0&P]Q-N8RH^!-ID;*EV7R&A'J^-.46`9A3.D.;5S@9/`G4T MKNWBWE=W,QZ3(!N,;]Y@(8\FY`'FWB!B!+%`;O@_%@3TZH=LR3=4R+I=`]4H MW#!F_CD[J`4*ULH(>3[VXNFZ[4!OB3J9=`,DHG"^F*F..4)!C4]C0[?[=8B/ MO0]+=9*\PP11/3&LU1Y(0^$UL:$67&@"?6CM<^+[T@H4]NMFM$)HCSZI^!2Y M\Y=9*43[JEKZ145$D89'+,NI)=*I" M;T`H"E.;'<40&-FJTB+0,V-#KXU=B_OB\2HI[H&$E+PRT^&B'JNLPJUF2^`` MA%@,+HF4]F]!2OZDOJ+PJ: MS8$'%,%IC2T)1CP(]&'/ADNN/JQ?]ZBC%H:]`"LH+)E-:49R%Z)YP02-VTNKL[;<0 M87X44'9WTOHPNO!^;*%??O[ZJ[?_\#STCC#"L20!&C^AO MLW>$X&+_T+N.[KV#_>GAXV`O`@M06 M]OQHACQ/U2/\*9EA)#&_(_(:SXB88Y^M/Z*<4@GE`0M!$XR<8QG8IL=+;@B]'"X%_$[$-GOM'^[ MNAQJ>)G%D+)/*]*/8QYF\H=M53S&@F3BJC20"X6\\.MV4K@0#1UV?[L$PWFC MU"%,F9"8^4L0&Z!3%SM'1T=M79J)QL*[PWB^$)Y@,=:B:8%N.&^_XQUV,A4_ MBIGD3ZL^"N+OW47W[;10J1VNJ<6<0[^SZ:6E2O'5JF)`J%D'"@SBY-&?FN55 MB<$?RNZ)D&:5I,S@#YR%F6$;\Z0+N%PT2,1;/S$8" MR=L*<1N$/)`BG/H+O>U*J0*$#H3>8L8BB"D0B_2]>C*?4S:)TEMXH/KWL0(\ M`G6D+C[<]LUA0;MU'OFQ"BU=%O28I/*I#^;X3%?20A1:QBFQJ#BK.B`3RJB& MV-GO0"3,U/.78`HEME#.V-OVNH6OOUHW'PL2#-C/^AK($V!-ZZJ(D>JG(F[= M925E-7T<^G%HK315:Z_PD#-9FJ"SB`6$@7FX$%%(`]5?3W&H8MYP2H@4"4T% MY-QD'0!#0VA-DK)U-K@^[UT/>^?J:CBX[)]W1W!SVKWL7I_UT/!]KS<:-IQ5 MX^P&0\274R(I8"M*X*J2F\W#*FRBWU>J^*-AMS"[B[86@\E@KI:1`,^]!KO]K#_6OX;[7<%V>Z\%D.(4`.(W"`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`@M_^;"1*"CW$W8QJ'&Y=LX[BBT;V[6)Q7> M?YC&6S%1-X4;1Q_V=R/-,'S6\WL3H]54G0P?;AR15#G;_[_F7OU1R\!;,D$Z M5^M8I<&XRS,)%0%CJ0QW7G6FRFM M-S.1)OZX4\G`2#0G7"UMVAGV%FH_GU_`1UF_5BFLI5'P5T^>TP_`J\B+A$SIJ':TBR3#-;+R->F'"KJSLOT//7( MZQQXAYV]1Q$L&[\,B*6/Y4!D>A5`F)-8"U:?*:AZ7Q>MT9F%:JE85VI4;)-0 MBNR)MS15RG]'1J@+D$$MO?:6)BH!,67:%D&2U\MN=L9BRMXM!":ON+CSEF8J MP=E(]"T"9:&DKW;M)IM)P$4P++622V]IH!**]%`&1* M^JH"A,T$9CW9,'*GTAF*1:Z0\Q4M%;Z.5-CLO-D91L'@F8,@GZ5Z=QIW44AY M*[VED0H(GC>)Y50L%\LF^&9>^?Q4!: M/!SBD`PFO0.93\E,*QT$TPY1]4:=LN"QNU,^!PM#/J5J# M@4$.#@_!.`THYD]@6@C5"OI4<;63S2((Q"!C"2H%=%Z5Z0>`?%5?G]WPZ(X3(;2=9W`_V?K(K=X'9%S&^8+P M+=[WH4H8LO?IF$:L%K\N*1[34+\1_+N<*QES[(@M+MX2-3'[L'Q6 M><-JM,(_]3[T'B(4DV+Q5JBVA);PP-(&9^IL:D+53RR)P22-7%U9?]>W`[=J,M[JGO_VL).Z&?/Y.WN;F40K8NW MY6<["]9A1CI]NHZ8'S')HS!4HX])`G;DY%7RQ[<1@2IJK^UL24G)/ M@O[?.IK+S32%P%L<'T"O6X"[R,ZM0E^D[V6< ML+3#-9')5X4OL@$*H;>M+?TI"6(MK*:)T_5/C$J2^^ M0`OD\10TN1^/27]U!5K=AV=L%?7-H\*UOACX\DO7'=%7;)/ESD[;_\#4>=(# MYL%+[39%';+%5I_">"3*ZBB"(9HDSK^HN;2P![:PNOP<3I\LVK^(J\VVKPKD MG;U7W^2=AKE]4[J;E]GS+[N7J`1\]T:H67@HC=S1`F`@-;6A7)=CG((PMVXB M7WC,*^V(I4$^:#LD,$TB=:&\"$9KIX;I<1*S0%6;O3VJ[W6A4X/WV:I1)F MB_\74^C'AMXKH1E/5%S,8/>-2'*3&U>^JV`48#?MI-OV33V_P%02P$"'@,4````"`#U@6Q'Z=U$D&U[ M``"_O0@`$``8```````!````I($`````86US+3(P,34P.3,P+GAM;%54!0`# M?0%%5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/6!;$=Q[&0`HPP``#G$ M```4`!@```````$```"D@;=[``!A;7,M,C`Q-3`Y,S!?8V%L+GAM;%54!0`# M?0%%5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/6!;$=7?4;>'"T``"K< M`@`4`!@```````$```"D@:B(``!A;7,M,C`Q-3`Y,S!?9&5F+GAM;%54!0`# M?0%%5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/6!;$?`U/.*R4H``/,N M!``4`!@```````$```"D@1*V``!A;7,M,C`Q-3`Y,S!?;&%B+GAM;%54!0`# M?0%%5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/6!;$`Q0````(`/6!;$<\Y69IT0H``")K M```0`!@```````$```"D@:TS`0!A;7,M,C`Q-3`Y,S`N>'-D550%``-]`456 E=7@+``$$)0X```0Y`0``4$L%!@`````&``8`%`(``,@^`0`````` ` end XML 43 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-based Compensation
9 Months Ended
Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 3.
Stock-based Compensation
 
On June 2, 2010, the Company’s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the “2006 Plan”). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the “Plan”) and increased the number of shares of the Company’s common stock reserved for issuance under the Plan by an additional 880,000 shares from 750,000 shares to 1,630,000 shares. The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors. The Plan serves as successor to the Company’s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans. The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans. On June 16, 2015, the Company’s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years.
 
Stock-based compensation expense associated with the Company’s stock-based awards to employees is calculated using the Black-Scholes valuation model. The Company’s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates. The estimated fair value of the Company’s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award. The estimated fair value of the Company’s options is amortized over the period during which an employee is required to provide service in exchange for the award (requisite service period), usually the vesting period. Accordingly, stock-based compensation cost before income tax effect in the amount of $58,000 and $152,000 is reflected in net income for the three and nine month periods ended September 30, 2015, compared to $7,000 and $53,000 in the same periods in the prior year, respectively.
 
  The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the nine month period ended September 30, 2015:
 
 
 
Restricted
Stock
Awards/Units
 
Grant Date
Weighted-
Average Fair
Value
 
Intrinsic
Value
 
Outstanding at January 1, 2015
 
 
3,000
 
$
2.43
 
$
-
 
Granted
 
 
31,000
 
$
2.87
 
$
-
 
Vested
 
 
(24,000)
 
$
2.84
 
$
-
 
Forfeited
 
 
-
 
$
-
 
$
-
 
Outstanding at September 30, 2015
 
 
10,000
 
$
2.80
 
$
-
 
 
The following table summarizes stock option activity for the nine month period ended September 30, 2015:
 
 
 
Stock
Options
 
Grant Date
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Life (in
Years)
 
Outstanding at January 1, 2015
 
 
659,000
 
$
3.13
 
 
5.57
 
Granted
 
 
20,000
 
$
2.48
 
 
-
 
Exercised
 
 
(2,000)
 
$
2.30
 
 
-
 
Forfeited
 
 
(55,000)
 
$
5.97
 
 
-
 
Outstanding at September 30, 2015
 
 
622,000
 
$
2.86
 
 
5.36
 
Exercisable at September 30, 2015
 
 
82,000
 
$
2.74
 
 
3.20
 
XML 44 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Line of Credit (Details Textual) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Line of Credit Facility [Line Items]    
Line of Credit Facility, Maximum Amount Outstanding   $ 9,000,000
Debt Instrument, Interest Rate Terms the banks prime rate minus 0.5 percentage point, or alternatively at the Companys discretion, the LIBOR rate plus 1.0 percentage point.  
Debt, Weighted Average Interest Rate 1.40%  
Line of Credit, Current $ 0 $ 8,780,000
Line of Credit Facility, Expiration Date Dec. 31, 2014  
XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 74 198 1 false 25 0 false 5 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.ashs.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.ashs.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.ashs.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Statements 3 false false R4.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 106 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY Sheet http://www.ashs.com/role/CondensedConsolidatedStatementOfShareholdersEquity CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY Statements 6 false false R7.htm 107 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 108 - Disclosure - Basis of Presentation Sheet http://www.ashs.com/role/BasisOfPresentation Basis of Presentation Notes 8 false false R9.htm 109 - Disclosure - Per Share Amounts Sheet http://www.ashs.com/role/PerShareAmounts Per Share Amounts Notes 9 false false R10.htm 110 - Disclosure - Stock-based Compensation Sheet http://www.ashs.com/role/StockbasedCompensation Stock-based Compensation Notes 10 false false R11.htm 111 - Disclosure - Investment in Equity Securities Sheet http://www.ashs.com/role/InvestmentInEquitySecurities Investment in Equity Securities Notes 11 false false R12.htm 112 - Disclosure - Line of Credit Sheet http://www.ashs.com/role/LineOfCredit Line of Credit Notes 12 false false R13.htm 113 - Disclosure - Fair Value of Financial Instruments Sheet http://www.ashs.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 13 false false R14.htm 114 - Disclosure - Repurchase of Common Stock Sheet http://www.ashs.com/role/RepurchaseOfCommonStock Repurchase of Common Stock Notes 14 false false R15.htm 115 - Disclosure - Income Taxes Sheet http://www.ashs.com/role/IncomeTaxes Income Taxes Notes 15 false false R16.htm 116 - Disclosure - Note, Warrant, & Common Stock Purchase Agreement Sheet http://www.ashs.com/role/NoteWarrantCommonStockPurchaseAgreement Note, Warrant, & Common Stock Purchase Agreement Notes 16 false false R17.htm 117 - Disclosure - Per Share Amounts (Tables) Sheet http://www.ashs.com/role/PerShareAmountsTables Per Share Amounts (Tables) Tables http://www.ashs.com/role/PerShareAmounts 17 false false R18.htm 118 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.ashs.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) Tables http://www.ashs.com/role/StockbasedCompensation 18 false false R19.htm 119 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.ashs.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.ashs.com/role/FairValueOfFinancialInstruments 19 false false R20.htm 120 - Disclosure - Basis of Presentation (Details Textual) Sheet http://www.ashs.com/role/BasisOfPresentationDetailsTextual Basis of Presentation (Details Textual) Details http://www.ashs.com/role/BasisOfPresentation 20 false false R21.htm 121 - Disclosure - Per Share Amounts (Details) Sheet http://www.ashs.com/role/PerShareAmountsDetails Per Share Amounts (Details) Details http://www.ashs.com/role/PerShareAmountsTables 21 false false R22.htm 122 - Disclosure - Per Share Amounts (Details Textual) Sheet http://www.ashs.com/role/PerShareAmountsDetailsTextual Per Share Amounts (Details Textual) Details http://www.ashs.com/role/PerShareAmountsTables 22 false false R23.htm 123 - Disclosure - Stock-based Compensation (Details) Sheet http://www.ashs.com/role/StockbasedCompensationDetails Stock-based Compensation (Details) Details http://www.ashs.com/role/StockbasedCompensationTables 23 false false R24.htm 124 - Disclosure - Stock-based Compensation (Details 1) Sheet http://www.ashs.com/role/StockbasedCompensationDetails1 Stock-based Compensation (Details 1) Details http://www.ashs.com/role/StockbasedCompensationTables 24 false false R25.htm 125 - Disclosure - Stock-based Compensation (Details Textual) Sheet http://www.ashs.com/role/StockbasedCompensationDetailsTextual Stock-based Compensation (Details Textual) Details http://www.ashs.com/role/StockbasedCompensationTables 25 false false R26.htm 126 - Disclosure - Investment in Equity Securities (Details Textual) Sheet http://www.ashs.com/role/InvestmentInEquitySecuritiesDetailsTextual Investment in Equity Securities (Details Textual) Details http://www.ashs.com/role/InvestmentInEquitySecurities 26 false false R27.htm 127 - Disclosure - Line of Credit (Details Textual) Sheet http://www.ashs.com/role/LineOfCreditDetailsTextual Line of Credit (Details Textual) Details http://www.ashs.com/role/LineOfCredit 27 false false R28.htm 128 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.ashs.com/role/FairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) Details http://www.ashs.com/role/FairValueOfFinancialInstrumentsTables 28 false false R29.htm 129 - Disclosure - Repurchase of Common Stock (Details Textual) Sheet http://www.ashs.com/role/RepurchaseOfCommonStockDetailsTextual Repurchase of Common Stock (Details Textual) Details http://www.ashs.com/role/RepurchaseOfCommonStock 29 false false R30.htm 130 - Disclosure - Note, Warrant, & Common Stock Purchase Agreement (Details Textual) Sheet http://www.ashs.com/role/NoteWarrantCommonStockPurchaseAgreementDetailsTextual Note, Warrant, & Common Stock Purchase Agreement (Details Textual) Details http://www.ashs.com/role/NoteWarrantCommonStockPurchaseAgreement 30 false false All Reports Book All Reports In ''CONDENSED CONSOLIDATED BALANCE SHEETS'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS'', column(s) 9 are contained in other reports, so were removed by flow through suppression. In ''CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS'', column(s) 1, 2, 5 are contained in other reports, so were removed by flow through suppression. ams-20150930.xml ams-20150930_cal.xml ams-20150930_def.xml ams-20150930_lab.xml ams-20150930_pre.xml ams-20150930.xsd true true XML 46 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814
Basis of Presentation (Details Textual)
€ in Millions
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May. 31, 2014
USD ($)
May. 31, 2014
EUR (€)
Sep. 30, 2015
USD ($)
Jun. 30, 2015
USD ($)
Sep. 30, 2014
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2014
USD ($)
Dec. 31, 2014
USD ($)
Aug. 04, 2015
Basis Of Presentation [Line Items]                  
Equity Method Investment, Ownership Percentage                 0.56%
Foreign Currency Transaction Gain, before Tax             $ 161,000    
Proceeds from Divestiture of Interest in Consolidated Subsidiaries           $ 0 768,000    
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total               $ 779,000  
Other than Temporary Impairment Losses, Investments     $ 0   $ 0 2,114,000 $ 0    
Mevion Medical Systems Inc [Member]                  
Basis Of Presentation [Line Items]                  
Investments, Fair Value Disclosure, Total     600,000 $ 600,000   600,000      
Other than Temporary Impairment Losses, Investments     $ 2,114,000 $ 2,114,000   $ 2,114,000      
EWRS Turkey [Member]                  
Basis Of Presentation [Line Items]                  
Equity Method Investment, Ownership Percentage     100.00%     100.00%      
Sale of EWRS Turkey [Member]                  
Basis Of Presentation [Line Items]                  
Proceeds from Divestiture of Interest in Consolidated Subsidiaries           $ 768,000      
Divestiture of Subsidiary, Gross Sale value $ 6,000,000 € 4.2              
Loss from Subsidiaries, Net of Tax           $ 572,000